{"data":{"filter_options":{"titles":[{"name":"Managing Partner Atlanta Office","value":"Managing Partner Atlanta Office"},{"name":"Partner","value":"Partner"},{"name":"Partner / Head of Pro Bono","value":"Partner / Head of Pro Bono"},{"name":"Partner / Chief Operating Officer","value":"Partner / Chief Operating Officer"},{"name":"Partner / General Counsel","value":"Partner / General Counsel"},{"name":"Partner / Dir. E-Discovery Ops","value":"Partner / Dir. E-Discovery Ops"},{"name":"Partner / Chairman, Saudi Arabia Practice","value":"Partner / Chairman, Saudi Arabia Practice"},{"name":"K\u0026S Talent Partner","value":"K\u0026S Talent Partner"},{"name":"Partner / Chief Human Resources Officer","value":"Partner / Chief Human Resources Officer"},{"name":"Chairman","value":"Chairman"},{"name":"Senior Counsel","value":"Senior Counsel"},{"name":"Associate Director, E-Discovery Operations","value":"Associate Director, E-Discovery Operations"},{"name":"Counsel","value":"Counsel"},{"name":"Senior Associate","value":"Senior Associate"},{"name":"Associate","value":"Associate"},{"name":"Senior Attorney","value":"Senior Attorney"},{"name":"Senior Lawyer","value":"Senior Lawyer"},{"name":"Attorney","value":"Attorney"},{"name":"Senior Counsel and Policy Advisor","value":"Senior Counsel and Policy Advisor"},{"name":"Managing Director - Capital Solutions","value":"Managing Director - Capital Solutions"},{"name":"Senior Government Relations Advisor","value":"Senior Government Relations Advisor"},{"name":"Associate General Counsel","value":"Associate General Counsel"},{"name":"Senior Advisor","value":"Senior Advisor"},{"name":"Patent Agent","value":"Patent Agent"},{"name":"Consultant","value":"Consultant"},{"name":"Government Relations Advisor","value":"Government Relations Advisor"},{"name":"Chief of Lateral Partner Recruiting \u0026 Integration","value":"Chief of Lateral Partner Recruiting \u0026 Integration"},{"name":"Chief Financial Officer","value":"Chief Financial Officer"},{"name":"Chief Information Officer","value":"Chief Information Officer"},{"name":"Chief Revenue Officer","value":"Chief Revenue Officer"},{"name":"Chief Recruiting Officer","value":"Chief Recruiting Officer"},{"name":"Chief Lawyer Talent Development Officer","value":"Chief Lawyer Talent Development Officer"},{"name":"Chief Marketing Officer","value":"Chief Marketing Officer"},{"name":"Tax Consultant","value":"Tax Consultant"},{"name":"Director of Community Affairs","value":"Director of Community Affairs"},{"name":"Director of Facilities \u0026 Admin Operations","value":"Director of Facilities \u0026 Admin Operations"},{"name":"Senior Office Manager","value":"Senior Office Manager"},{"name":"Director of Operations","value":"Director of Operations"},{"name":"Pro Bono Deputy","value":"Pro Bono Deputy"},{"name":"Director of Office Operations","value":"Director of Office Operations"},{"name":"Director of Operations Europe","value":"Director of Operations Europe"},{"name":"Law Clerk","value":"Law Clerk"},{"name":"Deputy General Counsel","value":"Deputy General Counsel"}],"schools":[{"name":"(Commercial Law), in front of Monash University, Australia","value":3045},{"name":"Aberystwyth University","value":3004},{"name":"Albany Law School","value":2118},{"name":"American University Washington College of Law","value":3042},{"name":"American University, Washington College of Law","value":3024},{"name":"Appalachian School of Law","value":2891},{"name":"Ateneo de Manila University","value":2914},{"name":"Ave Maria School of Law","value":2892},{"name":"Baylor University School of Law","value":181},{"name":"Benjamin N. Cardozo School of Law","value":2619},{"name":"Binghamton University","value":3002},{"name":"Boston College Law School","value":245},{"name":"Boston University School of Law","value":247},{"name":"BPP Law School Leeds","value":2642},{"name":"BPP Law School London","value":2782},{"name":"BPP University","value":2984},{"name":"Brooklyn Law School","value":2705},{"name":"Cairo University, Law School","value":2962},{"name":"California Western School of Law","value":315},{"name":"Capital University Law School","value":327},{"name":"Case Western Reserve University School of Law","value":345},{"name":"Cecil C. Humphreys School of Law","value":2235},{"name":"Chapman University School of Law","value":377},{"name":"Charleston School of Law","value":2910},{"name":"City Law School, London","value":2998},{"name":"City Law School","value":2857},{"name":"Clark University","value":3006},{"name":"Cleveland-Marshall College of Law","value":426},{"name":"Columbia University School of International and Public Affairs","value":3008},{"name":"Columbia University School of Law","value":485},{"name":"Columbia University","value":3126},{"name":"Columbus School of Law, Catholic University of America","value":3010},{"name":"Columbus School of Law","value":350},{"name":"Concord Law School of Kaplan University","value":1026},{"name":"Cornell Law School","value":512},{"name":"Creighton University School of Law","value":518},{"name":"Creighton University","value":3025},{"name":"Cumberland School of Law","value":1759},{"name":"CUNY School of Law","value":2893},{"name":"David A. Clarke School of Law","value":2399},{"name":"Deakin University School of Law","value":2907},{"name":"DePaul University College of Law","value":565},{"name":"DePaul University College of Law","value":3060},{"name":"Dickinson School of Law","value":2719},{"name":"Drake University Law School","value":609},{"name":"Duke University School of Law","value":613},{"name":"Duquesne University School of Law","value":614},{"name":"Dwayne O. Andreas School of Law","value":173},{"name":"Edinburgh Law School","value":3160},{"name":"Emory University School of Law","value":659},{"name":"ESADE Business and Law School – Universidad Ramon Llull","value":3215},{"name":"Fachseminare von Fürstenberg","value":2918},{"name":"Faculté Libre de Droit, Université Catholique de Lille","value":3055},{"name":"Faculty of Law, University of Zagreb","value":2983},{"name":"Faculty of Law","value":2944},{"name":"Faculty of Law","value":3039},{"name":"Federal University of Rio de Janeiro","value":3022},{"name":"Federal University of Rio Grande do Sul School of Law (Brazil)","value":3062},{"name":"Florida A\u0026M University College of Law","value":699},{"name":"Florida Coastal School of Law","value":2894},{"name":"Florida International College of Law","value":707},{"name":"Florida State University College of Law","value":720},{"name":"Fordham University School of Law","value":722},{"name":"Franklin Pierce Law Center","value":734},{"name":"Friedrich-Schiller-Universität Jena","value":3015},{"name":"George Mason University School of Law","value":752},{"name":"George Washington University Law School","value":753},{"name":"Georgetown University Law Center","value":755},{"name":"Georgia State University College of Law","value":761},{"name":"Ghent Law School","value":2793},{"name":"Golden Gate University School of Law","value":770},{"name":"Gonzaga University School of Law","value":772},{"name":"Graduate Institute of International and Development Studies, Geneva","value":2997},{"name":"Hamline University School of Law","value":811},{"name":"Harvard Law School","value":824},{"name":"Hebrew University of Jerusalem Faculty of Law","value":2994},{"name":"Hofstra University School of Law","value":858},{"name":"Howard University School of Law","value":872},{"name":"Huazhong University of Science and Technology","value":3016},{"name":"Humboldt University of Berlin","value":3012},{"name":"Indiana University School of Law","value":2711},{"name":"Indiana University School of Law","value":890},{"name":"International Association of Privacy Professionals","value":3009},{"name":"J. Reuben Clark Law School","value":262},{"name":"Jacob D. Fuchsberg Law Center","value":2084},{"name":"James Cook University of North Queensland","value":3034},{"name":"Jean Moulin University Lyon 3, France","value":2938},{"name":"Johns Hopkins Bloomberg School of Public Health","value":2992},{"name":"Justus-Liebig-Universität Gießen Rechtswissenschaft (Germany)","value":3063},{"name":"Kansas City School of Law","value":2247},{"name":"Keio University","value":2968},{"name":"Kent College of Law","value":883},{"name":"Kline School of Law","value":611},{"name":"KU Leuven","value":3007},{"name":"Levin College of Law","value":2189},{"name":"Lewis and Clark Law School","value":1089},{"name":"Liberty University School of Law","value":1094},{"name":"Lincoln College of Law","value":2253},{"name":"LL.M. in International Crime and Justice UNICRI","value":2937},{"name":"Loyola Law School","value":2895},{"name":"Loyola University Chicago School of Law","value":1135},{"name":"Loyola University New Orleans College of Law","value":1136},{"name":"Marquette University Law School","value":1176},{"name":"McGeorge School of Law","value":2402},{"name":"McGill University","value":2659},{"name":"Melbourne Law School","value":2899},{"name":"Mercer University Walter F. George School of Law","value":1221},{"name":"Mexico Autonomous Institute of Technology","value":2996},{"name":"Michael E. Moritz College of Law","value":2728},{"name":"Michigan State University College of Law","value":1245},{"name":"Mississippi College School of Law","value":1285},{"name":"Moscow State University","value":2815},{"name":"National and Kapodistrian University of Athens","value":3032},{"name":"National Law University Jodhpur","value":3020},{"name":"National University of Singapore, Faculty of Law","value":2662},{"name":"New England School of Law","value":2886},{"name":"New York Law School","value":1403},{"name":"New York University School of Law","value":1406},{"name":"Norman Adrian Wiggins School of Law","value":323},{"name":"North Carolina Central University School of Law","value":1417},{"name":"Northeastern University School of Law","value":1430},{"name":"Northern Illinois University College of Law","value":1432},{"name":"Northwestern Pritzker School of Law","value":1451},{"name":"Notre Dame Law School","value":2278},{"name":"Ohio Northern University Law School","value":3036},{"name":"Oklahoma City University School of Law","value":1487},{"name":"Osgoode Hall Law School","value":3124},{"name":"Pace University School of Law","value":1516},{"name":"Panteion University","value":3033},{"name":"Paul M. Hebert Law Center","value":2713},{"name":"Pennsylvania State University, Dickinson School of Law","value":1562},{"name":"Pepperdine University School of Law","value":1570},{"name":"Pettit College of Law","value":1473},{"name":"Pontificia Universidad Catolica de Chile","value":3203},{"name":"Pontificia Universidad Catolica del Peru","value":3011},{"name":"Pontificia Universidad Javeriana","value":3013},{"name":"Pontificia Universidade Catolica de Sao Paulo","value":3095},{"name":"Prince Sultan University College of Law","value":3167},{"name":"Queens College, Cambridge","value":3003},{"name":"Quinnipiac University School of Law","value":1626},{"name":"Ralph R. Papitto School of Law","value":1686},{"name":"Regent University School of Law","value":1649},{"name":"Rice University","value":3043},{"name":"Ruprecht-Karls-Universität Heidelberg","value":3049},{"name":"Rutgers University School of Law-Newark","value":1699},{"name":"Rutgers University School of Law","value":1697},{"name":"S.J. Quinney College of Law","value":2408},{"name":"Saint Louis University School of Law","value":1732},{"name":"Salmon P. Chase College of Law","value":1433},{"name":"Sandra Day O'Connor College of Law","value":103},{"name":"Santa Clara University School of Law","value":1771},{"name":"Seattle University School of Law","value":1787},{"name":"Seton Hall University School of Law","value":1790},{"name":"Shepard Broad Law Center","value":1460},{"name":"South Texas College of Law","value":2721},{"name":"Southern Illinois University School of Law","value":1849},{"name":"Southern Methodist University Dedman School of Law","value":1852},{"name":"Southern University Law Center","value":1857},{"name":"Southwestern Law School","value":1876},{"name":"St. John's University School of Law","value":2724},{"name":"St. Mary's University School of Law","value":1896},{"name":"St. Thomas University School of Law","value":1746},{"name":"Stanford Law School","value":1904},{"name":"Stetson University College of Law","value":1910},{"name":"Sturm College of Law","value":2184},{"name":"Suffolk University Law School","value":1921},{"name":"Syracuse University College of Law","value":1956},{"name":"Temple University Beasley School of Law","value":1974},{"name":"Texas A\u0026M School of Law","value":1980},{"name":"Texas Tech University School of Law","value":1994},{"name":"Texas Wesleyan University School of Law","value":1996},{"name":"The College of Law Australia","value":3091},{"name":"The College of Law, London","value":2935},{"name":"The John Marshall Law School","value":2034},{"name":"The Judge Advocate General's Legal Center and School","value":2896},{"name":"The Ohio State University Moritz College of Law","value":2990},{"name":"The University of Akron School of Law","value":2143},{"name":"The University of Alabama School of Law","value":2045},{"name":"The University of Birmingham, U.K.","value":2796},{"name":"The University of Iowa College of Law","value":2206},{"name":"The University of Texas School of Law","value":2055},{"name":"The University of Tulsa College of Law","value":2407},{"name":"Thomas Jefferson School of Law","value":685},{"name":"Thomas M. Cooley Law School","value":2729},{"name":"Thurgood Marshall School of Law","value":1992},{"name":"Tianjin University of Commerce","value":2995},{"name":"Tulane University Law School","value":2113},{"name":"UC Davis School of Law","value":2160},{"name":"UCLA School of Law","value":2162},{"name":"Universidad Católica de Honduras","value":2916},{"name":"Universidad Francisco Marroquin","value":3090},{"name":"Universidad Panamericana","value":2904},{"name":"Universidad Torcuato di Tella","value":3035},{"name":"Universidade de São Paulo, Faculdade de Direito","value":3028},{"name":"Universidade Presbiteriana Mackenzie","value":2977},{"name":"Università Commerciale Luigi Bocconi","value":3135},{"name":"University at Buffalo Law School","value":1928},{"name":"University College Dublin Law School","value":2900},{"name":"University of Alberta Faculty of Law","value":3088},{"name":"University of Amsterdam","value":2980},{"name":"University of Arizona, James E. Rogers College of Law","value":2149},{"name":"University of Arkansas School of Law","value":2154},{"name":"University of Baltimore School of Law","value":2156},{"name":"University of California College of the Law","value":3196},{"name":"University of California Hastings College of Law","value":2158},{"name":"University of California Irvine School of Law","value":2161},{"name":"University of California, Berkeley, School of Law","value":2159},{"name":"University of California, Davis","value":3019},{"name":"University of Cambridge, U.K","value":2991},{"name":"University of Canterbury","value":2981},{"name":"University of Central Florida","value":3027},{"name":"University of Chester Law School","value":3005},{"name":"University of Chicago Law School","value":2174},{"name":"University of Chicago","value":3038},{"name":"University of Cincinnati College of Law","value":2175},{"name":"University of Colorado School of Law","value":2177},{"name":"University of Connecticut School of Law","value":2180},{"name":"University of Dayton School of Law","value":2182},{"name":"University of Detroit Mercy School of Law","value":2185},{"name":"University of East Anglia","value":3000},{"name":"University of Florida, Levin College of Law","value":3188},{"name":"University of Georgia School of Law","value":2190},{"name":"University of Houston Law Center","value":2197},{"name":"University of Hull","value":3040},{"name":"University of Idaho College of Law","value":2201},{"name":"University of Illinois College of Law","value":2204},{"name":"University of Kansas School of Law","value":2208},{"name":"University of Kentucky College of Law","value":2210},{"name":"University of La Verne College of Law","value":2211},{"name":"University of Law, London","value":2999},{"name":"University of Lethbridge","value":3030},{"name":"University of Louisville Brandeis School of Law","value":2214},{"name":"University of Maine School of Law","value":2391},{"name":"University of Maryland School of Law","value":2224},{"name":"University of Miami School of Law","value":2236},{"name":"University of Michigan Law School","value":2237},{"name":"University of Minnesota Law School","value":2243},{"name":"University of Mississippi School of Law","value":2244},{"name":"University of Missouri School of Law","value":2246},{"name":"University of Montana School of Law","value":2048},{"name":"University of Nebraska College of Law","value":2744},{"name":"University of New Mexico School of Law","value":2262},{"name":"University of North Carolina School of Law","value":2266},{"name":"University of North Dakota School of Law","value":2271},{"name":"University of Oklahoma Law Center","value":2747},{"name":"University of Oregon School of Law","value":2281},{"name":"University of Pennsylvania Law School","value":2282},{"name":"University of Pittsburgh School of Law","value":2354},{"name":"University of Richmond School of Law","value":2370},{"name":"University of San Diego School of Law","value":2377},{"name":"University of San Francisco School of Law","value":2378},{"name":"University of South Carolina School of Law","value":2750},{"name":"University of South Dakota School of Law","value":2387},{"name":"University of Southern California Gould School of Law","value":3051},{"name":"University of St. Thomas School of Law","value":2751},{"name":"University of Sydney Law School","value":3031},{"name":"University of Tennessee College of Law","value":2051},{"name":"University of the West of England, Bristol","value":3001},{"name":"University of Toledo College of Law","value":2406},{"name":"University of Toronto","value":2912},{"name":"University of Utah","value":3026},{"name":"University of Virginia School of Law","value":2410},{"name":"University of Washington School of Law","value":2412},{"name":"University of Wisconsin Law School","value":2419},{"name":"University of Wyoming College of Law","value":2429},{"name":"University of Zürich","value":3037},{"name":"University Paris Dauphine","value":2976},{"name":"University Paris II Assas","value":2975},{"name":"University Paris II Assas","value":3052},{"name":"USC Gould School of Law","value":2389},{"name":"Utrecht University","value":3085},{"name":"Valparaiso University School of Law","value":2441},{"name":"Vanderbilt University School of Law","value":2442},{"name":"Vermont Law School","value":2451},{"name":"Villanova University School of Law","value":2454},{"name":"Wake Forest University School of Law","value":2471},{"name":"Washburn University School of Law","value":2482},{"name":"Washington and Lee University School of Law","value":2484},{"name":"Washington College of Law","value":61},{"name":"Washington University in St. Louis School of Law","value":2489},{"name":"Wayne State University Law School","value":2493},{"name":"West Virginia University College of Law","value":2517},{"name":"Western New England College School of Law","value":2528},{"name":"Western State College of Law","value":2897},{"name":"Wharton School of Business","value":3044},{"name":"Whittier Law School","value":2564},{"name":"Widener University Delaware Law School","value":2569},{"name":"Willamette University College of Law","value":2573},{"name":"William \u0026 Mary Law School","value":462},{"name":"William H. Bowen School of Law","value":2150},{"name":"William Mitchell College of Law","value":2758},{"name":"William S. Boyd School of Law","value":2256},{"name":"William S. Richardson School of Law","value":2195},{"name":"Wilmington University","value":2993},{"name":"Yale Law School","value":2605}],"offices":[{"name":"Abu Dhabi","value":13},{"name":"Atlanta","value":1},{"name":"Austin","value":12},{"name":"Brussels","value":23},{"name":"Charlotte","value":8},{"name":"Chicago","value":21},{"name":"Dallas","value":28},{"name":"Denver","value":22},{"name":"Dubai","value":6},{"name":"Frankfurt","value":9},{"name":"Geneva","value":15},{"name":"Houston","value":4},{"name":"London","value":5},{"name":"Los Angeles","value":19},{"name":"Miami","value":25},{"name":"New York","value":3},{"name":"Northern Virginia","value":24},{"name":"Paris","value":14},{"name":"Riyadh","value":27},{"name":"Sacramento","value":20},{"name":"San Francisco","value":10},{"name":"Silicon Valley","value":11},{"name":"Singapore","value":16},{"name":"Sydney","value":26},{"name":"Tokyo","value":18},{"name":"Washington, D.C.","value":2}],"capabilities":[{"name":"Corporate, Finance and Investments","value":"cg-1"},{"name":null,"value":72},{"name":null,"value":26},{"name":null,"value":40},{"name":null,"value":27},{"name":null,"value":80},{"name":null,"value":28},{"name":null,"value":35},{"name":null,"value":10},{"name":null,"value":134},{"name":null,"value":121},{"name":null,"value":78},{"name":null,"value":29},{"name":null,"value":32},{"name":null,"value":31},{"name":null,"value":33},{"name":null,"value":126},{"name":"Real Estate","value":36},{"name":null,"value":82},{"name":null,"value":37},{"name":null,"value":115},{"name":"Government Matters","value":"cg-2"},{"name":null,"value":1},{"name":null,"value":6},{"name":null,"value":71},{"name":null,"value":21},{"name":null,"value":23},{"name":null,"value":116},{"name":null,"value":24},{"name":null,"value":135},{"name":null,"value":25},{"name":null,"value":110},{"name":null,"value":20},{"name":null,"value":11},{"name":"Trial and Global Disputes","value":"cg-3"},{"name":null,"value":129},{"name":null,"value":2},{"name":null,"value":38},{"name":null,"value":3},{"name":null,"value":5},{"name":null,"value":19},{"name":null,"value":7},{"name":null,"value":4},{"name":null,"value":136},{"name":null,"value":13},{"name":null,"value":14},{"name":null,"value":15},{"name":null,"value":17},{"name":null,"value":18},{"name":null,"value":16},{"name":"Industries / Issues","value":"cg-4"},{"name":null,"value":133},{"name":null,"value":106},{"name":null,"value":124},{"name":null,"value":111},{"name":null,"value":132},{"name":null,"value":131},{"name":null,"value":102},{"name":null,"value":125},{"name":null,"value":127},{"name":null,"value":107},{"name":null,"value":112},{"name":null,"value":105},{"name":null,"value":109},{"name":null,"value":103},{"name":null,"value":128},{"name":null,"value":123},{"name":null,"value":118}]},"title_id":null,"school_id":null,"office_id":null,"capability_id":"24","extra_filter_id":null,"extra_filter_type":null,"q":null,"starts_with":"S","per_page":12,"people":[{"id":426539,"version":1,"owner_type":"Person","owner_id":4092,"payload":{"bio":"\u003cp\u003eKyle Sampson focuses on Food and Drug Administration regulatory, compliance and enforcement issues. As a partner in our FDA and Life Sciences practice, Kyle represents companies in the full range of regulatory and enforcement issues.\u003c/p\u003e\n\u003cp\u003e[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eKyle advises food, drug, biologics, medical device, cosmetics and dietary supplement companies on FDA compliance, regulatory and enforcement matters. His practice also includes strategic advice and compliance counseling, enforcement, litigation and transactional matters.\u003c/p\u003e\n\u003cp\u003eKyle has engaged in extensive public service in every branch of the federal government. He served in the White House as Associate Counsel to the President; at the Department of Justice as a Special Assistant U.S. Attorney and as Counselor and Chief of Staff to two attorneys general; and in the U.S. Senate as Counsel to the Senate Judiciary Committee.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e","slug":"kyle-sampson","email":"ksampson@kslaw.com","phone":"+1 202 340 8202","matters":["\u003cp\u003eAssist \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e in developing and implementing comprehensive regulatory and healthcare fraud and abuse compliance programs involving off-label promotion, anti-kickback violations, federal healthcare program reimbursement, and pricing and false claims actions.\u003c/p\u003e","\u003cp\u003eServe as counsel to \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical, biotechnology and medical device companies\u003c/strong\u003e in regulatory matters involving product development and commercialization.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device manufacturers\u003c/strong\u003e in responding to FDA enforcement actions, including Form FDA-483 observations and Warning Letters.\u003c/p\u003e","\u003cp\u003eServe as compliance counsel for \u003cstrong data-redactor-tag=\"strong\"\u003ea\u003c/strong\u003e \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical company\u003c/strong\u003e subject to consent decree resulting from allegation that company provided false scientific data to FDA in regulatory submissions.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003ea medical device manufacturer\u003c/strong\u003e in consent decree negotiations with FDA and Department of Justice.\u003c/p\u003e","\u003cp\u003eWith Monitor appointed by U.S. Attorney\u0026rsquo;s Office for the District of New Jersey under Deferred Prosecution Agreement (DPA), oversaw \u003cstrong data-redactor-tag=\"strong\"\u003eorthopedic device manufacturer\u003c/strong\u003e's compliance with federal Anti-Kickback Statute and other federal healthcare laws and its implementation of comprehensive compliance program.\u003c/p\u003e","\u003cp\u003eReview advertising and promotional materials and activities for prescription drugs, biologics and devices for \u003cstrong data-redactor-tag=\"strong\"\u003evarious clients.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eProvide advice to \u003cstrong data-redactor-tag=\"strong\"\u003emanufacturers\u003c/strong\u003e \u003cstrong data-redactor-tag=\"strong\"\u003eof controlled substances and listed chemicals\u003c/strong\u003e regarding compliance with the Controlled Substances Act and Drug Enforcement Administration regulations.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003emanufacturers of drug, medical device, human food, animal feed and consumer products\u003c/strong\u003e in negotiations with the FDA over recalls of manufacturers\u0026rsquo; products, including proper classification of recall, assessment of health hazard, and development and implementation of recall strategy.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003eforeign manufacturers and domestic importers\u003c/strong\u003e in responding to the FDA\u0026rsquo;s detention of imports and placement of firms on Import Alert, including negotiating firms\u0026rsquo; removal from Detention Without Physical Examination (DWPE).\u003c/p\u003e","\u003cp\u003eHelp \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e respond to widespread counterfeiting of products and unlawful importation by Internet pharmacies and others in violation of the Federal Food, Drug, and Cosmetic Act and the Lanham Act.\u003c/p\u003e","\u003cul\u003e\n\u003cli\u003eProvided advice to two \u003cstrong data-redactor-tag=\"strong\"\u003eattorneys general\u003c/strong\u003e on legal and policy issues, coordinated Justice Department positions in criminal prosecutions and civil litigation, and formulated and implemented policy initiatives and legislative proposals.\u003c/li\u003e\n\u003c/ul\u003e","\u003cp\u003eAs Special Assistant U.S. Attorney, conducted \u003cstrong data-redactor-tag=\"strong\"\u003etrial and appellate litigation,\u003c/strong\u003e including arguing three cases in the U.S. Courts of Appeals for the Fourth and Ninth Circuits.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":103,"guid":"103.capabilities","index":0,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":1,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":2,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":3,"source":"capabilities"},{"id":970,"guid":"970.smart_tags","index":4,"source":"smartTags"},{"id":112,"guid":"112.capabilities","index":5,"source":"capabilities"},{"id":1193,"guid":"1193.smart_tags","index":6,"source":"smartTags"},{"id":1223,"guid":"1223.smart_tags","index":7,"source":"smartTags"},{"id":133,"guid":"133.capabilities","index":8,"source":"capabilities"}],"is_active":true,"last_name":"Sampson","nick_name":"D.","clerkships":[{"name":"Law Clerk, Hon. Karen J. Williams, U.S. Court of Appeals for the Fourth Circuit","years_held":"1996-1997"}],"first_name":"D.","title_rank":9999,"updated_by":202,"law_schools":[{"id":2174,"meta":{"degree":"J.D.","honors":"with honors","is_law_school":1,"graduation_date":"1996-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"Kyle","name_suffix":"","recognitions":[{"title":"Attorney General’s Award for Outstanding Service to the Attorney General, the Department of Justice, and to America ","detail":"U.S. Department of Justice, 2005"}],"linked_in_url":"https://www.linkedin.com/in/kyle-sampson-4302348/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eKyle Sampson focuses on Food and Drug Administration regulatory, compliance and enforcement issues. As a partner in our FDA and Life Sciences practice, Kyle represents companies in the full range of regulatory and enforcement issues.\u003c/p\u003e\n\u003cp\u003e[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eKyle advises food, drug, biologics, medical device, cosmetics and dietary supplement companies on FDA compliance, regulatory and enforcement matters. His practice also includes strategic advice and compliance counseling, enforcement, litigation and transactional matters.\u003c/p\u003e\n\u003cp\u003eKyle has engaged in extensive public service in every branch of the federal government. He served in the White House as Associate Counsel to the President; at the Department of Justice as a Special Assistant U.S. Attorney and as Counselor and Chief of Staff to two attorneys general; and in the U.S. Senate as Counsel to the Senate Judiciary Committee.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e","matters":["\u003cp\u003eAssist \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e in developing and implementing comprehensive regulatory and healthcare fraud and abuse compliance programs involving off-label promotion, anti-kickback violations, federal healthcare program reimbursement, and pricing and false claims actions.\u003c/p\u003e","\u003cp\u003eServe as counsel to \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical, biotechnology and medical device companies\u003c/strong\u003e in regulatory matters involving product development and commercialization.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device manufacturers\u003c/strong\u003e in responding to FDA enforcement actions, including Form FDA-483 observations and Warning Letters.\u003c/p\u003e","\u003cp\u003eServe as compliance counsel for \u003cstrong data-redactor-tag=\"strong\"\u003ea\u003c/strong\u003e \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical company\u003c/strong\u003e subject to consent decree resulting from allegation that company provided false scientific data to FDA in regulatory submissions.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003ea medical device manufacturer\u003c/strong\u003e in consent decree negotiations with FDA and Department of Justice.\u003c/p\u003e","\u003cp\u003eWith Monitor appointed by U.S. Attorney\u0026rsquo;s Office for the District of New Jersey under Deferred Prosecution Agreement (DPA), oversaw \u003cstrong data-redactor-tag=\"strong\"\u003eorthopedic device manufacturer\u003c/strong\u003e's compliance with federal Anti-Kickback Statute and other federal healthcare laws and its implementation of comprehensive compliance program.\u003c/p\u003e","\u003cp\u003eReview advertising and promotional materials and activities for prescription drugs, biologics and devices for \u003cstrong data-redactor-tag=\"strong\"\u003evarious clients.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eProvide advice to \u003cstrong data-redactor-tag=\"strong\"\u003emanufacturers\u003c/strong\u003e \u003cstrong data-redactor-tag=\"strong\"\u003eof controlled substances and listed chemicals\u003c/strong\u003e regarding compliance with the Controlled Substances Act and Drug Enforcement Administration regulations.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003emanufacturers of drug, medical device, human food, animal feed and consumer products\u003c/strong\u003e in negotiations with the FDA over recalls of manufacturers\u0026rsquo; products, including proper classification of recall, assessment of health hazard, and development and implementation of recall strategy.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003eforeign manufacturers and domestic importers\u003c/strong\u003e in responding to the FDA\u0026rsquo;s detention of imports and placement of firms on Import Alert, including negotiating firms\u0026rsquo; removal from Detention Without Physical Examination (DWPE).\u003c/p\u003e","\u003cp\u003eHelp \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e respond to widespread counterfeiting of products and unlawful importation by Internet pharmacies and others in violation of the Federal Food, Drug, and Cosmetic Act and the Lanham Act.\u003c/p\u003e","\u003cul\u003e\n\u003cli\u003eProvided advice to two \u003cstrong data-redactor-tag=\"strong\"\u003eattorneys general\u003c/strong\u003e on legal and policy issues, coordinated Justice Department positions in criminal prosecutions and civil litigation, and formulated and implemented policy initiatives and legislative proposals.\u003c/li\u003e\n\u003c/ul\u003e","\u003cp\u003eAs Special Assistant U.S. Attorney, conducted \u003cstrong data-redactor-tag=\"strong\"\u003etrial and appellate litigation,\u003c/strong\u003e including arguing three cases in the U.S. Courts of Appeals for the Fourth and Ninth Circuits.\u003c/p\u003e"],"recognitions":[{"title":"Attorney General’s Award for Outstanding Service to the Attorney General, the Department of Justice, and to America ","detail":"U.S. Department of Justice, 2005"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12357}]},"capability_group_id":2},"created_at":"2025-05-26T04:54:31.000Z","updated_at":"2025-05-26T04:54:31.000Z","searchable_text":"Sampson{{ FIELD }}{:title=\u0026gt;\"Attorney General’s Award for Outstanding Service to the Attorney General, the Department of Justice, and to America \", :detail=\u0026gt;\"U.S. Department of Justice, 2005\"}{{ FIELD }}Assist pharmaceutical and medical device companies in developing and implementing comprehensive regulatory and healthcare fraud and abuse compliance programs involving off-label promotion, anti-kickback violations, federal healthcare program reimbursement, and pricing and false claims actions.{{ FIELD }}Serve as counsel to pharmaceutical, biotechnology and medical device companies in regulatory matters involving product development and commercialization.{{ FIELD }}Represent pharmaceutical and medical device manufacturers in responding to FDA enforcement actions, including Form FDA-483 observations and Warning Letters.{{ FIELD }}Serve as compliance counsel for a pharmaceutical company subject to consent decree resulting from allegation that company provided false scientific data to FDA in regulatory submissions.{{ FIELD }}Represent a medical device manufacturer in consent decree negotiations with FDA and Department of Justice.{{ FIELD }}With Monitor appointed by U.S. Attorney’s Office for the District of New Jersey under Deferred Prosecution Agreement (DPA), oversaw orthopedic device manufacturer's compliance with federal Anti-Kickback Statute and other federal healthcare laws and its implementation of comprehensive compliance program.{{ FIELD }}Review advertising and promotional materials and activities for prescription drugs, biologics and devices for various clients.{{ FIELD }}Provide advice to manufacturers of controlled substances and listed chemicals regarding compliance with the Controlled Substances Act and Drug Enforcement Administration regulations.{{ FIELD }}Represent manufacturers of drug, medical device, human food, animal feed and consumer products in negotiations with the FDA over recalls of manufacturers’ products, including proper classification of recall, assessment of health hazard, and development and implementation of recall strategy.{{ FIELD }}Represent foreign manufacturers and domestic importers in responding to the FDA’s detention of imports and placement of firms on Import Alert, including negotiating firms’ removal from Detention Without Physical Examination (DWPE).{{ FIELD }}Help pharmaceutical and medical device companies respond to widespread counterfeiting of products and unlawful importation by Internet pharmacies and others in violation of the Federal Food, Drug, and Cosmetic Act and the Lanham Act.{{ FIELD }}\nProvided advice to two attorneys general on legal and policy issues, coordinated Justice Department positions in criminal prosecutions and civil litigation, and formulated and implemented policy initiatives and legislative proposals.\n{{ FIELD }}As Special Assistant U.S. Attorney, conducted trial and appellate litigation, including arguing three cases in the U.S. Courts of Appeals for the Fourth and Ninth Circuits.{{ FIELD }}Kyle Sampson focuses on Food and Drug Administration regulatory, compliance and enforcement issues. As a partner in our FDA and Life Sciences practice, Kyle represents companies in the full range of regulatory and enforcement issues.\n\nKyle advises food, drug, biologics, medical device, cosmetics and dietary supplement companies on FDA compliance, regulatory and enforcement matters. His practice also includes strategic advice and compliance counseling, enforcement, litigation and transactional matters.\nKyle has engaged in extensive public service in every branch of the federal government. He served in the White House as Associate Counsel to the President; at the Department of Justice as a Special Assistant U.S. Attorney and as Counselor and Chief of Staff to two attorneys general; and in the U.S. Senate as Counsel to the Senate Judiciary Committee.\n \n  Partner Attorney General’s Award for Outstanding Service to the Attorney General, the Department of Justice, and to America  U.S. Department of Justice, 2005 Brigham Young University J. Reuben Clark Law School University of Chicago University of Chicago Law School U.S. Court of Appeals for the Fourth Circuit U.S. Court of Appeals for the Eleventh Circuit U.S. Court of Appeals for the D.C. Circuit U.S. District Court for the District of Utah District of Columbia Utah Law Clerk, Hon. Karen J. Williams, U.S. Court of Appeals for the Fourth Circuit Assist pharmaceutical and medical device companies in developing and implementing comprehensive regulatory and healthcare fraud and abuse compliance programs involving off-label promotion, anti-kickback violations, federal healthcare program reimbursement, and pricing and false claims actions. Serve as counsel to pharmaceutical, biotechnology and medical device companies in regulatory matters involving product development and commercialization. Represent pharmaceutical and medical device manufacturers in responding to FDA enforcement actions, including Form FDA-483 observations and Warning Letters. Serve as compliance counsel for a pharmaceutical company subject to consent decree resulting from allegation that company provided false scientific data to FDA in regulatory submissions. Represent a medical device manufacturer in consent decree negotiations with FDA and Department of Justice. With Monitor appointed by U.S. Attorney’s Office for the District of New Jersey under Deferred Prosecution Agreement (DPA), oversaw orthopedic device manufacturer's compliance with federal Anti-Kickback Statute and other federal healthcare laws and its implementation of comprehensive compliance program. Review advertising and promotional materials and activities for prescription drugs, biologics and devices for various clients. Provide advice to manufacturers of controlled substances and listed chemicals regarding compliance with the Controlled Substances Act and Drug Enforcement Administration regulations. Represent manufacturers of drug, medical device, human food, animal feed and consumer products in negotiations with the FDA over recalls of manufacturers’ products, including proper classification of recall, assessment of health hazard, and development and implementation of recall strategy. Represent foreign manufacturers and domestic importers in responding to the FDA’s detention of imports and placement of firms on Import Alert, including negotiating firms’ removal from Detention Without Physical Examination (DWPE). Help pharmaceutical and medical device companies respond to widespread counterfeiting of products and unlawful importation by Internet pharmacies and others in violation of the Federal Food, Drug, and Cosmetic Act and the Lanham Act. \nProvided advice to two attorneys general on legal and policy issues, coordinated Justice Department positions in criminal prosecutions and civil litigation, and formulated and implemented policy initiatives and legislative proposals.\n As Special Assistant U.S. Attorney, conducted trial and appellate litigation, including arguing three cases in the U.S. Courts of Appeals for the Fourth and Ninth Circuits.","searchable_name":"D. Kyle Sampson","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":442855,"version":1,"owner_type":"Person","owner_id":6047,"payload":{"bio":"\u003cp\u003eA former two-time U.S. Attorney for the Eastern District of California, a 34-county district headquartered in Sacramento\u0026nbsp;with an area that stretches from the Oregon border to Bakersfield, Greg Scott is an experienced trial lawyer who represents major companies facing government investigations and litigation, with a focus in the healthcare, retail, and construction industries. He has extensive knowledge on matters involving consumer protection, construction accidents, the Foreign Corrupt Practices Act (FCPA) and the False Claims Act (FCA).\u0026nbsp; The combination of his vast experience as a prosecutor and conducting internal investigations as a defense attorney consistently leads to great results for his clients.\u0026nbsp;\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eGreg represents corporations under criminal and/or civil\u0026nbsp;investigation by Federal, state, and local prosecutors' offices.\u0026nbsp; He has extensive experience conducing internal investigations for companies under scrutiny in a wide-range of subject matters, including health care, consumer protection, the False Claims Act, and Foreign Corrupt Practices Act.\u0026nbsp; Greg has been on the opposite side of the table in investigations brought by multiple Federal agencies, the California Attorney General, and several California District Attorneys.\u0026nbsp;\u0026nbsp;\u0026nbsp;The combination of his experience as a prosecutor and as a defense attorney and his stature among prosecutors in California has led to great results for his clients.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eGreg started his legal career as a deputy district attorney in Contra Costa County. CA where he tried approximately 100 jury trials to verdict and then became the\u0026nbsp;twice-elected District Attorney of Shasta County, CA. He also served as an Adjunct Professor of National Security Law at the McGeorge School of Law following his first term as U.S. Attorney for the E.D. of California. Between his two terms as U.S. Attorney, Greg was the vice chair of the white-collar defense and corporate investigations practice at an AmLaw 50 firm.\u0026nbsp; \u0026nbsp;He retired as a lieutenant colonel from the U.S. Army Reserve after 23 years of service as an infantry officer.\u0026nbsp;\u003c/p\u003e","slug":"greg-scott","email":"mscott@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":11,"guid":"11.capabilities","index":0,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":1,"source":"capabilities"},{"id":4,"guid":"4.capabilities","index":2,"source":"capabilities"},{"id":74,"guid":"74.capabilities","index":3,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":4,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":5,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":6,"source":"smartTags"},{"id":780,"guid":"780.smart_tags","index":7,"source":"smartTags"},{"id":750,"guid":"750.smart_tags","index":8,"source":"smartTags"},{"id":1199,"guid":"1199.smart_tags","index":9,"source":"smartTags"}],"is_active":true,"last_name":"Scott","nick_name":"Greg","clerkships":[],"first_name":"McGregor","title_rank":9999,"updated_by":32,"law_schools":[{"id":2158,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"1989-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Named Lawyer of the Year for Criminal Defense: White-Collar in Sacramento","detail":"Best Lawyers® in America (2023)"},{"title":"Recognized for Criminal Defense: White-Collar","detail":"Best Lawyers in America (2013-2023)"}],"linked_in_url":"https://www.linkedin.com/in/mcgregor-scott-9527ba21/","seodescription":null,"primary_title_id":155,"translated_fields":{"en":{"bio":"\u003cp\u003eA former two-time U.S. Attorney for the Eastern District of California, a 34-county district headquartered in Sacramento\u0026nbsp;with an area that stretches from the Oregon border to Bakersfield, Greg Scott is an experienced trial lawyer who represents major companies facing government investigations and litigation, with a focus in the healthcare, retail, and construction industries. He has extensive knowledge on matters involving consumer protection, construction accidents, the Foreign Corrupt Practices Act (FCPA) and the False Claims Act (FCA).\u0026nbsp; The combination of his vast experience as a prosecutor and conducting internal investigations as a defense attorney consistently leads to great results for his clients.\u0026nbsp;\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eGreg represents corporations under criminal and/or civil\u0026nbsp;investigation by Federal, state, and local prosecutors' offices.\u0026nbsp; He has extensive experience conducing internal investigations for companies under scrutiny in a wide-range of subject matters, including health care, consumer protection, the False Claims Act, and Foreign Corrupt Practices Act.\u0026nbsp; Greg has been on the opposite side of the table in investigations brought by multiple Federal agencies, the California Attorney General, and several California District Attorneys.\u0026nbsp;\u0026nbsp;\u0026nbsp;The combination of his experience as a prosecutor and as a defense attorney and his stature among prosecutors in California has led to great results for his clients.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eGreg started his legal career as a deputy district attorney in Contra Costa County. CA where he tried approximately 100 jury trials to verdict and then became the\u0026nbsp;twice-elected District Attorney of Shasta County, CA. He also served as an Adjunct Professor of National Security Law at the McGeorge School of Law following his first term as U.S. Attorney for the E.D. of California. Between his two terms as U.S. Attorney, Greg was the vice chair of the white-collar defense and corporate investigations practice at an AmLaw 50 firm.\u0026nbsp; \u0026nbsp;He retired as a lieutenant colonel from the U.S. Army Reserve after 23 years of service as an infantry officer.\u0026nbsp;\u003c/p\u003e","recognitions":[{"title":"Named Lawyer of the Year for Criminal Defense: White-Collar in Sacramento","detail":"Best Lawyers® in America (2023)"},{"title":"Recognized for Criminal Defense: White-Collar","detail":"Best Lawyers in America (2013-2023)"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":8858}]},"capability_group_id":2},"created_at":"2025-11-13T04:58:49.000Z","updated_at":"2025-11-13T04:58:49.000Z","searchable_text":"Scott{{ FIELD }}{:title=\u0026gt;\"Named Lawyer of the Year for Criminal Defense: White-Collar in Sacramento\", :detail=\u0026gt;\"Best Lawyers® in America (2023)\"}{{ FIELD }}{:title=\u0026gt;\"Recognized for Criminal Defense: White-Collar\", :detail=\u0026gt;\"Best Lawyers in America (2013-2023)\"}{{ FIELD }}A former two-time U.S. Attorney for the Eastern District of California, a 34-county district headquartered in Sacramento with an area that stretches from the Oregon border to Bakersfield, Greg Scott is an experienced trial lawyer who represents major companies facing government investigations and litigation, with a focus in the healthcare, retail, and construction industries. He has extensive knowledge on matters involving consumer protection, construction accidents, the Foreign Corrupt Practices Act (FCPA) and the False Claims Act (FCA).  The combination of his vast experience as a prosecutor and conducting internal investigations as a defense attorney consistently leads to great results for his clients.  \nGreg represents corporations under criminal and/or civil investigation by Federal, state, and local prosecutors' offices.  He has extensive experience conducing internal investigations for companies under scrutiny in a wide-range of subject matters, including health care, consumer protection, the False Claims Act, and Foreign Corrupt Practices Act.  Greg has been on the opposite side of the table in investigations brought by multiple Federal agencies, the California Attorney General, and several California District Attorneys.   The combination of his experience as a prosecutor and as a defense attorney and his stature among prosecutors in California has led to great results for his clients.  \nGreg started his legal career as a deputy district attorney in Contra Costa County. CA where he tried approximately 100 jury trials to verdict and then became the twice-elected District Attorney of Shasta County, CA. He also served as an Adjunct Professor of National Security Law at the McGeorge School of Law following his first term as U.S. Attorney for the E.D. of California. Between his two terms as U.S. Attorney, Greg was the vice chair of the white-collar defense and corporate investigations practice at an AmLaw 50 firm.   He retired as a lieutenant colonel from the U.S. Army Reserve after 23 years of service as an infantry officer.  Partner Named Lawyer of the Year for Criminal Defense: White-Collar in Sacramento Best Lawyers® in America (2023) Recognized for Criminal Defense: White-Collar Best Lawyers in America (2013-2023) Santa Clara University Santa Clara University School of Law University of California Hastings College of Law University of California Hastings College of Law California Federal Bar Association Sacramento County Bar Association","searchable_name":"McGregor Scott (Greg)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":32,"capability_group_featured":null,"home_page_featured":null},{"id":442375,"version":1,"owner_type":"Person","owner_id":923,"payload":{"bio":"\u003cp\u003eJohn Shakow\u0026nbsp;focuses on complex regulatory, commercial, investigation and litigation issues related to pharmaceutical government pricing and price reporting. A Chambers-ranked partner in our FDA and Life Sciences practice and co-chair of the firm's Life Sciences \u0026amp; Healthcare Industry Group, John represents pharmaceutical and biotechnology manufacturers in every facet of government drug payor program compliance and liability mitigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJohn has over 25 years'\u0026nbsp;experience in helping pharmaceutical and biotechnology clients resolve commercial and organizational challenges while maintaining the integrity of their price-reporting compliance efforts.\u003c/p\u003e\n\u003cp\u003eHe counsels clients on their rights and obligations under Medicaid, Medicare,340B, VA/FSS and related programs, and regularly assists them in interactions with the Centers for Medicare and Medicaid Services, the Health Resources and Services Administration, the Department of Health and Human Services Office of Inspector General, and the Veterans Administration.\u003c/p\u003e\n\u003cp\u003eJohn often conducts in-depth pricing assessments to develop and implement government price calculation and reporting policies, procedures, systems and methodologies. John has overseen\u0026nbsp;dozens of substantial\u0026nbsp;\u003cem\u003ebona fide\u003c/em\u003e\u0026nbsp;service fee analysis projects for large and small drug manufacturers. He is experienced in managing the coordination and integration of pricing methodologies in major pharmaceutical mergers.\u003c/p\u003e\n\u003cp\u003eJohn has significant pharmaceutical litigation and investigation experience. He regularly challenges government agencies' positions on drug pricing and reimbursement matters, and defends clients in federal and state investigations related to price reporting. John represents manufacturers in 340B, IRA, and Medicaid Drug Rebate Program litigation, and has counseled drug manufacturers before the House Energy \u0026amp; Commerce and Senate Finance committees in drug-pricing investigations and inquiries.\u003c/p\u003e","slug":"john-shakow","email":"jshakow@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[{"id":179}]},"expertise":[{"id":103,"guid":"103.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":23,"guid":"23.capabilities","index":2,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":3,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":4,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":5,"source":"capabilities"},{"id":122,"guid":"122.capabilities","index":6,"source":"capabilities"},{"id":1193,"guid":"1193.smart_tags","index":7,"source":"smartTags"},{"id":133,"guid":"133.capabilities","index":8,"source":"capabilities"}],"is_active":true,"last_name":"Shakow","nick_name":"John","clerkships":[],"first_name":"John","title_rank":9999,"updated_by":35,"law_schools":[],"middle_name":"D.","name_suffix":"","recognitions":[{"title":"“John is extremely strong and extremely client-focused.”","detail":"CHAMBERS USA, 2022"},{"title":"“Top Ranked Lawyer,” Healthcare: Pharmaceutical/Medical Products Regulatory","detail":"CHAMBERS USA, 2021, 2022, 2023 and 2024"},{"title":"Recommended Key Lawyer: 2021, 2022, 2023","detail":"Legal 500"},{"title":"Shortlist for Regulatory Attorney of the Year: Pricing \u0026 Reimbursement, 2017-2023","detail":"LMG Life Sciences"},{"title":"2016 Lifetime Achievement Award","detail":"Institute for International Research's Medicaid Drug Rebate Program"},{"title":"Life Sciences Star: Pricing and Reimbursement, 2012 to 2018","detail":"Guide to Leading Life Sciences Firms and Attorneys in North America"}],"linked_in_url":"https://www.linkedin.com/in/JohnShakow/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eJohn Shakow\u0026nbsp;focuses on complex regulatory, commercial, investigation and litigation issues related to pharmaceutical government pricing and price reporting. A Chambers-ranked partner in our FDA and Life Sciences practice and co-chair of the firm's Life Sciences \u0026amp; Healthcare Industry Group, John represents pharmaceutical and biotechnology manufacturers in every facet of government drug payor program compliance and liability mitigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJohn has over 25 years'\u0026nbsp;experience in helping pharmaceutical and biotechnology clients resolve commercial and organizational challenges while maintaining the integrity of their price-reporting compliance efforts.\u003c/p\u003e\n\u003cp\u003eHe counsels clients on their rights and obligations under Medicaid, Medicare,340B, VA/FSS and related programs, and regularly assists them in interactions with the Centers for Medicare and Medicaid Services, the Health Resources and Services Administration, the Department of Health and Human Services Office of Inspector General, and the Veterans Administration.\u003c/p\u003e\n\u003cp\u003eJohn often conducts in-depth pricing assessments to develop and implement government price calculation and reporting policies, procedures, systems and methodologies. John has overseen\u0026nbsp;dozens of substantial\u0026nbsp;\u003cem\u003ebona fide\u003c/em\u003e\u0026nbsp;service fee analysis projects for large and small drug manufacturers. He is experienced in managing the coordination and integration of pricing methodologies in major pharmaceutical mergers.\u003c/p\u003e\n\u003cp\u003eJohn has significant pharmaceutical litigation and investigation experience. He regularly challenges government agencies' positions on drug pricing and reimbursement matters, and defends clients in federal and state investigations related to price reporting. John represents manufacturers in 340B, IRA, and Medicaid Drug Rebate Program litigation, and has counseled drug manufacturers before the House Energy \u0026amp; Commerce and Senate Finance committees in drug-pricing investigations and inquiries.\u003c/p\u003e","recognitions":[{"title":"“John is extremely strong and extremely client-focused.”","detail":"CHAMBERS USA, 2022"},{"title":"“Top Ranked Lawyer,” Healthcare: Pharmaceutical/Medical Products Regulatory","detail":"CHAMBERS USA, 2021, 2022, 2023 and 2024"},{"title":"Recommended Key Lawyer: 2021, 2022, 2023","detail":"Legal 500"},{"title":"Shortlist for Regulatory Attorney of the Year: Pricing \u0026 Reimbursement, 2017-2023","detail":"LMG Life Sciences"},{"title":"2016 Lifetime Achievement Award","detail":"Institute for International Research's Medicaid Drug Rebate Program"},{"title":"Life Sciences Star: Pricing and Reimbursement, 2012 to 2018","detail":"Guide to Leading Life Sciences Firms and Attorneys in North America"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11649}]},"capability_group_id":2},"created_at":"2025-11-05T05:03:46.000Z","updated_at":"2025-11-05T05:03:46.000Z","searchable_text":"Shakow{{ FIELD }}{:title=\u0026gt;\"“John is extremely strong and extremely client-focused.”\", :detail=\u0026gt;\"CHAMBERS USA, 2022\"}{{ FIELD }}{:title=\u0026gt;\"“Top Ranked Lawyer,” Healthcare: Pharmaceutical/Medical Products Regulatory\", :detail=\u0026gt;\"CHAMBERS USA, 2021, 2022, 2023 and 2024\"}{{ FIELD }}{:title=\u0026gt;\"Recommended Key Lawyer: 2021, 2022, 2023\", :detail=\u0026gt;\"Legal 500\"}{{ FIELD }}{:title=\u0026gt;\"Shortlist for Regulatory Attorney of the Year: Pricing \u0026amp; Reimbursement, 2017-2023\", :detail=\u0026gt;\"LMG Life Sciences\"}{{ FIELD }}{:title=\u0026gt;\"2016 Lifetime Achievement Award\", :detail=\u0026gt;\"Institute for International Research's Medicaid Drug Rebate Program\"}{{ FIELD }}{:title=\u0026gt;\"Life Sciences Star: Pricing and Reimbursement, 2012 to 2018\", :detail=\u0026gt;\"Guide to Leading Life Sciences Firms and Attorneys in North America\"}{{ FIELD }}John Shakow focuses on complex regulatory, commercial, investigation and litigation issues related to pharmaceutical government pricing and price reporting. A Chambers-ranked partner in our FDA and Life Sciences practice and co-chair of the firm's Life Sciences \u0026amp; Healthcare Industry Group, John represents pharmaceutical and biotechnology manufacturers in every facet of government drug payor program compliance and liability mitigation.\nJohn has over 25 years' experience in helping pharmaceutical and biotechnology clients resolve commercial and organizational challenges while maintaining the integrity of their price-reporting compliance efforts.\nHe counsels clients on their rights and obligations under Medicaid, Medicare,340B, VA/FSS and related programs, and regularly assists them in interactions with the Centers for Medicare and Medicaid Services, the Health Resources and Services Administration, the Department of Health and Human Services Office of Inspector General, and the Veterans Administration.\nJohn often conducts in-depth pricing assessments to develop and implement government price calculation and reporting policies, procedures, systems and methodologies. John has overseen dozens of substantial bona fide service fee analysis projects for large and small drug manufacturers. He is experienced in managing the coordination and integration of pricing methodologies in major pharmaceutical mergers.\nJohn has significant pharmaceutical litigation and investigation experience. He regularly challenges government agencies' positions on drug pricing and reimbursement matters, and defends clients in federal and state investigations related to price reporting. John represents manufacturers in 340B, IRA, and Medicaid Drug Rebate Program litigation, and has counseled drug manufacturers before the House Energy \u0026amp; Commerce and Senate Finance committees in drug-pricing investigations and inquiries. John D Shakow Partner “John is extremely strong and extremely client-focused.” CHAMBERS USA, 2022 “Top Ranked Lawyer,” Healthcare: Pharmaceutical/Medical Products Regulatory CHAMBERS USA, 2021, 2022, 2023 and 2024 Recommended Key Lawyer: 2021, 2022, 2023 Legal 500 Shortlist for Regulatory Attorney of the Year: Pricing \u0026amp; Reimbursement, 2017-2023 LMG Life Sciences 2016 Lifetime Achievement Award Institute for International Research's Medicaid Drug Rebate Program Life Sciences Star: Pricing and Reimbursement, 2012 to 2018 Guide to Leading Life Sciences Firms and Attorneys in North America Swarthmore College  University of Virginia University of Virginia School of Law U.S. Court of Appeals for the Ninth Circuit U.S. Court of Appeals for the D.C. Circuit U.S. District Court for the Eastern District of Virginia U.S. District Court for the Central District of Illinois U.S. District Court for the District of Columbia District of Columbia Virginia District of Columbia Bar State Bar of Virginia","searchable_name":"John D. Shakow","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":442418,"version":1,"owner_type":"Person","owner_id":1470,"payload":{"bio":"\u003cp\u003eDarren focuses his practice on the defense of\u0026nbsp;high-stakes\u0026nbsp;ERISA litigation matters.\u0026nbsp; He defends leading companies\u0026nbsp;in a variety of ERISA class actions involving retirement\u0026nbsp;plan investments, breach of fiduciary duty claims, and other complex employee benefits disputes.\u0026nbsp;Darren also counsels clients in connection with governmental investigations involving employee benefit plans and assists clients with disputes and investigations involving executive compensation arrangements.\u0026nbsp; Darren has been recognized\u0026nbsp;as a Next Generation Lawyer by\u0026nbsp;\u003cem\u003eThe Legal 500\u003c/em\u003e\u0026nbsp;for ERISA Litigation in each of the last five years.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eDarren's representative clients include The Coca-Cola Company, The Home Depot, Bank of America, SunTrust Banks, Waste Management, and Aon Corporation.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eHe graduated, \u003cem\u003emagna cum laude\u003c/em\u003e, from The University of Tennessee College of Law, where he was elected to the Order of the Coif.\u0026nbsp;\u003c/p\u003e","slug":"darren-shuler","email":"dshuler@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":502,"guid":"502.smart_tags","index":1,"source":"smartTags"},{"id":3,"guid":"3.capabilities","index":2,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":3,"source":"capabilities"},{"id":121,"guid":"121.capabilities","index":4,"source":"capabilities"},{"id":15,"guid":"15.capabilities","index":5,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":6,"source":"capabilities"},{"id":19,"guid":"19.capabilities","index":7,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":8,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":9,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":10,"source":"capabilities"}],"is_active":true,"last_name":"Shuler","nick_name":"Darren","clerkships":[],"first_name":"Darren","title_rank":9999,"updated_by":35,"law_schools":[],"middle_name":"A.","name_suffix":"","recognitions":[{"title":"Named a Next Generation Lawyer for ERISA Litigation","detail":"Legal 500 US, 2020, 2021, 2022, and 2023"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eDarren focuses his practice on the defense of\u0026nbsp;high-stakes\u0026nbsp;ERISA litigation matters.\u0026nbsp; He defends leading companies\u0026nbsp;in a variety of ERISA class actions involving retirement\u0026nbsp;plan investments, breach of fiduciary duty claims, and other complex employee benefits disputes.\u0026nbsp;Darren also counsels clients in connection with governmental investigations involving employee benefit plans and assists clients with disputes and investigations involving executive compensation arrangements.\u0026nbsp; Darren has been recognized\u0026nbsp;as a Next Generation Lawyer by\u0026nbsp;\u003cem\u003eThe Legal 500\u003c/em\u003e\u0026nbsp;for ERISA Litigation in each of the last five years.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eDarren's representative clients include The Coca-Cola Company, The Home Depot, Bank of America, SunTrust Banks, Waste Management, and Aon Corporation.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eHe graduated, \u003cem\u003emagna cum laude\u003c/em\u003e, from The University of Tennessee College of Law, where he was elected to the Order of the Coif.\u0026nbsp;\u003c/p\u003e","recognitions":[{"title":"Named a Next Generation Lawyer for ERISA Litigation","detail":"Legal 500 US, 2020, 2021, 2022, and 2023"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11829}]},"capability_group_id":3},"created_at":"2025-11-05T05:04:54.000Z","updated_at":"2025-11-05T05:04:54.000Z","searchable_text":"Shuler{{ FIELD }}{:title=\u0026gt;\"Named a Next Generation Lawyer for ERISA Litigation\", :detail=\u0026gt;\"Legal 500 US, 2020, 2021, 2022, and 2023\"}{{ FIELD }}Darren focuses his practice on the defense of high-stakes ERISA litigation matters.  He defends leading companies in a variety of ERISA class actions involving retirement plan investments, breach of fiduciary duty claims, and other complex employee benefits disputes. Darren also counsels clients in connection with governmental investigations involving employee benefit plans and assists clients with disputes and investigations involving executive compensation arrangements.  Darren has been recognized as a Next Generation Lawyer by The Legal 500 for ERISA Litigation in each of the last five years. \nDarren's representative clients include The Coca-Cola Company, The Home Depot, Bank of America, SunTrust Banks, Waste Management, and Aon Corporation. \nHe graduated, magna cum laude, from The University of Tennessee College of Law, where he was elected to the Order of the Coif.  Partner Named a Next Generation Lawyer for ERISA Litigation Legal 500 US, 2020, 2021, 2022, and 2023 Maryville College  The University of Tennessee University of Tennessee College of Law University of Georgia University of Georgia School of Law Florida Georgia State Bar of Georgia State Bar of Florida","searchable_name":"Darren A. Shuler","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":442766,"version":1,"owner_type":"Person","owner_id":5387,"payload":{"bio":"\u003cp\u003eAs a data, privacy and security, health care, and employee benefits partner at King \u0026amp; Spalding LLP, Adam Solander provides counsel on data breach and cybersecurity issues across various industries, particularly health care. Adam represents clients with respect to employee benefits regulatory and compliance issues including designing, implementing, and maintaining employee benefit plans. He also advises clients on issues related to managed care laws and telemedicine.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAdam has experience helping clients preparing for, responding to, and recovering from data, privacy and security incidents. He is a Certified CSF Practitioner, a designation given by the Health Information Trust Alliance (HITRUST). This organization provides training to develop and maintain effective security programs for health care and life sciences companies that comply with security laws, regulations, and standards, including HITECH, HIPAA, PCI, JCAHO, CMS, ISO, NIST, and various other federal, state, and business requirements.\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Adam was a member of a nationally recognized law firm where he was a part of their health care and life sciences practice group. Much of his experience is centered around assisting health care clients with HIPAA compliance, ERISA, managed care laws, telemedicine, and privacy and data security. \u0026nbsp;He also assisted private equity companies with evaluating privacy and security and employee benefits compliance risk in connection with potential investments.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003ePreviously, he served as Health Policy Counsel at the ERISA Industry Committee. There, he counseled Fortune 500 companies on healthcare legislation, including ACA, the HITECH Act, and ERISA. He also has experience advocating on behalf of trade associations and advocacy groups to Congress and Executive branch.\u003c/p\u003e","slug":"adam-solander","email":"asolander@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":6,"guid":"6.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":28,"guid":"28.capabilities","index":2,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":80,"guid":"80.capabilities","index":5,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":6,"source":"smartTags"}],"is_active":true,"last_name":"Solander","nick_name":"Adam","clerkships":[],"first_name":"Adam","title_rank":9999,"updated_by":101,"law_schools":[{"id":1562,"meta":{"degree":"J.D.","honors":null,"is_law_school":1,"graduation_date":"2007-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"C.","name_suffix":"","recognitions":[{"title":"Named to Washington DC Rising Stars list","detail":"Super Lawyers, 2016-2018"},{"title":"Received Readers’ Choice Award","detail":"JD Supra, 2016"},{"title":"Received Burton Award for Legal Writing","detail":"Burton Awards Program in association with the Library of Congress, 2014"}],"linked_in_url":"https://www.linkedin.com/in/adamsolander/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eAs a data, privacy and security, health care, and employee benefits partner at King \u0026amp; Spalding LLP, Adam Solander provides counsel on data breach and cybersecurity issues across various industries, particularly health care. Adam represents clients with respect to employee benefits regulatory and compliance issues including designing, implementing, and maintaining employee benefit plans. He also advises clients on issues related to managed care laws and telemedicine.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAdam has experience helping clients preparing for, responding to, and recovering from data, privacy and security incidents. He is a Certified CSF Practitioner, a designation given by the Health Information Trust Alliance (HITRUST). This organization provides training to develop and maintain effective security programs for health care and life sciences companies that comply with security laws, regulations, and standards, including HITECH, HIPAA, PCI, JCAHO, CMS, ISO, NIST, and various other federal, state, and business requirements.\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Adam was a member of a nationally recognized law firm where he was a part of their health care and life sciences practice group. Much of his experience is centered around assisting health care clients with HIPAA compliance, ERISA, managed care laws, telemedicine, and privacy and data security. \u0026nbsp;He also assisted private equity companies with evaluating privacy and security and employee benefits compliance risk in connection with potential investments.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003ePreviously, he served as Health Policy Counsel at the ERISA Industry Committee. There, he counseled Fortune 500 companies on healthcare legislation, including ACA, the HITECH Act, and ERISA. He also has experience advocating on behalf of trade associations and advocacy groups to Congress and Executive branch.\u003c/p\u003e","recognitions":[{"title":"Named to Washington DC Rising Stars list","detail":"Super Lawyers, 2016-2018"},{"title":"Received Readers’ Choice Award","detail":"JD Supra, 2016"},{"title":"Received Burton Award for Legal Writing","detail":"Burton Awards Program in association with the Library of Congress, 2014"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":6393}]},"capability_group_id":2},"created_at":"2025-11-13T04:56:44.000Z","updated_at":"2025-11-13T04:56:44.000Z","searchable_text":"Solander{{ FIELD }}{:title=\u0026gt;\"Named to Washington DC Rising Stars list\", :detail=\u0026gt;\"Super Lawyers, 2016-2018\"}{{ FIELD }}{:title=\u0026gt;\"Received Readers’ Choice Award\", :detail=\u0026gt;\"JD Supra, 2016\"}{{ FIELD }}{:title=\u0026gt;\"Received Burton Award for Legal Writing\", :detail=\u0026gt;\"Burton Awards Program in association with the Library of Congress, 2014\"}{{ FIELD }}As a data, privacy and security, health care, and employee benefits partner at King \u0026amp; Spalding LLP, Adam Solander provides counsel on data breach and cybersecurity issues across various industries, particularly health care. Adam represents clients with respect to employee benefits regulatory and compliance issues including designing, implementing, and maintaining employee benefit plans. He also advises clients on issues related to managed care laws and telemedicine.\nAdam has experience helping clients preparing for, responding to, and recovering from data, privacy and security incidents. He is a Certified CSF Practitioner, a designation given by the Health Information Trust Alliance (HITRUST). This organization provides training to develop and maintain effective security programs for health care and life sciences companies that comply with security laws, regulations, and standards, including HITECH, HIPAA, PCI, JCAHO, CMS, ISO, NIST, and various other federal, state, and business requirements.\nPrior to joining King \u0026amp; Spalding, Adam was a member of a nationally recognized law firm where he was a part of their health care and life sciences practice group. Much of his experience is centered around assisting health care clients with HIPAA compliance, ERISA, managed care laws, telemedicine, and privacy and data security.  He also assisted private equity companies with evaluating privacy and security and employee benefits compliance risk in connection with potential investments. \nPreviously, he served as Health Policy Counsel at the ERISA Industry Committee. There, he counseled Fortune 500 companies on healthcare legislation, including ACA, the HITECH Act, and ERISA. He also has experience advocating on behalf of trade associations and advocacy groups to Congress and Executive branch. Partner Named to Washington DC Rising Stars list Super Lawyers, 2016-2018 Received Readers’ Choice Award JD Supra, 2016 Received Burton Award for Legal Writing Burton Awards Program in association with the Library of Congress, 2014 West Virginia University West Virginia University College of Law Pennsylvania State University Pennsylvania State University, Dickinson School of Law West Virginia University West Virginia University College of Law District of Columbia District of Columbia Bar Association Member, American Health Lawyers Association","searchable_name":"Adam C. Solander","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":442769,"version":1,"owner_type":"Person","owner_id":5404,"payload":{"bio":"\u003cdiv id=\"pnlProfileSummaryShort\"\u003e\n\u003cp\u003eGlenn Solomon specializes in commercial and government managed care, complex business litigation, arbitration, mediation, class action, investigations, and other dispute resolution matters. As a partner in our Healthcare practice, his diverse clientele includes prominent hospitals and health systems, medical groups, independent physician associations, management services organizations, and other health care providers and entities. On behalf of providers, he has both resolved significant disputes with health plans and negotiated high-profile contracts with them, as well as solved disagreements with other providers.\u0026nbsp; He has helped providers obtain several hundred million\u0026nbsp;dollars through underpayments recoveries, contract improvements, and negotiations.\u0026nbsp; He also has successfully defended against similarly large amounts of alleged overpayments.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eGlenn\u0026rsquo;s expertise allows him to break down complex disputes to identify and achieve the best options for his clients, whether that be through litigation, arbitration, mediation, or resolved through contractual negotiation. His clients have recovered combined awards and settlements totaling over several hundred million dollars on the plaintiffs\u0026rsquo; side; and have successfully avoided alleged financial exposures of similar figures on the defendants\u0026rsquo; side.\u003c/p\u003e\n\u003cp\u003eOver the course of his career, Glenn has litigated, arbitrated, mediated and resolved disputes involving managed care, contracting, management services, class actions, internal and external investigations, fraud and abuse, business relations, reimbursement, trade secrets, misappropriation, real estate, employment, and discrimination. His broad health industry experience involves dealings with health plans, insurance companies, ERISA plans, self-funded plans, qui tam relators, employees, other providers and the government. Glenn\u0026rsquo;s versatile background has allowed him to be a court-designated expert witness.\u003c/p\u003e\n\u003cp\u003eGlenn also has experience representing clients in other industries such as telecommunications, accounting, retail, and banking.\u003c/p\u003e\n\u003cp\u003eGlenn is also recognized by Legal 500 (2024) as a Key Lawyer in HealthCare: Service Providers, which group has been ranked Tier 1 for this industry.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eGlenn continues to be recognized by Legal 500 (2025) as a Key Lawyer in HealthCare: Service Providers.\u003c/p\u003e\n\u003cp\u003eGlenn also has been recognized by Chambers USA, LA Attorney Individual Ranking for Healthcare.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eGlenn has been selected for the Los Angeles Business Journal's 2025 Leaders of Influence: Litigators \u0026amp; Trial Attorneys.\u003c/p\u003e\n\u003c/div\u003e","slug":"glenn-solomon","email":"gsolomon@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented\u003cem\u003e\u0026nbsp;\u003c/em\u003e\u003cstrong\u003eCalifornia Hospital Association\u003c/strong\u003e,\u0026nbsp;\u003cstrong\u003eCalifornia Medical Association\u003c/strong\u003e,\u0026nbsp;\u003cstrong\u003eRegional Medical Center of San Jose, and Good Samaritan Hospital\u003c/strong\u003e\u0026nbsp;as amici in\u0026nbsp;\u003cem\u003eCounty of Santa Clara v. Sup. Ct.\u003c/em\u003e, 14 Cal.5th 1034 (2023), in which the California Supreme Court, reversing a lower court decision, held that government owned health plans are subject to the Knox-Keene Act and lawsuits for reimbursement by out-of-network providers; potential impact exceeds hundreds of millions of dollars for California out-of-network providers.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eCEP America California dba Vituity\u003c/strong\u003e\u0026nbsp;against Heritage Provider Network regarding underpayments for out-of-network emergency physician services at many hospitals, resulting in jury award in April 2023, against the health plan on claims exceeding $10 million.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eCalifornia Hospital Association\u003c/strong\u003e,\u0026nbsp;\u003cstrong\u003eCalifornia Medical Association\u003c/strong\u003e, and a plaintiff class of\u0026nbsp;\u003cstrong\u003eCalifornia hospitals\u003c/strong\u003e\u0026nbsp;against Blue Cross regarding post-claims underwriting; court-approved settlement pool of $11.8 million for the benefit of all California hospitals that were affected by Blue Cross\u0026rsquo;s rescissions of patient policies.\u003c/p\u003e","\u003cp\u003eRepresented plaintiff's class of California \u003cstrong\u003eAmbulatory Surgery Centers\u0026nbsp;\u003c/strong\u003eagainst United Healthcare, Ingenix (now Optum) and dozens of self-funded plans regarding out-of-network payments; class settlement reached for $9.5 million for the benefit of California ASCs.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eChildren's Hospital Central California\u003c/strong\u003e\u0026nbsp;against Blue Cross of California in which appeals court held that the parties can present to the jury ona variety of evidence, includingthe hospital's charges, contracted rates and government rates, but not the costs to render the services at issue.\u003c/p\u003e","\u003cp\u003eJury verdict for\u0026nbsp;\u003cstrong\u003eChildren's Hospital Central California\u0026nbsp;\u003c/strong\u003edetermining plan was liable at 100% of charges for post-stabilization services rendered by hospital when plan failed to transfer Medi-Cal managed care beneficiaries to alternative providers; jury rejected plan's argument that hospital had not received authorization or been deemed authored.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eCalifornia Hospital Association\u003c/strong\u003e, plus a national dialysis provider and a putative class of ambulatory surgery centers nationwide, in obtaining court order that national class action settlement agreement regarding United\u0026rsquo;s reimbursement practices to non-contracted physicians doesn\u0026rsquo;t bar facilities from pursuing underpayment claims for facility services.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eC/HCA, Inc.\u003c/strong\u003e\u0026nbsp;in federal court to obtain preliminary injunction against Regence Blue Cross Blue Shield of Utah from marketing the hospitals as being in-network providers for new tiered network product that was not contemplated by the parties\u0026rsquo; contract.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eCoast Plaza Doctors Hosp.\u003c/strong\u003e\u0026nbsp;against an Anthem Blue plan in appeals court decision that providers aren\u0026rsquo;t preempted from pursuing direct state law claims against non-self-funded ERISA health plans and can sue such plans, rather than as assignees of the patient\u0026rsquo;s ERISA benefits.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eMount Diablo Medical Center\u003c/strong\u003e\u0026nbsp;in successful defeat of Health Net of California's motion to compel arbitration where dispute also involved the health plan's entity who was not subject to arbitration in multiparty capitation network dispute.\u003c/p\u003e","\u003cp\u003eRepresented prominent\u0026nbsp;\u003cstrong\u003epsychiatric hospitals\u0026nbsp;\u003c/strong\u003ein complex negotiations with the city of Los Angeles for a pre-filing settlement and stipulated judgment to resolve allegations of improper psychiatric patient discharges and then develop patient safety standards with the city for wider use as part of a year-long collaborative task force.\u003c/p\u003e","\u003cp\u003eRepresented a number of prominent non-profit hospitals in\u0026nbsp;\u003cstrong\u003eclass action defense\u0026nbsp;\u003c/strong\u003eagainst uninsured patients challenging various charges and billing practices.\u003c/p\u003e","\u003cp\u003eIn addition to these and other public court matters, Mr. Solomon often resolves matters outside the court system, through settlement negotiations, mediations and arbitrations for providers throughout the country. Over the course of his career he has worked on matters collectively generating\u0026nbsp;\u003cstrong\u003eseveral hundred million dollars\u0026nbsp;\u003c/strong\u003efor his provider clients in additional revenue from underpayments and avoided recoupment of similar amounts in alleged overpayments.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":24,"guid":"24.capabilities","index":0,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":1,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":2,"source":"capabilities"},{"id":12,"guid":"12.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":5,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":6,"source":"capabilities"},{"id":74,"guid":"74.capabilities","index":7,"source":"capabilities"},{"id":740,"guid":"740.smart_tags","index":8,"source":"smartTags"},{"id":122,"guid":"122.capabilities","index":9,"source":"capabilities"},{"id":1185,"guid":"1185.smart_tags","index":10,"source":"smartTags"},{"id":1187,"guid":"1187.smart_tags","index":11,"source":"smartTags"}],"is_active":true,"last_name":"Solomon","nick_name":"Glenn","clerkships":[],"first_name":"Glenn","title_rank":9999,"updated_by":34,"law_schools":[{"id":824,"meta":{"degree":"J.D.","honors":"cum laude","is_law_school":"1","graduation_date":"1991-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Key Lawyer in HealthCare: Service Providers","detail":"Legal 500, 2024"},{"title":"Martindale-Hubbell","detail":"AV Rated"},{"title":"Southern California Super Lawyers","detail":"2013-2020"},{"title":"Best Lawyers in America","detail":"2013-2020"}],"linked_in_url":"https://www.linkedin.com/in/glenn-solomon-1188b52/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cdiv id=\"pnlProfileSummaryShort\"\u003e\n\u003cp\u003eGlenn Solomon specializes in commercial and government managed care, complex business litigation, arbitration, mediation, class action, investigations, and other dispute resolution matters. As a partner in our Healthcare practice, his diverse clientele includes prominent hospitals and health systems, medical groups, independent physician associations, management services organizations, and other health care providers and entities. On behalf of providers, he has both resolved significant disputes with health plans and negotiated high-profile contracts with them, as well as solved disagreements with other providers.\u0026nbsp; He has helped providers obtain several hundred million\u0026nbsp;dollars through underpayments recoveries, contract improvements, and negotiations.\u0026nbsp; He also has successfully defended against similarly large amounts of alleged overpayments.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eGlenn\u0026rsquo;s expertise allows him to break down complex disputes to identify and achieve the best options for his clients, whether that be through litigation, arbitration, mediation, or resolved through contractual negotiation. His clients have recovered combined awards and settlements totaling over several hundred million dollars on the plaintiffs\u0026rsquo; side; and have successfully avoided alleged financial exposures of similar figures on the defendants\u0026rsquo; side.\u003c/p\u003e\n\u003cp\u003eOver the course of his career, Glenn has litigated, arbitrated, mediated and resolved disputes involving managed care, contracting, management services, class actions, internal and external investigations, fraud and abuse, business relations, reimbursement, trade secrets, misappropriation, real estate, employment, and discrimination. His broad health industry experience involves dealings with health plans, insurance companies, ERISA plans, self-funded plans, qui tam relators, employees, other providers and the government. Glenn\u0026rsquo;s versatile background has allowed him to be a court-designated expert witness.\u003c/p\u003e\n\u003cp\u003eGlenn also has experience representing clients in other industries such as telecommunications, accounting, retail, and banking.\u003c/p\u003e\n\u003cp\u003eGlenn is also recognized by Legal 500 (2024) as a Key Lawyer in HealthCare: Service Providers, which group has been ranked Tier 1 for this industry.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eGlenn continues to be recognized by Legal 500 (2025) as a Key Lawyer in HealthCare: Service Providers.\u003c/p\u003e\n\u003cp\u003eGlenn also has been recognized by Chambers USA, LA Attorney Individual Ranking for Healthcare.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eGlenn has been selected for the Los Angeles Business Journal's 2025 Leaders of Influence: Litigators \u0026amp; Trial Attorneys.\u003c/p\u003e\n\u003c/div\u003e","matters":["\u003cp\u003eRepresented\u003cem\u003e\u0026nbsp;\u003c/em\u003e\u003cstrong\u003eCalifornia Hospital Association\u003c/strong\u003e,\u0026nbsp;\u003cstrong\u003eCalifornia Medical Association\u003c/strong\u003e,\u0026nbsp;\u003cstrong\u003eRegional Medical Center of San Jose, and Good Samaritan Hospital\u003c/strong\u003e\u0026nbsp;as amici in\u0026nbsp;\u003cem\u003eCounty of Santa Clara v. Sup. Ct.\u003c/em\u003e, 14 Cal.5th 1034 (2023), in which the California Supreme Court, reversing a lower court decision, held that government owned health plans are subject to the Knox-Keene Act and lawsuits for reimbursement by out-of-network providers; potential impact exceeds hundreds of millions of dollars for California out-of-network providers.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eCEP America California dba Vituity\u003c/strong\u003e\u0026nbsp;against Heritage Provider Network regarding underpayments for out-of-network emergency physician services at many hospitals, resulting in jury award in April 2023, against the health plan on claims exceeding $10 million.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eCalifornia Hospital Association\u003c/strong\u003e,\u0026nbsp;\u003cstrong\u003eCalifornia Medical Association\u003c/strong\u003e, and a plaintiff class of\u0026nbsp;\u003cstrong\u003eCalifornia hospitals\u003c/strong\u003e\u0026nbsp;against Blue Cross regarding post-claims underwriting; court-approved settlement pool of $11.8 million for the benefit of all California hospitals that were affected by Blue Cross\u0026rsquo;s rescissions of patient policies.\u003c/p\u003e","\u003cp\u003eRepresented plaintiff's class of California \u003cstrong\u003eAmbulatory Surgery Centers\u0026nbsp;\u003c/strong\u003eagainst United Healthcare, Ingenix (now Optum) and dozens of self-funded plans regarding out-of-network payments; class settlement reached for $9.5 million for the benefit of California ASCs.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eChildren's Hospital Central California\u003c/strong\u003e\u0026nbsp;against Blue Cross of California in which appeals court held that the parties can present to the jury ona variety of evidence, includingthe hospital's charges, contracted rates and government rates, but not the costs to render the services at issue.\u003c/p\u003e","\u003cp\u003eJury verdict for\u0026nbsp;\u003cstrong\u003eChildren's Hospital Central California\u0026nbsp;\u003c/strong\u003edetermining plan was liable at 100% of charges for post-stabilization services rendered by hospital when plan failed to transfer Medi-Cal managed care beneficiaries to alternative providers; jury rejected plan's argument that hospital had not received authorization or been deemed authored.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eCalifornia Hospital Association\u003c/strong\u003e, plus a national dialysis provider and a putative class of ambulatory surgery centers nationwide, in obtaining court order that national class action settlement agreement regarding United\u0026rsquo;s reimbursement practices to non-contracted physicians doesn\u0026rsquo;t bar facilities from pursuing underpayment claims for facility services.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eC/HCA, Inc.\u003c/strong\u003e\u0026nbsp;in federal court to obtain preliminary injunction against Regence Blue Cross Blue Shield of Utah from marketing the hospitals as being in-network providers for new tiered network product that was not contemplated by the parties\u0026rsquo; contract.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eCoast Plaza Doctors Hosp.\u003c/strong\u003e\u0026nbsp;against an Anthem Blue plan in appeals court decision that providers aren\u0026rsquo;t preempted from pursuing direct state law claims against non-self-funded ERISA health plans and can sue such plans, rather than as assignees of the patient\u0026rsquo;s ERISA benefits.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eMount Diablo Medical Center\u003c/strong\u003e\u0026nbsp;in successful defeat of Health Net of California's motion to compel arbitration where dispute also involved the health plan's entity who was not subject to arbitration in multiparty capitation network dispute.\u003c/p\u003e","\u003cp\u003eRepresented prominent\u0026nbsp;\u003cstrong\u003epsychiatric hospitals\u0026nbsp;\u003c/strong\u003ein complex negotiations with the city of Los Angeles for a pre-filing settlement and stipulated judgment to resolve allegations of improper psychiatric patient discharges and then develop patient safety standards with the city for wider use as part of a year-long collaborative task force.\u003c/p\u003e","\u003cp\u003eRepresented a number of prominent non-profit hospitals in\u0026nbsp;\u003cstrong\u003eclass action defense\u0026nbsp;\u003c/strong\u003eagainst uninsured patients challenging various charges and billing practices.\u003c/p\u003e","\u003cp\u003eIn addition to these and other public court matters, Mr. Solomon often resolves matters outside the court system, through settlement negotiations, mediations and arbitrations for providers throughout the country. Over the course of his career he has worked on matters collectively generating\u0026nbsp;\u003cstrong\u003eseveral hundred million dollars\u0026nbsp;\u003c/strong\u003efor his provider clients in additional revenue from underpayments and avoided recoupment of similar amounts in alleged overpayments.\u003c/p\u003e"],"recognitions":[{"title":"Key Lawyer in HealthCare: Service Providers","detail":"Legal 500, 2024"},{"title":"Martindale-Hubbell","detail":"AV Rated"},{"title":"Southern California Super Lawyers","detail":"2013-2020"},{"title":"Best Lawyers in America","detail":"2013-2020"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":6579}]},"capability_group_id":2},"created_at":"2025-11-13T04:56:47.000Z","updated_at":"2025-11-13T04:56:47.000Z","searchable_text":"Solomon{{ FIELD }}{:title=\u0026gt;\"Key Lawyer in HealthCare: Service Providers\", :detail=\u0026gt;\"Legal 500, 2024\"}{{ FIELD }}{:title=\u0026gt;\"Martindale-Hubbell\", :detail=\u0026gt;\"AV Rated\"}{{ FIELD }}{:title=\u0026gt;\"Southern California Super Lawyers\", :detail=\u0026gt;\"2013-2020\"}{{ FIELD }}{:title=\u0026gt;\"Best Lawyers in America\", :detail=\u0026gt;\"2013-2020\"}{{ FIELD }}Represented California Hospital Association, California Medical Association, Regional Medical Center of San Jose, and Good Samaritan Hospital as amici in County of Santa Clara v. Sup. Ct., 14 Cal.5th 1034 (2023), in which the California Supreme Court, reversing a lower court decision, held that government owned health plans are subject to the Knox-Keene Act and lawsuits for reimbursement by out-of-network providers; potential impact exceeds hundreds of millions of dollars for California out-of-network providers.{{ FIELD }}Represented CEP America California dba Vituity against Heritage Provider Network regarding underpayments for out-of-network emergency physician services at many hospitals, resulting in jury award in April 2023, against the health plan on claims exceeding $10 million.{{ FIELD }}Represented California Hospital Association, California Medical Association, and a plaintiff class of California hospitals against Blue Cross regarding post-claims underwriting; court-approved settlement pool of $11.8 million for the benefit of all California hospitals that were affected by Blue Cross’s rescissions of patient policies.{{ FIELD }}Represented plaintiff's class of California Ambulatory Surgery Centers against United Healthcare, Ingenix (now Optum) and dozens of self-funded plans regarding out-of-network payments; class settlement reached for $9.5 million for the benefit of California ASCs.{{ FIELD }}Represented Children's Hospital Central California against Blue Cross of California in which appeals court held that the parties can present to the jury ona variety of evidence, includingthe hospital's charges, contracted rates and government rates, but not the costs to render the services at issue.{{ FIELD }}Jury verdict for Children's Hospital Central California determining plan was liable at 100% of charges for post-stabilization services rendered by hospital when plan failed to transfer Medi-Cal managed care beneficiaries to alternative providers; jury rejected plan's argument that hospital had not received authorization or been deemed authored.{{ FIELD }}Represented California Hospital Association, plus a national dialysis provider and a putative class of ambulatory surgery centers nationwide, in obtaining court order that national class action settlement agreement regarding United’s reimbursement practices to non-contracted physicians doesn’t bar facilities from pursuing underpayment claims for facility services.{{ FIELD }}Represented C/HCA, Inc. in federal court to obtain preliminary injunction against Regence Blue Cross Blue Shield of Utah from marketing the hospitals as being in-network providers for new tiered network product that was not contemplated by the parties’ contract.{{ FIELD }}Represented Coast Plaza Doctors Hosp. against an Anthem Blue plan in appeals court decision that providers aren’t preempted from pursuing direct state law claims against non-self-funded ERISA health plans and can sue such plans, rather than as assignees of the patient’s ERISA benefits.{{ FIELD }}Represented Mount Diablo Medical Center in successful defeat of Health Net of California's motion to compel arbitration where dispute also involved the health plan's entity who was not subject to arbitration in multiparty capitation network dispute.{{ FIELD }}Represented prominent psychiatric hospitals in complex negotiations with the city of Los Angeles for a pre-filing settlement and stipulated judgment to resolve allegations of improper psychiatric patient discharges and then develop patient safety standards with the city for wider use as part of a year-long collaborative task force.{{ FIELD }}Represented a number of prominent non-profit hospitals in class action defense against uninsured patients challenging various charges and billing practices.{{ FIELD }}In addition to these and other public court matters, Mr. Solomon often resolves matters outside the court system, through settlement negotiations, mediations and arbitrations for providers throughout the country. Over the course of his career he has worked on matters collectively generating several hundred million dollars for his provider clients in additional revenue from underpayments and avoided recoupment of similar amounts in alleged overpayments.{{ FIELD }}\nGlenn Solomon specializes in commercial and government managed care, complex business litigation, arbitration, mediation, class action, investigations, and other dispute resolution matters. As a partner in our Healthcare practice, his diverse clientele includes prominent hospitals and health systems, medical groups, independent physician associations, management services organizations, and other health care providers and entities. On behalf of providers, he has both resolved significant disputes with health plans and negotiated high-profile contracts with them, as well as solved disagreements with other providers.  He has helped providers obtain several hundred million dollars through underpayments recoveries, contract improvements, and negotiations.  He also has successfully defended against similarly large amounts of alleged overpayments. \nGlenn’s expertise allows him to break down complex disputes to identify and achieve the best options for his clients, whether that be through litigation, arbitration, mediation, or resolved through contractual negotiation. His clients have recovered combined awards and settlements totaling over several hundred million dollars on the plaintiffs’ side; and have successfully avoided alleged financial exposures of similar figures on the defendants’ side.\nOver the course of his career, Glenn has litigated, arbitrated, mediated and resolved disputes involving managed care, contracting, management services, class actions, internal and external investigations, fraud and abuse, business relations, reimbursement, trade secrets, misappropriation, real estate, employment, and discrimination. His broad health industry experience involves dealings with health plans, insurance companies, ERISA plans, self-funded plans, qui tam relators, employees, other providers and the government. Glenn’s versatile background has allowed him to be a court-designated expert witness.\nGlenn also has experience representing clients in other industries such as telecommunications, accounting, retail, and banking.\nGlenn is also recognized by Legal 500 (2024) as a Key Lawyer in HealthCare: Service Providers, which group has been ranked Tier 1 for this industry. \nGlenn continues to be recognized by Legal 500 (2025) as a Key Lawyer in HealthCare: Service Providers.\nGlenn also has been recognized by Chambers USA, LA Attorney Individual Ranking for Healthcare. \nGlenn has been selected for the Los Angeles Business Journal's 2025 Leaders of Influence: Litigators \u0026amp; Trial Attorneys.\n Partner Key Lawyer in HealthCare: Service Providers Legal 500, 2024 Martindale-Hubbell AV Rated Southern California Super Lawyers 2013-2020 Best Lawyers in America 2013-2020 University of California, Berkeley University of California, Berkeley, School of Law Harvard University Harvard Law School U.S. Court of Appeals for the Ninth Circuit U.S. District Court for the Central District of California U.S. District Court for the Eastern District of California U.S. District Court for the Northern District of California U.S. District Court for the Southern District of California California Texas American Health Lawyers Association Healthcare Financial Management Association California Society of Healthcare Attorneys American Bar Association, Health Law and Litigation Sections California Bar Association, Litigation Section Los Angeles County Bar Association, Health Care and Litigation Sections Cedars-Sinai Medical Center, Board of Governors, Executive Committee The Maple Counseling Center, Board of Directors, Executive-Finance-Budget Committees Represented California Hospital Association, California Medical Association, Regional Medical Center of San Jose, and Good Samaritan Hospital as amici in County of Santa Clara v. Sup. Ct., 14 Cal.5th 1034 (2023), in which the California Supreme Court, reversing a lower court decision, held that government owned health plans are subject to the Knox-Keene Act and lawsuits for reimbursement by out-of-network providers; potential impact exceeds hundreds of millions of dollars for California out-of-network providers. Represented CEP America California dba Vituity against Heritage Provider Network regarding underpayments for out-of-network emergency physician services at many hospitals, resulting in jury award in April 2023, against the health plan on claims exceeding $10 million. Represented California Hospital Association, California Medical Association, and a plaintiff class of California hospitals against Blue Cross regarding post-claims underwriting; court-approved settlement pool of $11.8 million for the benefit of all California hospitals that were affected by Blue Cross’s rescissions of patient policies. Represented plaintiff's class of California Ambulatory Surgery Centers against United Healthcare, Ingenix (now Optum) and dozens of self-funded plans regarding out-of-network payments; class settlement reached for $9.5 million for the benefit of California ASCs. Represented Children's Hospital Central California against Blue Cross of California in which appeals court held that the parties can present to the jury ona variety of evidence, includingthe hospital's charges, contracted rates and government rates, but not the costs to render the services at issue. Jury verdict for Children's Hospital Central California determining plan was liable at 100% of charges for post-stabilization services rendered by hospital when plan failed to transfer Medi-Cal managed care beneficiaries to alternative providers; jury rejected plan's argument that hospital had not received authorization or been deemed authored. Represented California Hospital Association, plus a national dialysis provider and a putative class of ambulatory surgery centers nationwide, in obtaining court order that national class action settlement agreement regarding United’s reimbursement practices to non-contracted physicians doesn’t bar facilities from pursuing underpayment claims for facility services. Represented C/HCA, Inc. in federal court to obtain preliminary injunction against Regence Blue Cross Blue Shield of Utah from marketing the hospitals as being in-network providers for new tiered network product that was not contemplated by the parties’ contract. Represented Coast Plaza Doctors Hosp. against an Anthem Blue plan in appeals court decision that providers aren’t preempted from pursuing direct state law claims against non-self-funded ERISA health plans and can sue such plans, rather than as assignees of the patient’s ERISA benefits. Represented Mount Diablo Medical Center in successful defeat of Health Net of California's motion to compel arbitration where dispute also involved the health plan's entity who was not subject to arbitration in multiparty capitation network dispute. Represented prominent psychiatric hospitals in complex negotiations with the city of Los Angeles for a pre-filing settlement and stipulated judgment to resolve allegations of improper psychiatric patient discharges and then develop patient safety standards with the city for wider use as part of a year-long collaborative task force. Represented a number of prominent non-profit hospitals in class action defense against uninsured patients challenging various charges and billing practices. In addition to these and other public court matters, Mr. Solomon often resolves matters outside the court system, through settlement negotiations, mediations and arbitrations for providers throughout the country. Over the course of his career he has worked on matters collectively generating several hundred million dollars for his provider clients in additional revenue from underpayments and avoided recoupment of similar amounts in alleged overpayments.","searchable_name":"Glenn Solomon","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":34,"capability_group_featured":null,"home_page_featured":null},{"id":442367,"version":1,"owner_type":"Person","owner_id":888,"payload":{"bio":"\u003cp\u003eJeff Spigel focuses on advising clients on the antitrust issues related to successfully executing their business strategy. As a partner and co-head of our global Antitrust practice, clients routinely seek Jeff\u0026rsquo;s practical and business-friendly advice to guide them through their strategic transactions, criminal grand jury and civil DOJ, FTC, State AG and antitrust investigations and litigation. Working with our Brussels antitrust lawyers, Jeff also defends clients in multi-jurisdictional investigations that coordinate with the U.S., including the European Commission and the UK\u0026rsquo;s CMA.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJeff represents clients in responding to a range of civil and criminal antitrust investigations in the U.S. and abroad, obtaining Hart-Scott-Rodino clearance and coordinating approvals of proposed transactions in foreign jurisdictions. He also advises clients on pursuing or defending against antitrust claims and counsels on strategic antitrust issues such as those arising from benchmarking, compliance and audits, competitor collaborations, exclusivity and foreclosure, resale price maintenance, Robinson-Patman price discrimination, refusals to deal, and tying and predatory bundling issues.\u003c/p\u003e\n\u003cp\u003eWith significant experience in the healthcare sector, Jeff frequently advises healthcare clients on strategic transactions, messenger model networks, financially- and/or clinically-integrated networks, Group Purchasing Organizations and claims by commercial payors, competitors, or the government.\u003c/p\u003e\n\u003cp\u003eJeff\u0026rsquo;s antitrust experience also includes advising clients in a broad range of industries such as building materials, chemicals, communications, consumer products, energy (oil, gas, power, and renewables), entertainment, financial, metals, paper, pharmaceutical, retail, technology, and transportation.\u003c/p\u003e\n\u003cp\u003eOn behalf of his clients, Jeff appears regularly before the U.S. Department of Justice and the Federal Trade Commission, and he coordinates with foreign counsel in dealing with competition authorities in jurisdictions around the globe, including before the European Commission. In addition, he represents clients on unfair and deceptive trade practice matters before the Federal Trade Commission, Consumer Financial Protection Bureau, and state attorneys general.\u003c/p\u003e\n\u003cp\u003eA regular author and speaker, \u003cem\u003eChambers USA\u003c/em\u003e, \u003cem\u003eLegal 500\u003c/em\u003e and \u003cem\u003eSuper Lawyers\u003c/em\u003e have identified Jeff as a recognized practitioner and leading antitrust lawyer. In addition, \u003cem\u003eNightingale Healthcare News\u003c/em\u003e named him one of the \u0026ldquo;Outstanding Healthcare Antitrust Lawyers\u0026rdquo; in the U.S.\u003c/p\u003e","slug":"jeffrey-spigel","email":"jspigel@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cstrong\u003eAgricultural/Food\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDefending a\u0026nbsp;\u003cstrong\u003eleading food company\u003c/strong\u003e\u0026nbsp;in DOJ and State AG antitrust investigations.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eViserion Grain, LLC\u003c/strong\u003e, in DOJ\u0026rsquo;s approval of its acquisition of 11 grain elevator facilities from Zen-Noh Grain Corporation (\u0026ldquo;ZGC\u0026rdquo;). These facilities were required to be divested to remedy the DOJ\u0026rsquo;s challenge of ZGC\u0026rsquo;s acquisition of multiple grain facilities from Bunge North America.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eRockstar\u003c/strong\u003e, a leading energy drink maker, in an FTC investigation of its $3.85 billion acquisition by PepsiCo Inc.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eEnergy\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eSuccessfully represented a leading provider of natural gas processing and treatment and compression products and services in a DOJ merger investigation of a merger with a competitor.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eConocoPhillips\u003c/strong\u003e\u0026nbsp;on the sale of its Canadian oil, sand, and gas assets to Cenovus in a $13.3 billion transaction.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eone of the leading operators and builders of offshore supply vessels\u003c/strong\u003e\u0026nbsp;in a DOJ investigation of an acquisition of a leading provider of repair services and construction of offshore and military vessels.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003ea leading manufacturer of drill bits\u003c/strong\u003e\u0026nbsp;used in mining and oil and gas exploration in a DOJ investigation of its acquisition by a competitor.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003ea major global energy company\u003c/strong\u003e\u0026nbsp;in a DOJ criminal antitrust investigation.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eWeatherford Internationa\u003c/strong\u003el in the sale of its pipeline business to Baker Hughes.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eMarubeni-Itochu Tubulars\u003c/strong\u003e\u0026nbsp;on its acquisition of the casing and tubing business of Oil States International.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eTransocean Ltd\u003c/strong\u003e. in connection with its $2.7 billion acquisition of Ocean Rig UDW, Inc., in the offshore oil and gas drilling sector and successfully obtained antitrust clearances in several jurisdictions around the world.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eLS Power\u003c/strong\u003e\u0026nbsp;in obtaining antitrust clearances for various acquisitions of electric power-generating assets from several independent power producers around the U.S. and provided continued antitrust advice on subsequent potential transactions.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eone of the world\u0026rsquo;s largest integrated petroleum companies\u003c/strong\u003e\u0026nbsp;in an industry-wide investigation of gasoline prices by the FTC and Congress.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eMirant Corporation\u003c/strong\u003e\u0026nbsp;in a DOJ antitrust investigation of its merger with RRI Energy. The transaction closed without DOJ action.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eEntertainment\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eCox Enterprises\u003c/strong\u003e\u0026nbsp;in its acquisition of Axios Media.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eCarmike Cinemas\u003c/strong\u003e\u0026nbsp;in a DOJ investigation of its merger with AMC Theatres. Successfully negotiated a settlement with the DOJ. (\u003cem\u003eUnited States of America v. AMC Entertainment Holdings, Inc.)\u003c/em\u003e.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eFinancial Services\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003ea leading payment processor\u003c/strong\u003e\u0026nbsp;in a DOJ merger investigation of its acquisition by a competitor.\u003c/p\u003e","\u003cp\u003eDefending\u0026nbsp;\u003cstrong\u003eEquifax\u0026nbsp;\u003c/strong\u003ein antitrust litigation filed against it, TransUnion and Experian alleging violations of federal and California antitrust laws. (\u003cem\u003eAdams v. Experian Information Solutions, Inc. et al\u003c/em\u003e., E.D. Calif. (2:23-cv-01773).\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eTSYS\u003c/strong\u003e, a leading global payments provider, in merger clearances of its $54 billion all-stock merger of equals with Global Payments, a worldwide provider of payment technology and software solutions.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eBank of America\u003c/strong\u003e\u0026nbsp;in an FTC consumer protection investigation and litigation of Countrywide Financial Corporation related to Countrywide\u0026rsquo;s mortgage loan servicing practices.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eHealthcare/Life Sciences\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eSuccessfully represented a leading manufacturer of dental bone grafting products in a DOJ merger investigation of an acquisition by a competitor.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eOchsner Health System\u003c/strong\u003e\u0026nbsp;regarding Lafayette General Health System\u0026rsquo;s merger into Ochsner.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eOchsner Health System\u0026nbsp;\u003c/strong\u003ein the formation of a joint venture with LSU to acquire University Health Hospitals from BRFHH.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eOchsner Health System\u003c/strong\u003e\u0026nbsp;in forming JOAs with CHRISTUS Louisiana, Lafayette General Health, Slidell Memorial Hospital, St. Tammany Parish Hospital, and Terrebonne General Medical Center.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eOchsner Health System\u003c/strong\u003e\u0026nbsp;in its acquisition of Rush Health Systems, which added seven hospitals to extend Ochsner\u0026rsquo;s reach to east Mississippi/west Alabama region.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003ePiedmont Healthcare, Inc.\u003c/strong\u003e\u0026nbsp;in the acquisition of four hospitals in North Georgia and Macon from HCA Healthcare.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003ePiedmont Healthcare\u003c/strong\u003e\u0026nbsp;in an FTC merger investigation of its acquisition of University Healthcare.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eHouston Methodist\u003c/strong\u003e\u0026nbsp;in an FTC and Texas AG investigation of its acquisition of two CHRISTUS hospitals in the metropolitan Houston area.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eSt. Joseph\u0026rsquo;s Health System\u003c/strong\u003e\u0026nbsp;in an FTC investigation of its formation of a JOA with Emory Healthcare.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eUniversity of Texas Southwestern Medical Cente\u003c/strong\u003er\u0026nbsp;\u003cstrong\u003e(UTSW)\u003c/strong\u003e\u0026nbsp;in an FTC and Texas AG investigation of its formation of a JOA with Texas Health Resources.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eKing\u0026rsquo;s Daughter Hospital\u003c/strong\u003e\u0026nbsp;in its acquisition by Scott \u0026amp; White Healthcare, which ultimately received clearance from the FTC under a failing firm defense.\u003c/p\u003e","\u003cp\u003eSuccessfully represented a\u0026nbsp;\u003cstrong\u003e1,000-plus member, exclusive clinically-integrated physician network\u003c/strong\u003e\u0026nbsp;in an FTC price fixing investigation.\u003c/p\u003e","\u003cp\u003eSuccessfully represented physician clients and their messenger model network in an FTC civil price fixing and concerted refusal to deal investigation.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eHospital Corporation of America\u003c/strong\u003e\u0026nbsp;in a Sections 1 and 2 Sherman Act (tying) federal antitrust action against a competing hospital system.\u0026nbsp;\u003cem\u003e(Palmyra Park Medical Center, Inc. v. Phoebe Putney Memorial Hospital, Inc., et al.)\u003c/em\u003e.\u003c/p\u003e","\u003cp\u003eSuccessfully defended\u0026nbsp;\u003cstrong\u003ea branded pharmaceutical manufacturer\u003c/strong\u003e\u0026nbsp;in DOJ and FTC antitrust investigations of a proposed patent settlement and the use of authorized generics.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eManufacturing/Chemical/Paper\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eQuikrete Holdings, Inc.\u0026nbsp;\u003c/strong\u003ein a DOJ merger investigation of its acquisition of Forterra Inc.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eWestRock,\u003c/strong\u003e\u0026nbsp;which is a leading manufacturer of containerboard and paperboard, in DOJ and other competition authorities\u0026rsquo; investigations of strategic transactions, including WestRock\u0026rsquo;s $16 billion merger with MeadWestvaco, its $2.28 billion acquisition of MultiPackaging Solution, its $4.9 billion acquisition of KapStone, and its sale of its partitions business to Sonoco.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eSchweitzer-Mauduit International, Inc.\u003c/strong\u003e\u0026nbsp;(now known as\u0026nbsp;\u003cstrong\u003eMativ\u003c/strong\u003e) in a DOJ investigation of its merger of equals with Neenah, Inc.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eH.I.G. CAPITAL\u003c/strong\u003e\u0026nbsp;and its subsidiary\u0026nbsp;\u003cstrong\u003eDCL Corporation\u003c/strong\u003e\u0026nbsp;as the divestiture buyer of Sun Chemical\u0026rsquo;s DIC Corporation Bushy Park assets in front of the Federal Trade Commission, European Commission and the Japanese Fair Trade Commission as part of a settlement regarding DIC\u0026rsquo;s acquisition by BASF\u0026rsquo;s pigment business.\u003c/p\u003e","\u003cp\u003eSuccessfully represented global chemical company\u0026nbsp;\u003cstrong\u003eKraton Corporation\u003c/strong\u003e\u0026nbsp;in its merger with DL Chemical Co., Ltd., a subsidiary of DL Holdings Co., Ltd. (formerly Daelim Industrial Co., Ltd.).\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eForterra Brick\u003c/strong\u003e\u0026nbsp;on the combination of its brick business with Boral Brick as part of the formation of a new joint venture.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eForterra Building Products\u003c/strong\u003e\u0026nbsp;in its acquisition of U.S. Pipe.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eLafarge\u003c/strong\u003e\u0026nbsp;on numerous strategic transactions.\u003c/p\u003e","\u003cp\u003eDefended\u0026nbsp;\u003cstrong\u003eUCAR International\u003c/strong\u003e\u0026nbsp;\u003cstrong\u003e(now\u003c/strong\u003e\u0026nbsp;\u003cstrong\u003eGrafTech)\u003c/strong\u003e\u0026nbsp;in a federal grand jury price fixing investigation of graphite electrodes.\u0026nbsp;\u003cem\u003e(United States v. UCAR International Inc.)\u003c/em\u003e.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eRetail\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eSuccessfully represented a leading home furnishing company in an FTC merger investigation of a leading e-commerce platform.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003ea leading branded apparel company\u003c/strong\u003e\u0026nbsp;in an FTC merger investigation of an acquisition of a competitor.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eHanesBrands, Inc.,\u003c/strong\u003e\u0026nbsp;one of the leading providers of licensed athletic apparel and related services, in its collaboration with Fanatics, Inc.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003ea leading manufacturer and retailer of recreational boats\u003c/strong\u003e\u0026nbsp;in an FTC investigation of the acquisition of a competitor.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eThe Belk Stores\u003c/strong\u003e\u0026nbsp;in an FTC merger investigation of its acquisitions of the Parisian, Proffitt\u0026rsquo;s and McCrae\u0026rsquo;s department store chains from Saks Fifth Avenue.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eMcLane Company\u003c/strong\u003e\u0026nbsp;in a Section 1 Sherman Act in an action in federal District Court in Connecticut.\u0026nbsp;\u003cem\u003e(Loretta N. Bansavich D/B/A/Lori\u0026rsquo;s Mobil v. McLane Company, Inc.)\u003c/em\u003e.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eTechnology\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eEquifax\u0026nbsp;\u003c/strong\u003ein numerous strategic transactions, including the acquisitions of LawLogix Edge and LawLogix Guardian software solutions, Midigator Holdings, LLC, a leading provider of post-transaction fraud mitigation solutions, Appriss Insights, a trusted and comprehensive source of risk and criminal justice data intelligence, Health e(fx), a leading and experienced provider of Affordable Care Act digital services, Teletrack, a U.S. leader in alternative credit data and Kount, a leading provider of post-transaction fraud mitigation solutions.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eMailchimp\u003c/strong\u003e, a world-class, global customer engagement and marketing platform, in a DOJ investigation of its $12 billion acquisition by Mountain View, CA-based Intuit Inc.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eCox Enterprises\u003c/strong\u003e\u0026nbsp;in its acquisition of Logicworks, which provides cloud management, automation, migration, and operations services.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eRed Ventures\u003c/strong\u003e, whose portfolio includes\u0026nbsp;\u003cstrong\u003eHealthline\u003c/strong\u003e, a leading digital health company in its $675 million acquisition of Healthgrades.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eSharecare\u003c/strong\u003e, a leading digital health company, in its $3.9 billion SPAC merger with Falcon Capital.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eBrookfield Infrastructure Group\u003c/strong\u003e\u0026nbsp;in its $1.1 billion acquisition of 31 Data Centers in 10 Countries on 4 Continents from AT\u0026amp;T.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eChoicePoint\u003c/strong\u003e\u0026nbsp;in an FTC merger investigation of ChoicePoint\u0026rsquo;s acquisition by Reed Elsevier.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eSprint\u003c/strong\u003e\u0026nbsp;in a DOJ investigation of its $35 billion merger with Nextel.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":102,"guid":"102.capabilities","index":0,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":1,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":2,"source":"capabilities"},{"id":80,"guid":"80.capabilities","index":3,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":4,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":5,"source":"capabilities"},{"id":33,"guid":"33.capabilities","index":6,"source":"capabilities"},{"id":22,"guid":"22.capabilities","index":7,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":8,"source":"capabilities"},{"id":1,"guid":"1.capabilities","index":9,"source":"capabilities"},{"id":1114,"guid":"1114.smart_tags","index":10,"source":"smartTags"},{"id":114,"guid":"114.capabilities","index":11,"source":"capabilities"},{"id":750,"guid":"750.smart_tags","index":12,"source":"smartTags"},{"id":120,"guid":"120.capabilities","index":13,"source":"capabilities"},{"id":126,"guid":"126.capabilities","index":14,"source":"capabilities"},{"id":133,"guid":"133.capabilities","index":15,"source":"capabilities"},{"id":1248,"guid":"1248.smart_tags","index":16,"source":"smartTags"},{"id":129,"guid":"129.capabilities","index":17,"source":"capabilities"}],"is_active":true,"last_name":"Spigel","nick_name":"Jeff","clerkships":[],"first_name":"Jeffrey","title_rank":9999,"updated_by":35,"law_schools":[],"middle_name":"S.","name_suffix":"","recognitions":[{"title":"Recognized practitioner and leading antitrust lawyer","detail":"Chambers USA, Legal 500 and Super Lawyers"},{"title":"Named one of the “Outstanding Healthcare Antitrust Lawyers” in the U.S.","detail":"Nightingale Healthcare News"}],"linked_in_url":"https://www.linkedin.com/in/jeff-spigel-06a0914/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eJeff Spigel focuses on advising clients on the antitrust issues related to successfully executing their business strategy. As a partner and co-head of our global Antitrust practice, clients routinely seek Jeff\u0026rsquo;s practical and business-friendly advice to guide them through their strategic transactions, criminal grand jury and civil DOJ, FTC, State AG and antitrust investigations and litigation. Working with our Brussels antitrust lawyers, Jeff also defends clients in multi-jurisdictional investigations that coordinate with the U.S., including the European Commission and the UK\u0026rsquo;s CMA.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJeff represents clients in responding to a range of civil and criminal antitrust investigations in the U.S. and abroad, obtaining Hart-Scott-Rodino clearance and coordinating approvals of proposed transactions in foreign jurisdictions. He also advises clients on pursuing or defending against antitrust claims and counsels on strategic antitrust issues such as those arising from benchmarking, compliance and audits, competitor collaborations, exclusivity and foreclosure, resale price maintenance, Robinson-Patman price discrimination, refusals to deal, and tying and predatory bundling issues.\u003c/p\u003e\n\u003cp\u003eWith significant experience in the healthcare sector, Jeff frequently advises healthcare clients on strategic transactions, messenger model networks, financially- and/or clinically-integrated networks, Group Purchasing Organizations and claims by commercial payors, competitors, or the government.\u003c/p\u003e\n\u003cp\u003eJeff\u0026rsquo;s antitrust experience also includes advising clients in a broad range of industries such as building materials, chemicals, communications, consumer products, energy (oil, gas, power, and renewables), entertainment, financial, metals, paper, pharmaceutical, retail, technology, and transportation.\u003c/p\u003e\n\u003cp\u003eOn behalf of his clients, Jeff appears regularly before the U.S. Department of Justice and the Federal Trade Commission, and he coordinates with foreign counsel in dealing with competition authorities in jurisdictions around the globe, including before the European Commission. In addition, he represents clients on unfair and deceptive trade practice matters before the Federal Trade Commission, Consumer Financial Protection Bureau, and state attorneys general.\u003c/p\u003e\n\u003cp\u003eA regular author and speaker, \u003cem\u003eChambers USA\u003c/em\u003e, \u003cem\u003eLegal 500\u003c/em\u003e and \u003cem\u003eSuper Lawyers\u003c/em\u003e have identified Jeff as a recognized practitioner and leading antitrust lawyer. In addition, \u003cem\u003eNightingale Healthcare News\u003c/em\u003e named him one of the \u0026ldquo;Outstanding Healthcare Antitrust Lawyers\u0026rdquo; in the U.S.\u003c/p\u003e","matters":["\u003cp\u003e\u003cstrong\u003eAgricultural/Food\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDefending a\u0026nbsp;\u003cstrong\u003eleading food company\u003c/strong\u003e\u0026nbsp;in DOJ and State AG antitrust investigations.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eViserion Grain, LLC\u003c/strong\u003e, in DOJ\u0026rsquo;s approval of its acquisition of 11 grain elevator facilities from Zen-Noh Grain Corporation (\u0026ldquo;ZGC\u0026rdquo;). These facilities were required to be divested to remedy the DOJ\u0026rsquo;s challenge of ZGC\u0026rsquo;s acquisition of multiple grain facilities from Bunge North America.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eRockstar\u003c/strong\u003e, a leading energy drink maker, in an FTC investigation of its $3.85 billion acquisition by PepsiCo Inc.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eEnergy\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eSuccessfully represented a leading provider of natural gas processing and treatment and compression products and services in a DOJ merger investigation of a merger with a competitor.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eConocoPhillips\u003c/strong\u003e\u0026nbsp;on the sale of its Canadian oil, sand, and gas assets to Cenovus in a $13.3 billion transaction.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eone of the leading operators and builders of offshore supply vessels\u003c/strong\u003e\u0026nbsp;in a DOJ investigation of an acquisition of a leading provider of repair services and construction of offshore and military vessels.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003ea leading manufacturer of drill bits\u003c/strong\u003e\u0026nbsp;used in mining and oil and gas exploration in a DOJ investigation of its acquisition by a competitor.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003ea major global energy company\u003c/strong\u003e\u0026nbsp;in a DOJ criminal antitrust investigation.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eWeatherford Internationa\u003c/strong\u003el in the sale of its pipeline business to Baker Hughes.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eMarubeni-Itochu Tubulars\u003c/strong\u003e\u0026nbsp;on its acquisition of the casing and tubing business of Oil States International.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eTransocean Ltd\u003c/strong\u003e. in connection with its $2.7 billion acquisition of Ocean Rig UDW, Inc., in the offshore oil and gas drilling sector and successfully obtained antitrust clearances in several jurisdictions around the world.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eLS Power\u003c/strong\u003e\u0026nbsp;in obtaining antitrust clearances for various acquisitions of electric power-generating assets from several independent power producers around the U.S. and provided continued antitrust advice on subsequent potential transactions.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eone of the world\u0026rsquo;s largest integrated petroleum companies\u003c/strong\u003e\u0026nbsp;in an industry-wide investigation of gasoline prices by the FTC and Congress.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eMirant Corporation\u003c/strong\u003e\u0026nbsp;in a DOJ antitrust investigation of its merger with RRI Energy. The transaction closed without DOJ action.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eEntertainment\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eCox Enterprises\u003c/strong\u003e\u0026nbsp;in its acquisition of Axios Media.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eCarmike Cinemas\u003c/strong\u003e\u0026nbsp;in a DOJ investigation of its merger with AMC Theatres. Successfully negotiated a settlement with the DOJ. (\u003cem\u003eUnited States of America v. AMC Entertainment Holdings, Inc.)\u003c/em\u003e.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eFinancial Services\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003ea leading payment processor\u003c/strong\u003e\u0026nbsp;in a DOJ merger investigation of its acquisition by a competitor.\u003c/p\u003e","\u003cp\u003eDefending\u0026nbsp;\u003cstrong\u003eEquifax\u0026nbsp;\u003c/strong\u003ein antitrust litigation filed against it, TransUnion and Experian alleging violations of federal and California antitrust laws. (\u003cem\u003eAdams v. Experian Information Solutions, Inc. et al\u003c/em\u003e., E.D. Calif. (2:23-cv-01773).\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eTSYS\u003c/strong\u003e, a leading global payments provider, in merger clearances of its $54 billion all-stock merger of equals with Global Payments, a worldwide provider of payment technology and software solutions.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eBank of America\u003c/strong\u003e\u0026nbsp;in an FTC consumer protection investigation and litigation of Countrywide Financial Corporation related to Countrywide\u0026rsquo;s mortgage loan servicing practices.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eHealthcare/Life Sciences\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eSuccessfully represented a leading manufacturer of dental bone grafting products in a DOJ merger investigation of an acquisition by a competitor.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eOchsner Health System\u003c/strong\u003e\u0026nbsp;regarding Lafayette General Health System\u0026rsquo;s merger into Ochsner.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eOchsner Health System\u0026nbsp;\u003c/strong\u003ein the formation of a joint venture with LSU to acquire University Health Hospitals from BRFHH.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eOchsner Health System\u003c/strong\u003e\u0026nbsp;in forming JOAs with CHRISTUS Louisiana, Lafayette General Health, Slidell Memorial Hospital, St. Tammany Parish Hospital, and Terrebonne General Medical Center.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eOchsner Health System\u003c/strong\u003e\u0026nbsp;in its acquisition of Rush Health Systems, which added seven hospitals to extend Ochsner\u0026rsquo;s reach to east Mississippi/west Alabama region.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003ePiedmont Healthcare, Inc.\u003c/strong\u003e\u0026nbsp;in the acquisition of four hospitals in North Georgia and Macon from HCA Healthcare.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003ePiedmont Healthcare\u003c/strong\u003e\u0026nbsp;in an FTC merger investigation of its acquisition of University Healthcare.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eHouston Methodist\u003c/strong\u003e\u0026nbsp;in an FTC and Texas AG investigation of its acquisition of two CHRISTUS hospitals in the metropolitan Houston area.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eSt. Joseph\u0026rsquo;s Health System\u003c/strong\u003e\u0026nbsp;in an FTC investigation of its formation of a JOA with Emory Healthcare.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eUniversity of Texas Southwestern Medical Cente\u003c/strong\u003er\u0026nbsp;\u003cstrong\u003e(UTSW)\u003c/strong\u003e\u0026nbsp;in an FTC and Texas AG investigation of its formation of a JOA with Texas Health Resources.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eKing\u0026rsquo;s Daughter Hospital\u003c/strong\u003e\u0026nbsp;in its acquisition by Scott \u0026amp; White Healthcare, which ultimately received clearance from the FTC under a failing firm defense.\u003c/p\u003e","\u003cp\u003eSuccessfully represented a\u0026nbsp;\u003cstrong\u003e1,000-plus member, exclusive clinically-integrated physician network\u003c/strong\u003e\u0026nbsp;in an FTC price fixing investigation.\u003c/p\u003e","\u003cp\u003eSuccessfully represented physician clients and their messenger model network in an FTC civil price fixing and concerted refusal to deal investigation.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eHospital Corporation of America\u003c/strong\u003e\u0026nbsp;in a Sections 1 and 2 Sherman Act (tying) federal antitrust action against a competing hospital system.\u0026nbsp;\u003cem\u003e(Palmyra Park Medical Center, Inc. v. Phoebe Putney Memorial Hospital, Inc., et al.)\u003c/em\u003e.\u003c/p\u003e","\u003cp\u003eSuccessfully defended\u0026nbsp;\u003cstrong\u003ea branded pharmaceutical manufacturer\u003c/strong\u003e\u0026nbsp;in DOJ and FTC antitrust investigations of a proposed patent settlement and the use of authorized generics.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eManufacturing/Chemical/Paper\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eQuikrete Holdings, Inc.\u0026nbsp;\u003c/strong\u003ein a DOJ merger investigation of its acquisition of Forterra Inc.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eWestRock,\u003c/strong\u003e\u0026nbsp;which is a leading manufacturer of containerboard and paperboard, in DOJ and other competition authorities\u0026rsquo; investigations of strategic transactions, including WestRock\u0026rsquo;s $16 billion merger with MeadWestvaco, its $2.28 billion acquisition of MultiPackaging Solution, its $4.9 billion acquisition of KapStone, and its sale of its partitions business to Sonoco.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eSchweitzer-Mauduit International, Inc.\u003c/strong\u003e\u0026nbsp;(now known as\u0026nbsp;\u003cstrong\u003eMativ\u003c/strong\u003e) in a DOJ investigation of its merger of equals with Neenah, Inc.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eH.I.G. CAPITAL\u003c/strong\u003e\u0026nbsp;and its subsidiary\u0026nbsp;\u003cstrong\u003eDCL Corporation\u003c/strong\u003e\u0026nbsp;as the divestiture buyer of Sun Chemical\u0026rsquo;s DIC Corporation Bushy Park assets in front of the Federal Trade Commission, European Commission and the Japanese Fair Trade Commission as part of a settlement regarding DIC\u0026rsquo;s acquisition by BASF\u0026rsquo;s pigment business.\u003c/p\u003e","\u003cp\u003eSuccessfully represented global chemical company\u0026nbsp;\u003cstrong\u003eKraton Corporation\u003c/strong\u003e\u0026nbsp;in its merger with DL Chemical Co., Ltd., a subsidiary of DL Holdings Co., Ltd. (formerly Daelim Industrial Co., Ltd.).\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eForterra Brick\u003c/strong\u003e\u0026nbsp;on the combination of its brick business with Boral Brick as part of the formation of a new joint venture.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eForterra Building Products\u003c/strong\u003e\u0026nbsp;in its acquisition of U.S. Pipe.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eLafarge\u003c/strong\u003e\u0026nbsp;on numerous strategic transactions.\u003c/p\u003e","\u003cp\u003eDefended\u0026nbsp;\u003cstrong\u003eUCAR International\u003c/strong\u003e\u0026nbsp;\u003cstrong\u003e(now\u003c/strong\u003e\u0026nbsp;\u003cstrong\u003eGrafTech)\u003c/strong\u003e\u0026nbsp;in a federal grand jury price fixing investigation of graphite electrodes.\u0026nbsp;\u003cem\u003e(United States v. UCAR International Inc.)\u003c/em\u003e.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eRetail\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eSuccessfully represented a leading home furnishing company in an FTC merger investigation of a leading e-commerce platform.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003ea leading branded apparel company\u003c/strong\u003e\u0026nbsp;in an FTC merger investigation of an acquisition of a competitor.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eHanesBrands, Inc.,\u003c/strong\u003e\u0026nbsp;one of the leading providers of licensed athletic apparel and related services, in its collaboration with Fanatics, Inc.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003ea leading manufacturer and retailer of recreational boats\u003c/strong\u003e\u0026nbsp;in an FTC investigation of the acquisition of a competitor.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eThe Belk Stores\u003c/strong\u003e\u0026nbsp;in an FTC merger investigation of its acquisitions of the Parisian, Proffitt\u0026rsquo;s and McCrae\u0026rsquo;s department store chains from Saks Fifth Avenue.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eMcLane Company\u003c/strong\u003e\u0026nbsp;in a Section 1 Sherman Act in an action in federal District Court in Connecticut.\u0026nbsp;\u003cem\u003e(Loretta N. Bansavich D/B/A/Lori\u0026rsquo;s Mobil v. McLane Company, Inc.)\u003c/em\u003e.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eTechnology\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eEquifax\u0026nbsp;\u003c/strong\u003ein numerous strategic transactions, including the acquisitions of LawLogix Edge and LawLogix Guardian software solutions, Midigator Holdings, LLC, a leading provider of post-transaction fraud mitigation solutions, Appriss Insights, a trusted and comprehensive source of risk and criminal justice data intelligence, Health e(fx), a leading and experienced provider of Affordable Care Act digital services, Teletrack, a U.S. leader in alternative credit data and Kount, a leading provider of post-transaction fraud mitigation solutions.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eMailchimp\u003c/strong\u003e, a world-class, global customer engagement and marketing platform, in a DOJ investigation of its $12 billion acquisition by Mountain View, CA-based Intuit Inc.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eCox Enterprises\u003c/strong\u003e\u0026nbsp;in its acquisition of Logicworks, which provides cloud management, automation, migration, and operations services.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eRed Ventures\u003c/strong\u003e, whose portfolio includes\u0026nbsp;\u003cstrong\u003eHealthline\u003c/strong\u003e, a leading digital health company in its $675 million acquisition of Healthgrades.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eSharecare\u003c/strong\u003e, a leading digital health company, in its $3.9 billion SPAC merger with Falcon Capital.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eBrookfield Infrastructure Group\u003c/strong\u003e\u0026nbsp;in its $1.1 billion acquisition of 31 Data Centers in 10 Countries on 4 Continents from AT\u0026amp;T.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eChoicePoint\u003c/strong\u003e\u0026nbsp;in an FTC merger investigation of ChoicePoint\u0026rsquo;s acquisition by Reed Elsevier.\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eSprint\u003c/strong\u003e\u0026nbsp;in a DOJ investigation of its $35 billion merger with Nextel.\u003c/p\u003e"],"recognitions":[{"title":"Recognized practitioner and leading antitrust lawyer","detail":"Chambers USA, Legal 500 and Super Lawyers"},{"title":"Named one of the “Outstanding Healthcare Antitrust Lawyers” in the U.S.","detail":"Nightingale Healthcare News"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":1194}]},"capability_group_id":2},"created_at":"2025-11-05T05:03:37.000Z","updated_at":"2025-11-05T05:03:37.000Z","searchable_text":"Spigel{{ FIELD }}{:title=\u0026gt;\"Recognized practitioner and leading antitrust lawyer\", :detail=\u0026gt;\"Chambers USA, Legal 500 and Super Lawyers\"}{{ FIELD }}{:title=\u0026gt;\"Named one of the “Outstanding Healthcare Antitrust Lawyers” in the U.S.\", :detail=\u0026gt;\"Nightingale Healthcare News\"}{{ FIELD }}Agricultural/Food\nDefending a leading food company in DOJ and State AG antitrust investigations.{{ FIELD }}Successfully represented Viserion Grain, LLC, in DOJ’s approval of its acquisition of 11 grain elevator facilities from Zen-Noh Grain Corporation (“ZGC”). These facilities were required to be divested to remedy the DOJ’s challenge of ZGC’s acquisition of multiple grain facilities from Bunge North America.{{ FIELD }}Successfully represented Rockstar, a leading energy drink maker, in an FTC investigation of its $3.85 billion acquisition by PepsiCo Inc.{{ FIELD }}Energy\nSuccessfully represented a leading provider of natural gas processing and treatment and compression products and services in a DOJ merger investigation of a merger with a competitor.{{ FIELD }}Successfully represented ConocoPhillips on the sale of its Canadian oil, sand, and gas assets to Cenovus in a $13.3 billion transaction.{{ FIELD }}Successfully represented one of the leading operators and builders of offshore supply vessels in a DOJ investigation of an acquisition of a leading provider of repair services and construction of offshore and military vessels.{{ FIELD }}Successfully represented a leading manufacturer of drill bits used in mining and oil and gas exploration in a DOJ investigation of its acquisition by a competitor.{{ FIELD }}Successfully represented a major global energy company in a DOJ criminal antitrust investigation.{{ FIELD }}Successfully represented Weatherford International in the sale of its pipeline business to Baker Hughes.{{ FIELD }}Successfully represented Marubeni-Itochu Tubulars on its acquisition of the casing and tubing business of Oil States International.{{ FIELD }}Successfully represented Transocean Ltd. in connection with its $2.7 billion acquisition of Ocean Rig UDW, Inc., in the offshore oil and gas drilling sector and successfully obtained antitrust clearances in several jurisdictions around the world.{{ FIELD }}Successfully represented LS Power in obtaining antitrust clearances for various acquisitions of electric power-generating assets from several independent power producers around the U.S. and provided continued antitrust advice on subsequent potential transactions.{{ FIELD }}Successfully represented one of the world’s largest integrated petroleum companies in an industry-wide investigation of gasoline prices by the FTC and Congress.{{ FIELD }}Successfully represented Mirant Corporation in a DOJ antitrust investigation of its merger with RRI Energy. The transaction closed without DOJ action.{{ FIELD }}Entertainment\nSuccessfully represented Cox Enterprises in its acquisition of Axios Media.{{ FIELD }}Successfully represented Carmike Cinemas in a DOJ investigation of its merger with AMC Theatres. Successfully negotiated a settlement with the DOJ. (United States of America v. AMC Entertainment Holdings, Inc.).{{ FIELD }}Financial Services\nSuccessfully represented a leading payment processor in a DOJ merger investigation of its acquisition by a competitor.{{ FIELD }}Defending Equifax in antitrust litigation filed against it, TransUnion and Experian alleging violations of federal and California antitrust laws. (Adams v. Experian Information Solutions, Inc. et al., E.D. Calif. (2:23-cv-01773).{{ FIELD }}Successfully represented TSYS, a leading global payments provider, in merger clearances of its $54 billion all-stock merger of equals with Global Payments, a worldwide provider of payment technology and software solutions.{{ FIELD }}Successfully represented Bank of America in an FTC consumer protection investigation and litigation of Countrywide Financial Corporation related to Countrywide’s mortgage loan servicing practices.{{ FIELD }}Healthcare/Life Sciences\nSuccessfully represented a leading manufacturer of dental bone grafting products in a DOJ merger investigation of an acquisition by a competitor.{{ FIELD }}Successfully represented Ochsner Health System regarding Lafayette General Health System’s merger into Ochsner.{{ FIELD }}Successfully represented Ochsner Health System in the formation of a joint venture with LSU to acquire University Health Hospitals from BRFHH.{{ FIELD }}Successfully represented Ochsner Health System in forming JOAs with CHRISTUS Louisiana, Lafayette General Health, Slidell Memorial Hospital, St. Tammany Parish Hospital, and Terrebonne General Medical Center.{{ FIELD }}Successfully represented Ochsner Health System in its acquisition of Rush Health Systems, which added seven hospitals to extend Ochsner’s reach to east Mississippi/west Alabama region.{{ FIELD }}Successfully represented Piedmont Healthcare, Inc. in the acquisition of four hospitals in North Georgia and Macon from HCA Healthcare.{{ FIELD }}Successfully represented Piedmont Healthcare in an FTC merger investigation of its acquisition of University Healthcare.{{ FIELD }}Successfully represented Houston Methodist in an FTC and Texas AG investigation of its acquisition of two CHRISTUS hospitals in the metropolitan Houston area.{{ FIELD }}Successfully represented St. Joseph’s Health System in an FTC investigation of its formation of a JOA with Emory Healthcare.{{ FIELD }}Successfully represented University of Texas Southwestern Medical Center (UTSW) in an FTC and Texas AG investigation of its formation of a JOA with Texas Health Resources.{{ FIELD }}Successfully represented King’s Daughter Hospital in its acquisition by Scott \u0026amp; White Healthcare, which ultimately received clearance from the FTC under a failing firm defense.{{ FIELD }}Successfully represented a 1,000-plus member, exclusive clinically-integrated physician network in an FTC price fixing investigation.{{ FIELD }}Successfully represented physician clients and their messenger model network in an FTC civil price fixing and concerted refusal to deal investigation.{{ FIELD }}Successfully represented Hospital Corporation of America in a Sections 1 and 2 Sherman Act (tying) federal antitrust action against a competing hospital system. (Palmyra Park Medical Center, Inc. v. Phoebe Putney Memorial Hospital, Inc., et al.).{{ FIELD }}Successfully defended a branded pharmaceutical manufacturer in DOJ and FTC antitrust investigations of a proposed patent settlement and the use of authorized generics.{{ FIELD }}Manufacturing/Chemical/Paper\nSuccessfully represented Quikrete Holdings, Inc. in a DOJ merger investigation of its acquisition of Forterra Inc.{{ FIELD }}Successfully represented WestRock, which is a leading manufacturer of containerboard and paperboard, in DOJ and other competition authorities’ investigations of strategic transactions, including WestRock’s $16 billion merger with MeadWestvaco, its $2.28 billion acquisition of MultiPackaging Solution, its $4.9 billion acquisition of KapStone, and its sale of its partitions business to Sonoco.{{ FIELD }}Successfully represented Schweitzer-Mauduit International, Inc. (now known as Mativ) in a DOJ investigation of its merger of equals with Neenah, Inc.{{ FIELD }}Successfully represented H.I.G. CAPITAL and its subsidiary DCL Corporation as the divestiture buyer of Sun Chemical’s DIC Corporation Bushy Park assets in front of the Federal Trade Commission, European Commission and the Japanese Fair Trade Commission as part of a settlement regarding DIC’s acquisition by BASF’s pigment business.{{ FIELD }}Successfully represented global chemical company Kraton Corporation in its merger with DL Chemical Co., Ltd., a subsidiary of DL Holdings Co., Ltd. (formerly Daelim Industrial Co., Ltd.).{{ FIELD }}Successfully represented Forterra Brick on the combination of its brick business with Boral Brick as part of the formation of a new joint venture.{{ FIELD }}Successfully represented Forterra Building Products in its acquisition of U.S. Pipe.{{ FIELD }}Successfully represented Lafarge on numerous strategic transactions.{{ FIELD }}Defended UCAR International (now GrafTech) in a federal grand jury price fixing investigation of graphite electrodes. (United States v. UCAR International Inc.).{{ FIELD }}Retail\nSuccessfully represented a leading home furnishing company in an FTC merger investigation of a leading e-commerce platform.{{ FIELD }}Successfully represented a leading branded apparel company in an FTC merger investigation of an acquisition of a competitor.{{ FIELD }}Successfully represented HanesBrands, Inc., one of the leading providers of licensed athletic apparel and related services, in its collaboration with Fanatics, Inc.{{ FIELD }}Successfully represented a leading manufacturer and retailer of recreational boats in an FTC investigation of the acquisition of a competitor.{{ FIELD }}Successfully represented The Belk Stores in an FTC merger investigation of its acquisitions of the Parisian, Proffitt’s and McCrae’s department store chains from Saks Fifth Avenue.{{ FIELD }}Successfully represented McLane Company in a Section 1 Sherman Act in an action in federal District Court in Connecticut. (Loretta N. Bansavich D/B/A/Lori’s Mobil v. McLane Company, Inc.).{{ FIELD }}Technology\nSuccessfully represented Equifax in numerous strategic transactions, including the acquisitions of LawLogix Edge and LawLogix Guardian software solutions, Midigator Holdings, LLC, a leading provider of post-transaction fraud mitigation solutions, Appriss Insights, a trusted and comprehensive source of risk and criminal justice data intelligence, Health e(fx), a leading and experienced provider of Affordable Care Act digital services, Teletrack, a U.S. leader in alternative credit data and Kount, a leading provider of post-transaction fraud mitigation solutions.{{ FIELD }}Successfully represented Mailchimp, a world-class, global customer engagement and marketing platform, in a DOJ investigation of its $12 billion acquisition by Mountain View, CA-based Intuit Inc.{{ FIELD }}Successfully represented Cox Enterprises in its acquisition of Logicworks, which provides cloud management, automation, migration, and operations services.{{ FIELD }}Successfully represented Red Ventures, whose portfolio includes Healthline, a leading digital health company in its $675 million acquisition of Healthgrades.{{ FIELD }}Successfully represented Sharecare, a leading digital health company, in its $3.9 billion SPAC merger with Falcon Capital.{{ FIELD }}Successfully represented Brookfield Infrastructure Group in its $1.1 billion acquisition of 31 Data Centers in 10 Countries on 4 Continents from AT\u0026amp;T.{{ FIELD }}Successfully represented ChoicePoint in an FTC merger investigation of ChoicePoint’s acquisition by Reed Elsevier.{{ FIELD }}Successfully represented Sprint in a DOJ investigation of its $35 billion merger with Nextel.{{ FIELD }}Jeff Spigel focuses on advising clients on the antitrust issues related to successfully executing their business strategy. As a partner and co-head of our global Antitrust practice, clients routinely seek Jeff’s practical and business-friendly advice to guide them through their strategic transactions, criminal grand jury and civil DOJ, FTC, State AG and antitrust investigations and litigation. Working with our Brussels antitrust lawyers, Jeff also defends clients in multi-jurisdictional investigations that coordinate with the U.S., including the European Commission and the UK’s CMA.\nJeff represents clients in responding to a range of civil and criminal antitrust investigations in the U.S. and abroad, obtaining Hart-Scott-Rodino clearance and coordinating approvals of proposed transactions in foreign jurisdictions. He also advises clients on pursuing or defending against antitrust claims and counsels on strategic antitrust issues such as those arising from benchmarking, compliance and audits, competitor collaborations, exclusivity and foreclosure, resale price maintenance, Robinson-Patman price discrimination, refusals to deal, and tying and predatory bundling issues.\nWith significant experience in the healthcare sector, Jeff frequently advises healthcare clients on strategic transactions, messenger model networks, financially- and/or clinically-integrated networks, Group Purchasing Organizations and claims by commercial payors, competitors, or the government.\nJeff’s antitrust experience also includes advising clients in a broad range of industries such as building materials, chemicals, communications, consumer products, energy (oil, gas, power, and renewables), entertainment, financial, metals, paper, pharmaceutical, retail, technology, and transportation.\nOn behalf of his clients, Jeff appears regularly before the U.S. Department of Justice and the Federal Trade Commission, and he coordinates with foreign counsel in dealing with competition authorities in jurisdictions around the globe, including before the European Commission. In addition, he represents clients on unfair and deceptive trade practice matters before the Federal Trade Commission, Consumer Financial Protection Bureau, and state attorneys general.\nA regular author and speaker, Chambers USA, Legal 500 and Super Lawyers have identified Jeff as a recognized practitioner and leading antitrust lawyer. In addition, Nightingale Healthcare News named him one of the “Outstanding Healthcare Antitrust Lawyers” in the U.S. Partner Recognized practitioner and leading antitrust lawyer Chambers USA, Legal 500 and Super Lawyers Named one of the “Outstanding Healthcare Antitrust Lawyers” in the U.S. Nightingale Healthcare News Emory University Emory University School of Law University of Miami University of Miami School of Law Georgetown University Georgetown University Law Center U.S. District Court for the District of Columbia District of Columbia Tennessee The District of Columbia Bar American Health Lawyers Association American Bar Association Section of Antitrust Law Agricultural/Food\nDefending a leading food company in DOJ and State AG antitrust investigations. Successfully represented Viserion Grain, LLC, in DOJ’s approval of its acquisition of 11 grain elevator facilities from Zen-Noh Grain Corporation (“ZGC”). These facilities were required to be divested to remedy the DOJ’s challenge of ZGC’s acquisition of multiple grain facilities from Bunge North America. Successfully represented Rockstar, a leading energy drink maker, in an FTC investigation of its $3.85 billion acquisition by PepsiCo Inc. Energy\nSuccessfully represented a leading provider of natural gas processing and treatment and compression products and services in a DOJ merger investigation of a merger with a competitor. Successfully represented ConocoPhillips on the sale of its Canadian oil, sand, and gas assets to Cenovus in a $13.3 billion transaction. Successfully represented one of the leading operators and builders of offshore supply vessels in a DOJ investigation of an acquisition of a leading provider of repair services and construction of offshore and military vessels. Successfully represented a leading manufacturer of drill bits used in mining and oil and gas exploration in a DOJ investigation of its acquisition by a competitor. Successfully represented a major global energy company in a DOJ criminal antitrust investigation. Successfully represented Weatherford International in the sale of its pipeline business to Baker Hughes. Successfully represented Marubeni-Itochu Tubulars on its acquisition of the casing and tubing business of Oil States International. Successfully represented Transocean Ltd. in connection with its $2.7 billion acquisition of Ocean Rig UDW, Inc., in the offshore oil and gas drilling sector and successfully obtained antitrust clearances in several jurisdictions around the world. Successfully represented LS Power in obtaining antitrust clearances for various acquisitions of electric power-generating assets from several independent power producers around the U.S. and provided continued antitrust advice on subsequent potential transactions. Successfully represented one of the world’s largest integrated petroleum companies in an industry-wide investigation of gasoline prices by the FTC and Congress. Successfully represented Mirant Corporation in a DOJ antitrust investigation of its merger with RRI Energy. The transaction closed without DOJ action. Entertainment\nSuccessfully represented Cox Enterprises in its acquisition of Axios Media. Successfully represented Carmike Cinemas in a DOJ investigation of its merger with AMC Theatres. Successfully negotiated a settlement with the DOJ. (United States of America v. AMC Entertainment Holdings, Inc.). Financial Services\nSuccessfully represented a leading payment processor in a DOJ merger investigation of its acquisition by a competitor. Defending Equifax in antitrust litigation filed against it, TransUnion and Experian alleging violations of federal and California antitrust laws. (Adams v. Experian Information Solutions, Inc. et al., E.D. Calif. (2:23-cv-01773). Successfully represented TSYS, a leading global payments provider, in merger clearances of its $54 billion all-stock merger of equals with Global Payments, a worldwide provider of payment technology and software solutions. Successfully represented Bank of America in an FTC consumer protection investigation and litigation of Countrywide Financial Corporation related to Countrywide’s mortgage loan servicing practices. Healthcare/Life Sciences\nSuccessfully represented a leading manufacturer of dental bone grafting products in a DOJ merger investigation of an acquisition by a competitor. Successfully represented Ochsner Health System regarding Lafayette General Health System’s merger into Ochsner. Successfully represented Ochsner Health System in the formation of a joint venture with LSU to acquire University Health Hospitals from BRFHH. Successfully represented Ochsner Health System in forming JOAs with CHRISTUS Louisiana, Lafayette General Health, Slidell Memorial Hospital, St. Tammany Parish Hospital, and Terrebonne General Medical Center. Successfully represented Ochsner Health System in its acquisition of Rush Health Systems, which added seven hospitals to extend Ochsner’s reach to east Mississippi/west Alabama region. Successfully represented Piedmont Healthcare, Inc. in the acquisition of four hospitals in North Georgia and Macon from HCA Healthcare. Successfully represented Piedmont Healthcare in an FTC merger investigation of its acquisition of University Healthcare. Successfully represented Houston Methodist in an FTC and Texas AG investigation of its acquisition of two CHRISTUS hospitals in the metropolitan Houston area. Successfully represented St. Joseph’s Health System in an FTC investigation of its formation of a JOA with Emory Healthcare. Successfully represented University of Texas Southwestern Medical Center (UTSW) in an FTC and Texas AG investigation of its formation of a JOA with Texas Health Resources. Successfully represented King’s Daughter Hospital in its acquisition by Scott \u0026amp; White Healthcare, which ultimately received clearance from the FTC under a failing firm defense. Successfully represented a 1,000-plus member, exclusive clinically-integrated physician network in an FTC price fixing investigation. Successfully represented physician clients and their messenger model network in an FTC civil price fixing and concerted refusal to deal investigation. Successfully represented Hospital Corporation of America in a Sections 1 and 2 Sherman Act (tying) federal antitrust action against a competing hospital system. (Palmyra Park Medical Center, Inc. v. Phoebe Putney Memorial Hospital, Inc., et al.). Successfully defended a branded pharmaceutical manufacturer in DOJ and FTC antitrust investigations of a proposed patent settlement and the use of authorized generics. Manufacturing/Chemical/Paper\nSuccessfully represented Quikrete Holdings, Inc. in a DOJ merger investigation of its acquisition of Forterra Inc. Successfully represented WestRock, which is a leading manufacturer of containerboard and paperboard, in DOJ and other competition authorities’ investigations of strategic transactions, including WestRock’s $16 billion merger with MeadWestvaco, its $2.28 billion acquisition of MultiPackaging Solution, its $4.9 billion acquisition of KapStone, and its sale of its partitions business to Sonoco. Successfully represented Schweitzer-Mauduit International, Inc. (now known as Mativ) in a DOJ investigation of its merger of equals with Neenah, Inc. Successfully represented H.I.G. CAPITAL and its subsidiary DCL Corporation as the divestiture buyer of Sun Chemical’s DIC Corporation Bushy Park assets in front of the Federal Trade Commission, European Commission and the Japanese Fair Trade Commission as part of a settlement regarding DIC’s acquisition by BASF’s pigment business. Successfully represented global chemical company Kraton Corporation in its merger with DL Chemical Co., Ltd., a subsidiary of DL Holdings Co., Ltd. (formerly Daelim Industrial Co., Ltd.). Successfully represented Forterra Brick on the combination of its brick business with Boral Brick as part of the formation of a new joint venture. Successfully represented Forterra Building Products in its acquisition of U.S. Pipe. Successfully represented Lafarge on numerous strategic transactions. Defended UCAR International (now GrafTech) in a federal grand jury price fixing investigation of graphite electrodes. (United States v. UCAR International Inc.). Retail\nSuccessfully represented a leading home furnishing company in an FTC merger investigation of a leading e-commerce platform. Successfully represented a leading branded apparel company in an FTC merger investigation of an acquisition of a competitor. Successfully represented HanesBrands, Inc., one of the leading providers of licensed athletic apparel and related services, in its collaboration with Fanatics, Inc. Successfully represented a leading manufacturer and retailer of recreational boats in an FTC investigation of the acquisition of a competitor. Successfully represented The Belk Stores in an FTC merger investigation of its acquisitions of the Parisian, Proffitt’s and McCrae’s department store chains from Saks Fifth Avenue. Successfully represented McLane Company in a Section 1 Sherman Act in an action in federal District Court in Connecticut. (Loretta N. Bansavich D/B/A/Lori’s Mobil v. McLane Company, Inc.). Technology\nSuccessfully represented Equifax in numerous strategic transactions, including the acquisitions of LawLogix Edge and LawLogix Guardian software solutions, Midigator Holdings, LLC, a leading provider of post-transaction fraud mitigation solutions, Appriss Insights, a trusted and comprehensive source of risk and criminal justice data intelligence, Health e(fx), a leading and experienced provider of Affordable Care Act digital services, Teletrack, a U.S. leader in alternative credit data and Kount, a leading provider of post-transaction fraud mitigation solutions. Successfully represented Mailchimp, a world-class, global customer engagement and marketing platform, in a DOJ investigation of its $12 billion acquisition by Mountain View, CA-based Intuit Inc. Successfully represented Cox Enterprises in its acquisition of Logicworks, which provides cloud management, automation, migration, and operations services. Successfully represented Red Ventures, whose portfolio includes Healthline, a leading digital health company in its $675 million acquisition of Healthgrades. Successfully represented Sharecare, a leading digital health company, in its $3.9 billion SPAC merger with Falcon Capital. Successfully represented Brookfield Infrastructure Group in its $1.1 billion acquisition of 31 Data Centers in 10 Countries on 4 Continents from AT\u0026amp;T. Successfully represented ChoicePoint in an FTC merger investigation of ChoicePoint’s acquisition by Reed Elsevier. Successfully represented Sprint in a DOJ investigation of its $35 billion merger with Nextel.","searchable_name":"Jeffrey S. Spigel (Jeff)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":436386,"version":1,"owner_type":"Person","owner_id":2856,"payload":{"bio":"\u003cp\u003ePeter A. Strotz has been litigating tort, product liability, and commercial matters for over 30 years\u0026nbsp;and has first-chaired dozens of trials in courts throughout California and the U.S.\u0026nbsp; His\u0026nbsp;cases involve\u0026nbsp;novel medical, scientific and legal issues for global manufacturing companies, including pharmaceutical, healthcare, oil, gas, engineered and specialty materials, paints, and coatings companies.\u0026nbsp; Peter has acted as national, regional and local trial counsel in a variety of commercial, antitrust, and toxic tort matters.\u0026nbsp; He is\u0026nbsp;the founding and managing partner of the firm\u0026rsquo;s Los Angeles, California office.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePeter is a senior member\u0026nbsp;of the firm\u0026rsquo;s Product Liability Practice, which was selected by\u0026nbsp;\u003cem\u003eLaw360\u003c/em\u003e\u0026nbsp;as the Product Liability Group of the Year for seven of the last eight years.\u0026nbsp;In what was recognized as a Top Verdict of 2019 by\u0026nbsp;\u003cem\u003eThe Daily Journal,\u0026nbsp;\u003c/em\u003ePeter\u0026nbsp;achieved a complete defense verdict on behalf of Prime Healthcare against the California Department of Insurance (CDI) and a Relator in a major Insurance Frauds Prevention Act trial in Los Angeles County Superior Court that established a precedent for healthcare providers facing these types of allegations.\u003c/p\u003e","slug":"peter-strotz","email":"pstrotz@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cstrong\u003ePharmaceutical\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eServes as national coordinating counsel for\u0026nbsp;\u003cstrong\u003ea major innovator pharmaceutical company\u003c/strong\u003e\u0026nbsp;in the defense of hundreds of claims that treatment with a widely prescribed branded statin causes diabetes, cardiovascular problems, and liver and kidney problems.\u003c/p\u003e","\u003cp\u003eActed as California counsel for\u0026nbsp;\u003cstrong\u003ea major pharmaceutical company\u003c/strong\u003e\u0026nbsp;in the defense of product liability litigation involving a branded proton pump inhibitor.\u003c/p\u003e","\u003cp\u003eRepresents\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eGlaxoSmithKline\u003c/strong\u003e\u0026nbsp;in product liability cases in California involving claims of birth defects.\u003c/p\u003e","\u003cp\u003eDefends\u0026nbsp;\u003cstrong\u003ea global pharmaceutical company\u003c/strong\u003e\u0026nbsp;in product liability cases involving the administration of a corticosteroid.\u003c/p\u003e","\u003cp\u003eServed on the national trial and leadership teams representing\u0026nbsp;\u003cstrong\u003ea major innovator pharmaceutical company\u003c/strong\u003e\u0026nbsp;in the defense of claims that an antipsychotic medication causes weight gain, diabetes, and pancreatitis.\u003c/p\u003e","\u003cp\u003eDefended\u0026nbsp;\u003cstrong\u003ethe manufacturer of a dental anesthetic\u003c/strong\u003e\u0026nbsp;in product liability cases filed throughout the U.S.\u003c/p\u003e","\u003cp\u003eActed as California counsel representing\u0026nbsp;\u003cstrong\u003ea major innovator pharmaceutical company\u003c/strong\u003e\u0026nbsp;in the defense of multiple personal injury cases which involved claims that pain pumps cause degeneration of shoulder joint cartilage.\u003c/p\u003e","\u003cp\u003eServed as California trial counsel for\u0026nbsp;\u003cstrong\u003ea global brand name pharmaceutical company\u003c/strong\u003e\u0026nbsp;in an action brought by independent pharmacies alleging a nationwide price-fixing conspiracy among the manufacturers of brand name prescription drugs.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eThe Dow Chemical Company\u003c/strong\u003e\u0026nbsp;as the alleged successor to the manufacturer of the Salk polio vaccine. In numerous product liability actions filed by individual plaintiffs in San Francisco, Los Angeles and Orange counties, Peter led a team that successfully formulated an end-game strategy resulting in the statewide dismissals of all plaintiffs\u0026rsquo; claims at the pleading stage.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eSmartHealth Inc.,\u003c/strong\u003e\u0026nbsp;in the defense of the latex glove product liability cases.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eHealthcare\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eAchieved a defense verdict on behalf of a hospital and healthcare system in a\u0026nbsp;\u003cem\u003equi tam\u003c/em\u003e\u0026nbsp;trial involving allegations of healthcare fraud related to licensing and patient steering brought by a Relator and the California Department of Insurance.\u003c/p\u003e","\u003cp\u003eRepresents\u0026nbsp;\u003cstrong\u003ea South American Public Health Agency\u003c/strong\u003e\u0026nbsp;in a breach of contract action arising out of its attempted purchase of ventilators to address the Covid-19 health crisis.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eToxic Tort \u0026ndash; Benzene\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented a number of Fortune and Global 1000 companies, including\u0026nbsp;\u003cstrong\u003eAkzoNobel, D Aircraft Products, Cytec Industries, Inc., Indopco, Inc.,\u0026nbsp;\u003c/strong\u003eand\u0026nbsp;\u003cstrong\u003eChevron U.S.A. Inc.\u003c/strong\u003e, in personal injury cases venued in Northern and Southern California, involving claims of exposure to benzene.\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eToxic Tort \u0026ndash; Silica\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eLed a team that represented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eChevron U.S.A. Inc., Union Oil Company of California and Hewlett-Packard Company\u003c/strong\u003e\u0026nbsp;in the defense of silica-related product and premises personal injury claims filed in California state court.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eToxic Tort \u0026ndash; Asbestos\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDefends Chevron U.S.A. Inc. and Texaco Inc. in cases involving claims of exposure to asbestos at the Abadan Refinery in Iran in the 1950s, 1960s and 1970s. Won summary judgments in four cases and won appellate arguments in the cases where those summary judgment wins have been appealed.\u003c/p\u003e","\u003cp\u003eHandled, through trial verdict, asbestos product and premises liability dockets throughout the State of California on behalf of numerous companies, including\u0026nbsp;\u003cstrong\u003eChevron U.S.A. Inc., Texaco Inc., Unocal Corporation, Hewlett-Packard Company, UOP LLC, The Glidden Company, American Cyanamid Company, Fiberite Inc, Flintkote, Western MacArthur, Baxter Healthcare, The Dow Chemical Company and Rhone-Poulenc,\u003c/strong\u003e\u0026nbsp;for a period of over 25 years. He obtained a defense verdict for Fiberite after a seven-week jury trial in Los Angeles County Superior Court where plaintiff claimed he developed mesothelioma as a result of exposure to a Fiberite molding compound.\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eToxic Tort \u0026ndash; Agricultural Chemicals\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eActed as national counsel for\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ethe manufacturer of synthetic pyrethrin pesticides\u003c/strong\u003e\u0026nbsp;in product liability actions filed throughout the United States.\u003c/p\u003e","\u003cp\u003eServed as co-counsel on a trial team that obtained a defense verdict in an alleged Paraquat\u0026reg; exposure trial in a California state action.\u003c/p\u003e","\u003cp\u003eServed on a team that successfully defended\u003cstrong\u003e\u0026nbsp;Rhone-Poulenc (nka Rhodia)\u0026nbsp;\u003c/strong\u003ein the personal injury claims of over 400 individuals arising out of a chemical fire at a sulfuric acid regeneration facility in Martinez, California. Lead Paint.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eLead Paint\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eAmerican Cyanamid Company\u003c/strong\u003e\u0026nbsp;in an action being prosecuted by cities and counties throughout the State of California against the manufacturers of paint pigments alleging that presence of lead in paint in commercial and residential buildings constituted a public nuisance.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eMtBE\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eChevron U.S.A. Inc. and Union Oil Company of California\u003c/strong\u003e\u0026nbsp;in Methyl Tertiary Butyl Ether (MtBE) cases involving claims of personal injury and groundwater contamination.\u003c/p\u003e","\u003cp\u003eObtained a defense verdict in favor of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea specialty ink manufacturer\u003c/strong\u003e\u0026nbsp;in a commercial sales action.\u003c/p\u003e","\u003cp\u003eDefended successfully\u0026nbsp;\u003cstrong\u003ethe manufacturer of food flavoring products\u003c/strong\u003e\u0026nbsp;in a commercial action filed in federal district court.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eCommercial Design Claims.\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDefending\u0026nbsp;\u003cstrong\u003ea process design engineering company\u003c/strong\u003e\u0026nbsp;in professional negligence claims and recently won a nonsuit after a five-week jury trial in Los Angeles County Superior Court.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":1,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":2,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":5,"source":"smartTags"},{"id":17,"guid":"17.capabilities","index":6,"source":"capabilities"},{"id":16,"guid":"16.capabilities","index":7,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":8,"source":"capabilities"},{"id":1303,"guid":"1303.smart_tags","index":9,"source":"smartTags"},{"id":970,"guid":"970.smart_tags","index":10,"source":"smartTags"}],"is_active":true,"last_name":"Strotz","nick_name":"Peter","clerkships":[],"first_name":"Peter","title_rank":9999,"updated_by":196,"law_schools":[],"middle_name":"A.","name_suffix":"","recognitions":[{"title":"Outstanding Individual in Product Liability","detail":"Who's Who Legal 2019"},{"title":"Best Lawyers in America","detail":"2013 – 2017"},{"title":"San Francisco’s Best Lawyers","detail":"2013"},{"title":"Recommended Lawyer for Product Liability and Mass Tort Defense: Toxic Tort (Tier 1) ","detail":"U.S. Legal 500 , 2013. 2015 and 2016"},{"title":"Highest AV Rating ","detail":"Martindale-Hubbell"},{"title":"Super Lawyer ","detail":"San Francisco Magazine, 2004–2006, 2011–2013"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003ePeter A. Strotz has been litigating tort, product liability, and commercial matters for over 30 years\u0026nbsp;and has first-chaired dozens of trials in courts throughout California and the U.S.\u0026nbsp; His\u0026nbsp;cases involve\u0026nbsp;novel medical, scientific and legal issues for global manufacturing companies, including pharmaceutical, healthcare, oil, gas, engineered and specialty materials, paints, and coatings companies.\u0026nbsp; Peter has acted as national, regional and local trial counsel in a variety of commercial, antitrust, and toxic tort matters.\u0026nbsp; He is\u0026nbsp;the founding and managing partner of the firm\u0026rsquo;s Los Angeles, California office.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePeter is a senior member\u0026nbsp;of the firm\u0026rsquo;s Product Liability Practice, which was selected by\u0026nbsp;\u003cem\u003eLaw360\u003c/em\u003e\u0026nbsp;as the Product Liability Group of the Year for seven of the last eight years.\u0026nbsp;In what was recognized as a Top Verdict of 2019 by\u0026nbsp;\u003cem\u003eThe Daily Journal,\u0026nbsp;\u003c/em\u003ePeter\u0026nbsp;achieved a complete defense verdict on behalf of Prime Healthcare against the California Department of Insurance (CDI) and a Relator in a major Insurance Frauds Prevention Act trial in Los Angeles County Superior Court that established a precedent for healthcare providers facing these types of allegations.\u003c/p\u003e","matters":["\u003cp\u003e\u003cstrong\u003ePharmaceutical\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eServes as national coordinating counsel for\u0026nbsp;\u003cstrong\u003ea major innovator pharmaceutical company\u003c/strong\u003e\u0026nbsp;in the defense of hundreds of claims that treatment with a widely prescribed branded statin causes diabetes, cardiovascular problems, and liver and kidney problems.\u003c/p\u003e","\u003cp\u003eActed as California counsel for\u0026nbsp;\u003cstrong\u003ea major pharmaceutical company\u003c/strong\u003e\u0026nbsp;in the defense of product liability litigation involving a branded proton pump inhibitor.\u003c/p\u003e","\u003cp\u003eRepresents\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eGlaxoSmithKline\u003c/strong\u003e\u0026nbsp;in product liability cases in California involving claims of birth defects.\u003c/p\u003e","\u003cp\u003eDefends\u0026nbsp;\u003cstrong\u003ea global pharmaceutical company\u003c/strong\u003e\u0026nbsp;in product liability cases involving the administration of a corticosteroid.\u003c/p\u003e","\u003cp\u003eServed on the national trial and leadership teams representing\u0026nbsp;\u003cstrong\u003ea major innovator pharmaceutical company\u003c/strong\u003e\u0026nbsp;in the defense of claims that an antipsychotic medication causes weight gain, diabetes, and pancreatitis.\u003c/p\u003e","\u003cp\u003eDefended\u0026nbsp;\u003cstrong\u003ethe manufacturer of a dental anesthetic\u003c/strong\u003e\u0026nbsp;in product liability cases filed throughout the U.S.\u003c/p\u003e","\u003cp\u003eActed as California counsel representing\u0026nbsp;\u003cstrong\u003ea major innovator pharmaceutical company\u003c/strong\u003e\u0026nbsp;in the defense of multiple personal injury cases which involved claims that pain pumps cause degeneration of shoulder joint cartilage.\u003c/p\u003e","\u003cp\u003eServed as California trial counsel for\u0026nbsp;\u003cstrong\u003ea global brand name pharmaceutical company\u003c/strong\u003e\u0026nbsp;in an action brought by independent pharmacies alleging a nationwide price-fixing conspiracy among the manufacturers of brand name prescription drugs.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eThe Dow Chemical Company\u003c/strong\u003e\u0026nbsp;as the alleged successor to the manufacturer of the Salk polio vaccine. In numerous product liability actions filed by individual plaintiffs in San Francisco, Los Angeles and Orange counties, Peter led a team that successfully formulated an end-game strategy resulting in the statewide dismissals of all plaintiffs\u0026rsquo; claims at the pleading stage.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eSmartHealth Inc.,\u003c/strong\u003e\u0026nbsp;in the defense of the latex glove product liability cases.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eHealthcare\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eAchieved a defense verdict on behalf of a hospital and healthcare system in a\u0026nbsp;\u003cem\u003equi tam\u003c/em\u003e\u0026nbsp;trial involving allegations of healthcare fraud related to licensing and patient steering brought by a Relator and the California Department of Insurance.\u003c/p\u003e","\u003cp\u003eRepresents\u0026nbsp;\u003cstrong\u003ea South American Public Health Agency\u003c/strong\u003e\u0026nbsp;in a breach of contract action arising out of its attempted purchase of ventilators to address the Covid-19 health crisis.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eToxic Tort \u0026ndash; Benzene\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented a number of Fortune and Global 1000 companies, including\u0026nbsp;\u003cstrong\u003eAkzoNobel, D Aircraft Products, Cytec Industries, Inc., Indopco, Inc.,\u0026nbsp;\u003c/strong\u003eand\u0026nbsp;\u003cstrong\u003eChevron U.S.A. Inc.\u003c/strong\u003e, in personal injury cases venued in Northern and Southern California, involving claims of exposure to benzene.\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eToxic Tort \u0026ndash; Silica\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eLed a team that represented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eChevron U.S.A. Inc., Union Oil Company of California and Hewlett-Packard Company\u003c/strong\u003e\u0026nbsp;in the defense of silica-related product and premises personal injury claims filed in California state court.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eToxic Tort \u0026ndash; Asbestos\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDefends Chevron U.S.A. Inc. and Texaco Inc. in cases involving claims of exposure to asbestos at the Abadan Refinery in Iran in the 1950s, 1960s and 1970s. Won summary judgments in four cases and won appellate arguments in the cases where those summary judgment wins have been appealed.\u003c/p\u003e","\u003cp\u003eHandled, through trial verdict, asbestos product and premises liability dockets throughout the State of California on behalf of numerous companies, including\u0026nbsp;\u003cstrong\u003eChevron U.S.A. Inc., Texaco Inc., Unocal Corporation, Hewlett-Packard Company, UOP LLC, The Glidden Company, American Cyanamid Company, Fiberite Inc, Flintkote, Western MacArthur, Baxter Healthcare, The Dow Chemical Company and Rhone-Poulenc,\u003c/strong\u003e\u0026nbsp;for a period of over 25 years. He obtained a defense verdict for Fiberite after a seven-week jury trial in Los Angeles County Superior Court where plaintiff claimed he developed mesothelioma as a result of exposure to a Fiberite molding compound.\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eToxic Tort \u0026ndash; Agricultural Chemicals\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eActed as national counsel for\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ethe manufacturer of synthetic pyrethrin pesticides\u003c/strong\u003e\u0026nbsp;in product liability actions filed throughout the United States.\u003c/p\u003e","\u003cp\u003eServed as co-counsel on a trial team that obtained a defense verdict in an alleged Paraquat\u0026reg; exposure trial in a California state action.\u003c/p\u003e","\u003cp\u003eServed on a team that successfully defended\u003cstrong\u003e\u0026nbsp;Rhone-Poulenc (nka Rhodia)\u0026nbsp;\u003c/strong\u003ein the personal injury claims of over 400 individuals arising out of a chemical fire at a sulfuric acid regeneration facility in Martinez, California. Lead Paint.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eLead Paint\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eAmerican Cyanamid Company\u003c/strong\u003e\u0026nbsp;in an action being prosecuted by cities and counties throughout the State of California against the manufacturers of paint pigments alleging that presence of lead in paint in commercial and residential buildings constituted a public nuisance.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eMtBE\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eChevron U.S.A. Inc. and Union Oil Company of California\u003c/strong\u003e\u0026nbsp;in Methyl Tertiary Butyl Ether (MtBE) cases involving claims of personal injury and groundwater contamination.\u003c/p\u003e","\u003cp\u003eObtained a defense verdict in favor of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea specialty ink manufacturer\u003c/strong\u003e\u0026nbsp;in a commercial sales action.\u003c/p\u003e","\u003cp\u003eDefended successfully\u0026nbsp;\u003cstrong\u003ethe manufacturer of food flavoring products\u003c/strong\u003e\u0026nbsp;in a commercial action filed in federal district court.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eCommercial Design Claims.\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDefending\u0026nbsp;\u003cstrong\u003ea process design engineering company\u003c/strong\u003e\u0026nbsp;in professional negligence claims and recently won a nonsuit after a five-week jury trial in Los Angeles County Superior Court.\u003c/p\u003e"],"recognitions":[{"title":"Outstanding Individual in Product Liability","detail":"Who's Who Legal 2019"},{"title":"Best Lawyers in America","detail":"2013 – 2017"},{"title":"San Francisco’s Best Lawyers","detail":"2013"},{"title":"Recommended Lawyer for Product Liability and Mass Tort Defense: Toxic Tort (Tier 1) ","detail":"U.S. Legal 500 , 2013. 2015 and 2016"},{"title":"Highest AV Rating ","detail":"Martindale-Hubbell"},{"title":"Super Lawyer ","detail":"San Francisco Magazine, 2004–2006, 2011–2013"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":4719}]},"capability_group_id":3},"created_at":"2025-09-02T04:51:37.000Z","updated_at":"2025-09-02T04:51:37.000Z","searchable_text":"Strotz{{ FIELD }}{:title=\u0026gt;\"Outstanding Individual in Product Liability\", :detail=\u0026gt;\"Who's Who Legal 2019\"}{{ FIELD }}{:title=\u0026gt;\"Best Lawyers in America\", :detail=\u0026gt;\"2013 – 2017\"}{{ FIELD }}{:title=\u0026gt;\"San Francisco’s Best Lawyers\", :detail=\u0026gt;\"2013\"}{{ FIELD }}{:title=\u0026gt;\"Recommended Lawyer for Product Liability and Mass Tort Defense: Toxic Tort (Tier 1) \", :detail=\u0026gt;\"U.S. Legal 500 , 2013. 2015 and 2016\"}{{ FIELD }}{:title=\u0026gt;\"Highest AV Rating \", :detail=\u0026gt;\"Martindale-Hubbell\"}{{ FIELD }}{:title=\u0026gt;\"Super Lawyer \", :detail=\u0026gt;\"San Francisco Magazine, 2004–2006, 2011–2013\"}{{ FIELD }}Pharmaceutical\nServes as national coordinating counsel for a major innovator pharmaceutical company in the defense of hundreds of claims that treatment with a widely prescribed branded statin causes diabetes, cardiovascular problems, and liver and kidney problems.{{ FIELD }}Acted as California counsel for a major pharmaceutical company in the defense of product liability litigation involving a branded proton pump inhibitor.{{ FIELD }}Represents GlaxoSmithKline in product liability cases in California involving claims of birth defects.{{ FIELD }}Defends a global pharmaceutical company in product liability cases involving the administration of a corticosteroid.{{ FIELD }}Served on the national trial and leadership teams representing a major innovator pharmaceutical company in the defense of claims that an antipsychotic medication causes weight gain, diabetes, and pancreatitis.{{ FIELD }}Defended the manufacturer of a dental anesthetic in product liability cases filed throughout the U.S.{{ FIELD }}Acted as California counsel representing a major innovator pharmaceutical company in the defense of multiple personal injury cases which involved claims that pain pumps cause degeneration of shoulder joint cartilage.{{ FIELD }}Served as California trial counsel for a global brand name pharmaceutical company in an action brought by independent pharmacies alleging a nationwide price-fixing conspiracy among the manufacturers of brand name prescription drugs.{{ FIELD }}Represented The Dow Chemical Company as the alleged successor to the manufacturer of the Salk polio vaccine. In numerous product liability actions filed by individual plaintiffs in San Francisco, Los Angeles and Orange counties, Peter led a team that successfully formulated an end-game strategy resulting in the statewide dismissals of all plaintiffs’ claims at the pleading stage.{{ FIELD }}Represented SmartHealth Inc., in the defense of the latex glove product liability cases.{{ FIELD }}Healthcare\nAchieved a defense verdict on behalf of a hospital and healthcare system in a qui tam trial involving allegations of healthcare fraud related to licensing and patient steering brought by a Relator and the California Department of Insurance.{{ FIELD }}Represents a South American Public Health Agency in a breach of contract action arising out of its attempted purchase of ventilators to address the Covid-19 health crisis.{{ FIELD }}Toxic Tort – Benzene\nRepresented a number of Fortune and Global 1000 companies, including AkzoNobel, D Aircraft Products, Cytec Industries, Inc., Indopco, Inc., and Chevron U.S.A. Inc., in personal injury cases venued in Northern and Southern California, involving claims of exposure to benzene.{{ FIELD }}Toxic Tort – Silica\nLed a team that represented Chevron U.S.A. Inc., Union Oil Company of California and Hewlett-Packard Company in the defense of silica-related product and premises personal injury claims filed in California state court.{{ FIELD }}Toxic Tort – Asbestos\nDefends Chevron U.S.A. Inc. and Texaco Inc. in cases involving claims of exposure to asbestos at the Abadan Refinery in Iran in the 1950s, 1960s and 1970s. Won summary judgments in four cases and won appellate arguments in the cases where those summary judgment wins have been appealed.{{ FIELD }}Handled, through trial verdict, asbestos product and premises liability dockets throughout the State of California on behalf of numerous companies, including Chevron U.S.A. Inc., Texaco Inc., Unocal Corporation, Hewlett-Packard Company, UOP LLC, The Glidden Company, American Cyanamid Company, Fiberite Inc, Flintkote, Western MacArthur, Baxter Healthcare, The Dow Chemical Company and Rhone-Poulenc, for a period of over 25 years. He obtained a defense verdict for Fiberite after a seven-week jury trial in Los Angeles County Superior Court where plaintiff claimed he developed mesothelioma as a result of exposure to a Fiberite molding compound.{{ FIELD }}Toxic Tort – Agricultural Chemicals\nActed as national counsel for the manufacturer of synthetic pyrethrin pesticides in product liability actions filed throughout the United States.{{ FIELD }}Served as co-counsel on a trial team that obtained a defense verdict in an alleged Paraquat® exposure trial in a California state action.{{ FIELD }}Served on a team that successfully defended Rhone-Poulenc (nka Rhodia) in the personal injury claims of over 400 individuals arising out of a chemical fire at a sulfuric acid regeneration facility in Martinez, California. Lead Paint.{{ FIELD }}Lead Paint\nRepresented American Cyanamid Company in an action being prosecuted by cities and counties throughout the State of California against the manufacturers of paint pigments alleging that presence of lead in paint in commercial and residential buildings constituted a public nuisance.{{ FIELD }}MtBE\nRepresented Chevron U.S.A. Inc. and Union Oil Company of California in Methyl Tertiary Butyl Ether (MtBE) cases involving claims of personal injury and groundwater contamination.{{ FIELD }}Obtained a defense verdict in favor of a specialty ink manufacturer in a commercial sales action.{{ FIELD }}Defended successfully the manufacturer of food flavoring products in a commercial action filed in federal district court.{{ FIELD }}Commercial Design Claims.\nDefending a process design engineering company in professional negligence claims and recently won a nonsuit after a five-week jury trial in Los Angeles County Superior Court.{{ FIELD }}Peter A. Strotz has been litigating tort, product liability, and commercial matters for over 30 years and has first-chaired dozens of trials in courts throughout California and the U.S.  His cases involve novel medical, scientific and legal issues for global manufacturing companies, including pharmaceutical, healthcare, oil, gas, engineered and specialty materials, paints, and coatings companies.  Peter has acted as national, regional and local trial counsel in a variety of commercial, antitrust, and toxic tort matters.  He is the founding and managing partner of the firm’s Los Angeles, California office.\nPeter is a senior member of the firm’s Product Liability Practice, which was selected by Law360 as the Product Liability Group of the Year for seven of the last eight years. In what was recognized as a Top Verdict of 2019 by The Daily Journal, Peter achieved a complete defense verdict on behalf of Prime Healthcare against the California Department of Insurance (CDI) and a Relator in a major Insurance Frauds Prevention Act trial in Los Angeles County Superior Court that established a precedent for healthcare providers facing these types of allegations. Partner Outstanding Individual in Product Liability Who's Who Legal 2019 Best Lawyers in America 2013 – 2017 San Francisco’s Best Lawyers 2013 Recommended Lawyer for Product Liability and Mass Tort Defense: Toxic Tort (Tier 1)  U.S. Legal 500 , 2013. 2015 and 2016 Highest AV Rating  Martindale-Hubbell Super Lawyer  San Francisco Magazine, 2004–2006, 2011–2013 University of California, Berkeley University of California, Berkeley, School of Law University of San Francisco University of San Francisco School of Law U.S. District Court for the Eastern District of California U.S. District Court for the Northern District of California U.S. District Court for the Southern District of California California State Bar of California Bar Association of San Francisco USF Inns of Court Swiss American Chamber of Commerce International Association of Defense Counsel American Bar Association (Environmental, Product Liability and Mass Tort sections) Alameda County Bar Association Bar Association of San Francisco Defense Research Institute (Drug and Medical Device, Product Liability and Toxic Tort committees) Association of Defense Counsel Pharmaceutical\nServes as national coordinating counsel for a major innovator pharmaceutical company in the defense of hundreds of claims that treatment with a widely prescribed branded statin causes diabetes, cardiovascular problems, and liver and kidney problems. Acted as California counsel for a major pharmaceutical company in the defense of product liability litigation involving a branded proton pump inhibitor. Represents GlaxoSmithKline in product liability cases in California involving claims of birth defects. Defends a global pharmaceutical company in product liability cases involving the administration of a corticosteroid. Served on the national trial and leadership teams representing a major innovator pharmaceutical company in the defense of claims that an antipsychotic medication causes weight gain, diabetes, and pancreatitis. Defended the manufacturer of a dental anesthetic in product liability cases filed throughout the U.S. Acted as California counsel representing a major innovator pharmaceutical company in the defense of multiple personal injury cases which involved claims that pain pumps cause degeneration of shoulder joint cartilage. Served as California trial counsel for a global brand name pharmaceutical company in an action brought by independent pharmacies alleging a nationwide price-fixing conspiracy among the manufacturers of brand name prescription drugs. Represented The Dow Chemical Company as the alleged successor to the manufacturer of the Salk polio vaccine. In numerous product liability actions filed by individual plaintiffs in San Francisco, Los Angeles and Orange counties, Peter led a team that successfully formulated an end-game strategy resulting in the statewide dismissals of all plaintiffs’ claims at the pleading stage. Represented SmartHealth Inc., in the defense of the latex glove product liability cases. Healthcare\nAchieved a defense verdict on behalf of a hospital and healthcare system in a qui tam trial involving allegations of healthcare fraud related to licensing and patient steering brought by a Relator and the California Department of Insurance. Represents a South American Public Health Agency in a breach of contract action arising out of its attempted purchase of ventilators to address the Covid-19 health crisis. Toxic Tort – Benzene\nRepresented a number of Fortune and Global 1000 companies, including AkzoNobel, D Aircraft Products, Cytec Industries, Inc., Indopco, Inc., and Chevron U.S.A. Inc., in personal injury cases venued in Northern and Southern California, involving claims of exposure to benzene. Toxic Tort – Silica\nLed a team that represented Chevron U.S.A. Inc., Union Oil Company of California and Hewlett-Packard Company in the defense of silica-related product and premises personal injury claims filed in California state court. Toxic Tort – Asbestos\nDefends Chevron U.S.A. Inc. and Texaco Inc. in cases involving claims of exposure to asbestos at the Abadan Refinery in Iran in the 1950s, 1960s and 1970s. Won summary judgments in four cases and won appellate arguments in the cases where those summary judgment wins have been appealed. Handled, through trial verdict, asbestos product and premises liability dockets throughout the State of California on behalf of numerous companies, including Chevron U.S.A. Inc., Texaco Inc., Unocal Corporation, Hewlett-Packard Company, UOP LLC, The Glidden Company, American Cyanamid Company, Fiberite Inc, Flintkote, Western MacArthur, Baxter Healthcare, The Dow Chemical Company and Rhone-Poulenc, for a period of over 25 years. He obtained a defense verdict for Fiberite after a seven-week jury trial in Los Angeles County Superior Court where plaintiff claimed he developed mesothelioma as a result of exposure to a Fiberite molding compound. Toxic Tort – Agricultural Chemicals\nActed as national counsel for the manufacturer of synthetic pyrethrin pesticides in product liability actions filed throughout the United States. Served as co-counsel on a trial team that obtained a defense verdict in an alleged Paraquat® exposure trial in a California state action. Served on a team that successfully defended Rhone-Poulenc (nka Rhodia) in the personal injury claims of over 400 individuals arising out of a chemical fire at a sulfuric acid regeneration facility in Martinez, California. Lead Paint. Lead Paint\nRepresented American Cyanamid Company in an action being prosecuted by cities and counties throughout the State of California against the manufacturers of paint pigments alleging that presence of lead in paint in commercial and residential buildings constituted a public nuisance. MtBE\nRepresented Chevron U.S.A. Inc. and Union Oil Company of California in Methyl Tertiary Butyl Ether (MtBE) cases involving claims of personal injury and groundwater contamination. Obtained a defense verdict in favor of a specialty ink manufacturer in a commercial sales action. Defended successfully the manufacturer of food flavoring products in a commercial action filed in federal district court. Commercial Design Claims.\nDefending a process design engineering company in professional negligence claims and recently won a nonsuit after a five-week jury trial in Los Angeles County Superior Court.","searchable_name":"Peter A. Strotz","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":196,"capability_group_featured":null,"home_page_featured":null},{"id":427580,"version":1,"owner_type":"Person","owner_id":835,"payload":{"bio":"\u003cp\u003ePhyllis B. Sumner is a Partner in King \u0026amp; Spalding's Atlanta office and the firm's Chief Privacy Officer. She leads the firm's Data, Privacy and Security Practice and regularly counsels corporate boards, senior executives and other clients on cybersecurity preparedness, emergency response, remediation, compliance, internal and regulatory enforcement investigations, and data breach and privacy litigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eShe is a crisis manager and trial lawyer, who works with her clients' legal, compliance and business teams to strategize, manage and defend when significant privacy and security issues arise. She has assisted clients with their response to and management of hundreds of data security incidents and has represented clients defending against class actions and regulator investigations in some of the largest and most high-profile data security incidents.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eA nationwide top ranked Privacy \u0026amp; Data Security lawyer by \u003cem\u003eChambers USA\u003c/em\u003e, Phyllis\u0026rsquo; clients note \u0026ldquo;Her knowledge and expertise when it comes to ransomware incident response is second to none.\u0026rdquo; Phyllis is a recognized leader in the industry and consistently named to \u003cem\u003eCybersecurity Docket\u0026rsquo;s\u003c/em\u003e annual list of \u0026ldquo;best and brightest Incident Response attorneys,\u0026rdquo; including the 2023 and 2024 Global Incident Response Top 50. Three-time \u003cem\u003eLaw360\u003c/em\u003e MVP, she also has earned recognition as a \u003cem\u003eDaily Report\u0026rsquo;s\u003c/em\u003e \u0026ldquo;Distinguished Leader,\u0026rdquo; \u003cem\u003eAtlanta Magazine\u0026rsquo;s\u003c/em\u003e \"Women Making a Mark,\" and as one of \u003cem\u003eGlobal Data Review\u0026rsquo;s\u003c/em\u003e \u0026ldquo;Women in Data,\u0026rdquo; and she is listed in the \u003cem\u003eBest Lawyers of America\u003c/em\u003e for her high caliber work in privacy and data security law.\u003c/p\u003e\n\u003cp\u003eShe served as an Assistant U.S. Attorney for eight years, first for the Northern District of Illinois and then for the Northern District of Georgia, prosecuting high-profile cases such as Eric Rudolph, the Centennial Olympic Park bomber.\u003c/p\u003e","slug":"phyllis-sumner","email":"psumner@kslaw.com","phone":null,"matters":["\u003cp\u003eDefending\u0026nbsp;\u003cstrong\u003eCapital One\u0026nbsp;\u003c/strong\u003ein 2019 data breach.\u003c/p\u003e","\u003cp\u003eLed defense of\u0026nbsp;\u003cstrong\u003eEquifax Inc.\u0026nbsp;\u003c/strong\u003ein 2017 data breach.\u003c/p\u003e","\u003cp\u003eLed defense of\u003cstrong\u003e\u0026nbsp;The Home Depot\u003c/strong\u003e\u0026nbsp;in 2014 data breach consumer class action MDL.\u003c/p\u003e","\u003cp\u003eLed defense of\u003cstrong\u003e\u0026nbsp;Sears/Kmart\u003c/strong\u003e\u0026nbsp;in the 2014 data breach financial institution consolidated class actions.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":209}]},"expertise":[{"id":6,"guid":"6.capabilities","index":0,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":1,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":2,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":3,"source":"capabilities"},{"id":80,"guid":"80.capabilities","index":4,"source":"capabilities"},{"id":104,"guid":"104.capabilities","index":5,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":6,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":7,"source":"capabilities"},{"id":20,"guid":"20.capabilities","index":8,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":9,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":10,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":11,"source":"smartTags"},{"id":106,"guid":"106.capabilities","index":12,"source":"capabilities"},{"id":109,"guid":"109.capabilities","index":13,"source":"capabilities"},{"id":750,"guid":"750.smart_tags","index":14,"source":"smartTags"},{"id":1097,"guid":"1097.smart_tags","index":15,"source":"smartTags"},{"id":110,"guid":"110.capabilities","index":16,"source":"capabilities"},{"id":111,"guid":"111.capabilities","index":17,"source":"capabilities"},{"id":114,"guid":"114.capabilities","index":18,"source":"capabilities"},{"id":120,"guid":"120.capabilities","index":19,"source":"capabilities"},{"id":126,"guid":"126.capabilities","index":20,"source":"capabilities"},{"id":128,"guid":"128.capabilities","index":21,"source":"capabilities"},{"id":133,"guid":"133.capabilities","index":22,"source":"capabilities"},{"id":1248,"guid":"1248.smart_tags","index":23,"source":"smartTags"}],"is_active":true,"last_name":"Sumner","nick_name":"Phyllis","clerkships":[],"first_name":"Phyllis","title_rank":9999,"updated_by":35,"law_schools":[],"middle_name":"B.","name_suffix":"","recognitions":[{"title":"Top Ranked Lawyer, Privacy \u0026 Data Security","detail":"Chambers USA, Nationwide (2022)"},{"title":"\"Her knowledge and expertise when it comes to ransomware incident response is second to none.\"","detail":"Chambers USA (2022)"},{"title":"Incident Response Top 30","detail":"Cybersecurity Docket (2016, 2018-2022)"},{"title":"She \"leads a top-notch team with deep experience in the full spectrum of data privacy.. in investigations and lawsuits.\"","detail":"Legal 500 (2022)"},{"title":"Recommended, Cyber Law","detail":"Legal 500 (2022-2022)"},{"title":"Recommended, General Commercial Disputes","detail":"Legal 500 (2020)"},{"title":"Named, Women in Data","detail":"Global Data Review (2019)"},{"title":"Named, Distinguished Leader","detail":"Daily Report (2017)"},{"title":"MVP, Cybersecurity \u0026 Privacy ","detail":"Law360 (2017)"},{"title":"MVP, Privacy","detail":"Law360 (2016)"},{"title":"Named, Women Making a Mark ","detail":"Atlanta Magazine (2016)"},{"title":"Super Lawyer","detail":"Super Lawyers, Georgia (2013-2016)"},{"title":"MVP, Healthcare","detail":"Law360 (2014)"},{"title":"Director’s Award, Superior Performance in Trial of former Atlanta Mayor Bill Campbell ","detail":"Executive Office for the United States Attorneys (2008)"},{"title":"John Marshall Award, Prosecution of Olympic Park bomber Eric Rudolph","detail":"Attorney General (2006)"},{"title":"Director’s Award, Prosecution of Olympic Park bomber Eric Rudolph","detail":"Bureau of Alcohol, Tobacco, Firearms and Explosives (2006)"},{"title":"Award, Prosecution of Olympic Park bomber Eric Rudolph","detail":"Federal Bureau of Investigation (2006)"},{"title":"Honorary Special Agent Award, Trial and Conviction of former Atlanta Mayor Bill Campbell ","detail":"Internal Revenue Service (2006)"},{"title":"Director’s Award of Recognition, Trial and Conviction of a former Atlanta City Commissioner","detail":"Federal Bureau of Investigation (2003)"},{"title":"Honorary Special Agent Award, Trial and Conviction in a Multimillion Dollar Fraud Case","detail":"Internal Revenue Service (2003)"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003ePhyllis B. Sumner is a Partner in King \u0026amp; Spalding's Atlanta office and the firm's Chief Privacy Officer. She leads the firm's Data, Privacy and Security Practice and regularly counsels corporate boards, senior executives and other clients on cybersecurity preparedness, emergency response, remediation, compliance, internal and regulatory enforcement investigations, and data breach and privacy litigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eShe is a crisis manager and trial lawyer, who works with her clients' legal, compliance and business teams to strategize, manage and defend when significant privacy and security issues arise. She has assisted clients with their response to and management of hundreds of data security incidents and has represented clients defending against class actions and regulator investigations in some of the largest and most high-profile data security incidents.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eA nationwide top ranked Privacy \u0026amp; Data Security lawyer by \u003cem\u003eChambers USA\u003c/em\u003e, Phyllis\u0026rsquo; clients note \u0026ldquo;Her knowledge and expertise when it comes to ransomware incident response is second to none.\u0026rdquo; Phyllis is a recognized leader in the industry and consistently named to \u003cem\u003eCybersecurity Docket\u0026rsquo;s\u003c/em\u003e annual list of \u0026ldquo;best and brightest Incident Response attorneys,\u0026rdquo; including the 2023 and 2024 Global Incident Response Top 50. Three-time \u003cem\u003eLaw360\u003c/em\u003e MVP, she also has earned recognition as a \u003cem\u003eDaily Report\u0026rsquo;s\u003c/em\u003e \u0026ldquo;Distinguished Leader,\u0026rdquo; \u003cem\u003eAtlanta Magazine\u0026rsquo;s\u003c/em\u003e \"Women Making a Mark,\" and as one of \u003cem\u003eGlobal Data Review\u0026rsquo;s\u003c/em\u003e \u0026ldquo;Women in Data,\u0026rdquo; and she is listed in the \u003cem\u003eBest Lawyers of America\u003c/em\u003e for her high caliber work in privacy and data security law.\u003c/p\u003e\n\u003cp\u003eShe served as an Assistant U.S. Attorney for eight years, first for the Northern District of Illinois and then for the Northern District of Georgia, prosecuting high-profile cases such as Eric Rudolph, the Centennial Olympic Park bomber.\u003c/p\u003e","matters":["\u003cp\u003eDefending\u0026nbsp;\u003cstrong\u003eCapital One\u0026nbsp;\u003c/strong\u003ein 2019 data breach.\u003c/p\u003e","\u003cp\u003eLed defense of\u0026nbsp;\u003cstrong\u003eEquifax Inc.\u0026nbsp;\u003c/strong\u003ein 2017 data breach.\u003c/p\u003e","\u003cp\u003eLed defense of\u003cstrong\u003e\u0026nbsp;The Home Depot\u003c/strong\u003e\u0026nbsp;in 2014 data breach consumer class action MDL.\u003c/p\u003e","\u003cp\u003eLed defense of\u003cstrong\u003e\u0026nbsp;Sears/Kmart\u003c/strong\u003e\u0026nbsp;in the 2014 data breach financial institution consolidated class actions.\u003c/p\u003e"],"recognitions":[{"title":"Top Ranked Lawyer, Privacy \u0026 Data Security","detail":"Chambers USA, Nationwide (2022)"},{"title":"\"Her knowledge and expertise when it comes to ransomware incident response is second to none.\"","detail":"Chambers USA (2022)"},{"title":"Incident Response Top 30","detail":"Cybersecurity Docket (2016, 2018-2022)"},{"title":"She \"leads a top-notch team with deep experience in the full spectrum of data privacy.. in investigations and lawsuits.\"","detail":"Legal 500 (2022)"},{"title":"Recommended, Cyber Law","detail":"Legal 500 (2022-2022)"},{"title":"Recommended, General Commercial Disputes","detail":"Legal 500 (2020)"},{"title":"Named, Women in Data","detail":"Global Data Review (2019)"},{"title":"Named, Distinguished Leader","detail":"Daily Report (2017)"},{"title":"MVP, Cybersecurity \u0026 Privacy ","detail":"Law360 (2017)"},{"title":"MVP, Privacy","detail":"Law360 (2016)"},{"title":"Named, Women Making a Mark ","detail":"Atlanta Magazine (2016)"},{"title":"Super Lawyer","detail":"Super Lawyers, Georgia (2013-2016)"},{"title":"MVP, Healthcare","detail":"Law360 (2014)"},{"title":"Director’s Award, Superior Performance in Trial of former Atlanta Mayor Bill Campbell ","detail":"Executive Office for the United States Attorneys (2008)"},{"title":"John Marshall Award, Prosecution of Olympic Park bomber Eric Rudolph","detail":"Attorney General (2006)"},{"title":"Director’s Award, Prosecution of Olympic Park bomber Eric Rudolph","detail":"Bureau of Alcohol, Tobacco, Firearms and Explosives (2006)"},{"title":"Award, Prosecution of Olympic Park bomber Eric Rudolph","detail":"Federal Bureau of Investigation (2006)"},{"title":"Honorary Special Agent Award, Trial and Conviction of former Atlanta Mayor Bill Campbell ","detail":"Internal Revenue Service (2006)"},{"title":"Director’s Award of Recognition, Trial and Conviction of a former Atlanta City Commissioner","detail":"Federal Bureau of Investigation (2003)"},{"title":"Honorary Special Agent Award, Trial and Conviction in a Multimillion Dollar Fraud Case","detail":"Internal Revenue Service (2003)"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11805}]},"capability_group_id":2},"created_at":"2025-05-26T05:02:25.000Z","updated_at":"2025-05-26T05:02:25.000Z","searchable_text":"Sumner{{ FIELD }}{:title=\u0026gt;\"Top Ranked Lawyer, Privacy \u0026amp; Data Security\", :detail=\u0026gt;\"Chambers USA, Nationwide (2022)\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Her knowledge and expertise when it comes to ransomware incident response is second to none.\\\"\", :detail=\u0026gt;\"Chambers USA (2022)\"}{{ FIELD }}{:title=\u0026gt;\"Incident Response Top 30\", :detail=\u0026gt;\"Cybersecurity Docket (2016, 2018-2022)\"}{{ FIELD }}{:title=\u0026gt;\"She \\\"leads a top-notch team with deep experience in the full spectrum of data privacy.. in investigations and lawsuits.\\\"\", :detail=\u0026gt;\"Legal 500 (2022)\"}{{ FIELD }}{:title=\u0026gt;\"Recommended, Cyber Law\", :detail=\u0026gt;\"Legal 500 (2022-2022)\"}{{ FIELD }}{:title=\u0026gt;\"Recommended, General Commercial Disputes\", :detail=\u0026gt;\"Legal 500 (2020)\"}{{ FIELD }}{:title=\u0026gt;\"Named, Women in Data\", :detail=\u0026gt;\"Global Data Review (2019)\"}{{ FIELD }}{:title=\u0026gt;\"Named, Distinguished Leader\", :detail=\u0026gt;\"Daily Report (2017)\"}{{ FIELD }}{:title=\u0026gt;\"MVP, Cybersecurity \u0026amp; Privacy \", :detail=\u0026gt;\"Law360 (2017)\"}{{ FIELD }}{:title=\u0026gt;\"MVP, Privacy\", :detail=\u0026gt;\"Law360 (2016)\"}{{ FIELD }}{:title=\u0026gt;\"Named, Women Making a Mark \", :detail=\u0026gt;\"Atlanta Magazine (2016)\"}{{ FIELD }}{:title=\u0026gt;\"Super Lawyer\", :detail=\u0026gt;\"Super Lawyers, Georgia (2013-2016)\"}{{ FIELD }}{:title=\u0026gt;\"MVP, Healthcare\", :detail=\u0026gt;\"Law360 (2014)\"}{{ FIELD }}{:title=\u0026gt;\"Director’s Award, Superior Performance in Trial of former Atlanta Mayor Bill Campbell \", :detail=\u0026gt;\"Executive Office for the United States Attorneys (2008)\"}{{ FIELD }}{:title=\u0026gt;\"John Marshall Award, Prosecution of Olympic Park bomber Eric Rudolph\", :detail=\u0026gt;\"Attorney General (2006)\"}{{ FIELD }}{:title=\u0026gt;\"Director’s Award, Prosecution of Olympic Park bomber Eric Rudolph\", :detail=\u0026gt;\"Bureau of Alcohol, Tobacco, Firearms and Explosives (2006)\"}{{ FIELD }}{:title=\u0026gt;\"Award, Prosecution of Olympic Park bomber Eric Rudolph\", :detail=\u0026gt;\"Federal Bureau of Investigation (2006)\"}{{ FIELD }}{:title=\u0026gt;\"Honorary Special Agent Award, Trial and Conviction of former Atlanta Mayor Bill Campbell \", :detail=\u0026gt;\"Internal Revenue Service (2006)\"}{{ FIELD }}{:title=\u0026gt;\"Director’s Award of Recognition, Trial and Conviction of a former Atlanta City Commissioner\", :detail=\u0026gt;\"Federal Bureau of Investigation (2003)\"}{{ FIELD }}{:title=\u0026gt;\"Honorary Special Agent Award, Trial and Conviction in a Multimillion Dollar Fraud Case\", :detail=\u0026gt;\"Internal Revenue Service (2003)\"}{{ FIELD }}Defending Capital One in 2019 data breach.{{ FIELD }}Led defense of Equifax Inc. in 2017 data breach.{{ FIELD }}Led defense of The Home Depot in 2014 data breach consumer class action MDL.{{ FIELD }}Led defense of Sears/Kmart in the 2014 data breach financial institution consolidated class actions.{{ FIELD }}Phyllis B. Sumner is a Partner in King \u0026amp; Spalding's Atlanta office and the firm's Chief Privacy Officer. She leads the firm's Data, Privacy and Security Practice and regularly counsels corporate boards, senior executives and other clients on cybersecurity preparedness, emergency response, remediation, compliance, internal and regulatory enforcement investigations, and data breach and privacy litigation.\nShe is a crisis manager and trial lawyer, who works with her clients' legal, compliance and business teams to strategize, manage and defend when significant privacy and security issues arise. She has assisted clients with their response to and management of hundreds of data security incidents and has represented clients defending against class actions and regulator investigations in some of the largest and most high-profile data security incidents. \nA nationwide top ranked Privacy \u0026amp; Data Security lawyer by Chambers USA, Phyllis’ clients note “Her knowledge and expertise when it comes to ransomware incident response is second to none.” Phyllis is a recognized leader in the industry and consistently named to Cybersecurity Docket’s annual list of “best and brightest Incident Response attorneys,” including the 2023 and 2024 Global Incident Response Top 50. Three-time Law360 MVP, she also has earned recognition as a Daily Report’s “Distinguished Leader,” Atlanta Magazine’s \"Women Making a Mark,\" and as one of Global Data Review’s “Women in Data,” and she is listed in the Best Lawyers of America for her high caliber work in privacy and data security law.\nShe served as an Assistant U.S. Attorney for eight years, first for the Northern District of Illinois and then for the Northern District of Georgia, prosecuting high-profile cases such as Eric Rudolph, the Centennial Olympic Park bomber. Phyllis B Sumner Partner Top Ranked Lawyer, Privacy \u0026amp; Data Security Chambers USA, Nationwide (2022) \"Her knowledge and expertise when it comes to ransomware incident response is second to none.\" Chambers USA (2022) Incident Response Top 30 Cybersecurity Docket (2016, 2018-2022) She \"leads a top-notch team with deep experience in the full spectrum of data privacy.. in investigations and lawsuits.\" Legal 500 (2022) Recommended, Cyber Law Legal 500 (2022-2022) Recommended, General Commercial Disputes Legal 500 (2020) Named, Women in Data Global Data Review (2019) Named, Distinguished Leader Daily Report (2017) MVP, Cybersecurity \u0026amp; Privacy  Law360 (2017) MVP, Privacy Law360 (2016) Named, Women Making a Mark  Atlanta Magazine (2016) Super Lawyer Super Lawyers, Georgia (2013-2016) MVP, Healthcare Law360 (2014) Director’s Award, Superior Performance in Trial of former Atlanta Mayor Bill Campbell  Executive Office for the United States Attorneys (2008) John Marshall Award, Prosecution of Olympic Park bomber Eric Rudolph Attorney General (2006) Director’s Award, Prosecution of Olympic Park bomber Eric Rudolph Bureau of Alcohol, Tobacco, Firearms and Explosives (2006) Award, Prosecution of Olympic Park bomber Eric Rudolph Federal Bureau of Investigation (2006) Honorary Special Agent Award, Trial and Conviction of former Atlanta Mayor Bill Campbell  Internal Revenue Service (2006) Director’s Award of Recognition, Trial and Conviction of a former Atlanta City Commissioner Federal Bureau of Investigation (2003) Honorary Special Agent Award, Trial and Conviction in a Multimillion Dollar Fraud Case Internal Revenue Service (2003) University of Georgia University of Georgia School of Law Vanderbilt University Vanderbilt University School of Law U.S. Court of Appeals for the Ninth Circuit U.S. Court of Appeals for the Eleventh Circuit U.S. District Court for the Northern District of Illinois U.S. District Court for the Middle District of Georgia U.S. District Court for the Northern District of Georgia Georgia Illinois Supreme Court of Georgia Defending Capital One in 2019 data breach. Led defense of Equifax Inc. in 2017 data breach. Led defense of The Home Depot in 2014 data breach consumer class action MDL. Led defense of Sears/Kmart in the 2014 data breach financial institution consolidated class actions.","searchable_name":"Phyllis B. Sumner","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":444232,"version":1,"owner_type":"Person","owner_id":5416,"payload":{"bio":"\u003cp\u003eJonathan Shin is a counsel in the Los Angeles\u0026nbsp;office of King \u0026amp; Spalding and a member of the firm's Healthcare practice. He represents\u0026nbsp;hospitals, behavioral health facilities, laboratories, medical device manufacturers and other healthcare providers in managed care and general commercial litigation\u0026nbsp;in arbitrations and state and federal civil actions throughout the country.\u0026nbsp; Jonathan also has experience defending companies\u0026nbsp;against government investigations and\u0026nbsp;accusations of fraud and abuse.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJonathan has counseled and represented companies in matters involving managed care, contracting, insurance, fraud and abuse, e-discovery, commercial real estate, trade secrets and intellectual property.\u0026nbsp; Jonathan has significant case management, deposition, motion and trial experience, and has been a member of numerous trial and arbitration teams in matters that resulted in favorable outcomes for his clients.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eJonathan received his Bachelor of Science in Biology from Stony Brook University\u0026nbsp;and his Juris Doctor\u0026nbsp;from UCLA School of Law, where he was Order of the Coif, a participant in the Moot Court Honors Program,\u0026nbsp;and managing editor of the\u0026nbsp;\u003cem\u003ePacific Basin Law Journal\u003c/em\u003e.\u0026nbsp; \u0026nbsp;\u0026nbsp;\u003c/p\u003e","slug":"jonathan-shin","email":"jshin@kslaw.com","phone":null,"matters":[""],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":24,"guid":"24.capabilities","index":0,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":1,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":2,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":3,"source":"capabilities"},{"id":740,"guid":"740.smart_tags","index":4,"source":"smartTags"}],"is_active":true,"last_name":"Shin","nick_name":"Jonathan","clerkships":[],"first_name":"Jonathan","title_rank":9999,"updated_by":34,"law_schools":[{"id":2162,"meta":{"degree":"J.D.","honors":"Order of the Coif","is_law_school":1,"graduation_date":"2012-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"H.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":14,"translated_fields":{"en":{"bio":"\u003cp\u003eJonathan Shin is a counsel in the Los Angeles\u0026nbsp;office of King \u0026amp; Spalding and a member of the firm's Healthcare practice. He represents\u0026nbsp;hospitals, behavioral health facilities, laboratories, medical device manufacturers and other healthcare providers in managed care and general commercial litigation\u0026nbsp;in arbitrations and state and federal civil actions throughout the country.\u0026nbsp; Jonathan also has experience defending companies\u0026nbsp;against government investigations and\u0026nbsp;accusations of fraud and abuse.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJonathan has counseled and represented companies in matters involving managed care, contracting, insurance, fraud and abuse, e-discovery, commercial real estate, trade secrets and intellectual property.\u0026nbsp; Jonathan has significant case management, deposition, motion and trial experience, and has been a member of numerous trial and arbitration teams in matters that resulted in favorable outcomes for his clients.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eJonathan received his Bachelor of Science in Biology from Stony Brook University\u0026nbsp;and his Juris Doctor\u0026nbsp;from UCLA School of Law, where he was Order of the Coif, a participant in the Moot Court Honors Program,\u0026nbsp;and managing editor of the\u0026nbsp;\u003cem\u003ePacific Basin Law Journal\u003c/em\u003e.\u0026nbsp; \u0026nbsp;\u0026nbsp;\u003c/p\u003e","matters":[""]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":6577}]},"capability_group_id":2},"created_at":"2025-12-12T21:56:32.000Z","updated_at":"2025-12-12T21:56:32.000Z","searchable_text":"Shin{{ FIELD }}{{ FIELD }}Jonathan Shin is a counsel in the Los Angeles office of King \u0026amp; Spalding and a member of the firm's Healthcare practice. He represents hospitals, behavioral health facilities, laboratories, medical device manufacturers and other healthcare providers in managed care and general commercial litigation in arbitrations and state and federal civil actions throughout the country.  Jonathan also has experience defending companies against government investigations and accusations of fraud and abuse. \nJonathan has counseled and represented companies in matters involving managed care, contracting, insurance, fraud and abuse, e-discovery, commercial real estate, trade secrets and intellectual property.  Jonathan has significant case management, deposition, motion and trial experience, and has been a member of numerous trial and arbitration teams in matters that resulted in favorable outcomes for his clients.  \nJonathan received his Bachelor of Science in Biology from Stony Brook University and his Juris Doctor from UCLA School of Law, where he was Order of the Coif, a participant in the Moot Court Honors Program, and managing editor of the Pacific Basin Law Journal.     Counsel Stony Brook University  University of California-Los Angeles UCLA School of Law U.S. Court of Appeals for the Third Circuit California ","searchable_name":"Jonathan H. Shin","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":34,"capability_group_featured":null,"home_page_featured":null},{"id":427356,"version":1,"owner_type":"Person","owner_id":6778,"payload":{"bio":"\u003cp\u003ePriya Sinha is an associate in King \u0026amp; Spalding's\u0026nbsp;Healthcare practice in the Atlanta office. Priya represents clients in the healthcare and life sciences industries in complex litigation, government investigations, and transactions. In addition, Priya advises clients on a wide range of regulatory and compliance matters.\u003c/p\u003e","slug":"priya-sinha","email":"psinha@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":24,"guid":"24.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"}],"is_active":true,"last_name":"Sinha","nick_name":"Priya","clerkships":[],"first_name":"Priya","title_rank":9999,"updated_by":35,"law_schools":[{"id":755,"meta":{"degree":"J.D.","honors":null,"is_law_school":1,"graduation_date":"2023-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":2,"translated_fields":{"en":{"bio":"\u003cp\u003ePriya Sinha is an associate in King \u0026amp; Spalding's\u0026nbsp;Healthcare practice in the Atlanta office. Priya represents clients in the healthcare and life sciences industries in complex litigation, government investigations, and transactions. In addition, Priya advises clients on a wide range of regulatory and compliance matters.\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12134}]},"capability_group_id":2},"created_at":"2025-05-26T04:59:53.000Z","updated_at":"2025-05-26T04:59:53.000Z","searchable_text":"Sinha{{ FIELD }}Priya Sinha is an associate in King \u0026amp; Spalding's Healthcare practice in the Atlanta office. Priya represents clients in the healthcare and life sciences industries in complex litigation, government investigations, and transactions. In addition, Priya advises clients on a wide range of regulatory and compliance matters. Associate Amherst College  Georgetown University Georgetown University Law Center Georgia","searchable_name":"Priya Sinha","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":444041,"version":1,"owner_type":"Person","owner_id":7251,"payload":{"bio":"\u003cp\u003eRobert Stenzel is an associate in the Washington, D.C. office of King \u0026amp; Spalding and a member of the firm\u0026rsquo;s Healthcare practice in Government Matters and Regulations.\u0026nbsp; Robert represents hospitals and other healthcare providers in administrative and court litigation\u0026nbsp;involving government payors such as Medicare and Medicaid and non-government payors.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eRobert's practice focuses primarily on Medicare reimbursement litigation before the Provider Reimbursement Review Board, administrative law judges, and federal courts. Robert also counsels\u0026nbsp;providers on other reimbursement matters and conflicts involving private payors.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eRobert graduated\u0026nbsp;from the University of Maryland Francis King Carey School of Law where he served as an editor and author for the\u0026nbsp;\u003cem\u003eMaryland Journal of Healthcare Law and Policy\u003c/em\u003e. \u0026nbsp;Robert also holds a Master\u0026rsquo;s degree in Bioethics from the Johns Hopkins University Bloomberg School of Public Health.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e","slug":"robert-stenzel","email":"rstenzel@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":81,"guid":"81.capabilities","index":0,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":1,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":2,"source":"capabilities"}],"is_active":true,"last_name":"Stenzel","nick_name":"Robert","clerkships":[],"first_name":"Robert","title_rank":9999,"updated_by":202,"law_schools":[{"id":2224,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2022-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":2,"translated_fields":{"en":{"bio":"\u003cp\u003eRobert Stenzel is an associate in the Washington, D.C. office of King \u0026amp; Spalding and a member of the firm\u0026rsquo;s Healthcare practice in Government Matters and Regulations.\u0026nbsp; Robert represents hospitals and other healthcare providers in administrative and court litigation\u0026nbsp;involving government payors such as Medicare and Medicaid and non-government payors.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eRobert's practice focuses primarily on Medicare reimbursement litigation before the Provider Reimbursement Review Board, administrative law judges, and federal courts. Robert also counsels\u0026nbsp;providers on other reimbursement matters and conflicts involving private payors.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eRobert graduated\u0026nbsp;from the University of Maryland Francis King Carey School of Law where he served as an editor and author for the\u0026nbsp;\u003cem\u003eMaryland Journal of Healthcare Law and Policy\u003c/em\u003e. \u0026nbsp;Robert also holds a Master\u0026rsquo;s degree in Bioethics from the Johns Hopkins University Bloomberg School of Public Health.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":13245}]},"capability_group_id":2},"created_at":"2025-12-08T19:52:00.000Z","updated_at":"2025-12-08T19:52:00.000Z","searchable_text":"Stenzel{{ FIELD }}Robert Stenzel is an associate in the Washington, D.C. office of King \u0026amp; Spalding and a member of the firm’s Healthcare practice in Government Matters and Regulations.  Robert represents hospitals and other healthcare providers in administrative and court litigation involving government payors such as Medicare and Medicaid and non-government payors. \nRobert's practice focuses primarily on Medicare reimbursement litigation before the Provider Reimbursement Review Board, administrative law judges, and federal courts. Robert also counsels providers on other reimbursement matters and conflicts involving private payors. \nRobert graduated from the University of Maryland Francis King Carey School of Law where he served as an editor and author for the Maryland Journal of Healthcare Law and Policy.  Robert also holds a Master’s degree in Bioethics from the Johns Hopkins University Bloomberg School of Public Health. \n  Associate University of Maryland-Baltimore County  University of Maryland-Baltimore University of Maryland School of Law Johns Hopkins Bloomberg School of Public Health Johns Hopkins Bloomberg School of Public Health District of Columbia Maryland","searchable_name":"Robert Stenzel","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null}]}}